Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
H2AFY	macroH2A1.2	ENSG00000113648	"H2A histone family member Y"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		4700000	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	34.9	26.0	24.8	32.2	27.2	75.1	21.7	37.6	27.6	22.5	40.0	19.7	14.0	40.2	22.0	21.8	60.7	22.4	38.8	41.9	21.4	28.8	23.8	24.1	36.7	39.4	24.1	26.5	21.8	16.6	24.2	25.8	30.0	21.0	20.2	43.2	24.4	28.3	14.0	34.9	33.4	52.0	21.9	21.8	33.8	28.5	21.4	16.9	76.9	22.2	40.7	47.2	28.7	29.6	16.0	51.8	23.8	45.6	21.5	15.9	30.1	45.6	32.2	49.7	34.0	23.3	13.9	44.7	19.2	20.7	34.2	24.2	50.6	45.9	54.2	32.8	15.5	29.0	31.2	37.2	81.4	25.7	29.3	37.1	64.7	38.0	34.0	17.1	30.7	28.5	14.7	22.1	28.5	30.7	21.0	21.9	37.1	22.4	22.3	19.4	39.9	88.2	58.5	19.4	54.7	17.2	79.8	28.3	38.3	42.4	52.2	70.0	44.1	37.4	36.4	30.8	27.2	43.2	85.1	17.6	30.0	25.3	22.0	39.1	10.7	43.5	50.8	25.0	69.3	21.1	4.1	45.6	20.5	10.8	30.1	9.1	11.7	14.0	13.4	51.8	16.0	13.6	11.2	23.8	21.5	19.0	37.3	15.9	30.1	24.8	27.2	37.6	27.6	21.4	28.8	24.1	26.5	21.0	16.9	89.3	73.9	95.3	103.9	115.3	133.0	49.8	99.3	112.4	113.7	75.0	90.3	125.6	61.3	217.9	39.7	83.0	188.9	46.7	110.7	116.9	69.9	135.3	50.8	51.0	384.3	322.6	171.4	63.8	399.4	18.3	56.7	337.9	86.0	166.9	190.1	115.6	179.5	156.5	77.4	76.7	166.8	71.1	91.4	52.4	75.0	139.4	153.4	97.8	202.7	196.4
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321211-22331484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 132.9;Late spermatids: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 89.1;U-937: 104.6"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	19.7	23.5	28.0	17.0	35.0	13.3	26.5	26.1	33.7	21.6	22.3	26.3	11.6	14.1	23.9	22.8	16.0	17.0	17.4	15.1	28.3	24.2	19.2	25.5	16.7	17.9	42.3	27.7	18.8	18.6	40.0	37.6	20.6	24.8	25.5	16.0	16.5	15.7	20.3	28.5	10.3	14.6	26.3	34.8	24.6	16.5	24.3	40.7	12.9	17.6	10.6	18.8	21.5	25.9	5.0	1.8	13.0	3.4	6.2	8.4	2.4	13.0	6.3	7.3	2.2	12.8	10.3	7.3	8.8	4.0	6.7	8.0	6.6	16.3	6.7	6.0	8.0	7.5	4.6	10.5	6.2	8.4	89.1	13.1	18.4	5.4	7.4	7.6	6.8	10.2	6.6	10.9	7.4	8.2	8.5	4.7	10.8	18.2	11.3	8.9	5.2	18.2	2.0	1.7	6.1	15.1	13.6	10.4	6.4	6.4	4.2	6.1	12.1	5.8	7.6	9.8	3.3	6.9	27.3	10.1	7.5	22.7	18.1	11.8	14.0	18.2	14.7	10.7	104.6	4.9	13.0	1.5	2.5	6.1	3.4	8.4	5.0	6.4	5.8	1.0	2.6	5.5	5.2	0.6	6.2	2.1	1.8	4.3	2.4	28.0	35.0	26.1	33.7	28.3	24.2	42.3	27.7	24.8	40.7	23.8	20.0	13.4	18.4	14.2	21.3	16.1	10.2	16.0	25.0	12.2	7.9	10.9	11.6	14.2	132.9	25.3	4.2	0.0	15.8	17.8	14.4	26.4	11.5	25.2	8.6	28.6	12.7	28.3	19.0	118.0	33.4	13.9	35.4	17.2	12.0	12.6	17.8	5.8	34.3	7.6	13.9	19.4	37.7	10.4	24.3	12.8	5.6	18.3	9.5	17.6
CTCF		ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562407-67639185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	19.1	17.5	22.3	35.0	24.3	32.2	20.2	31.6	26.6	23.0	19.4	20.5	21.0	16.5	24.2	15.4	23.1	21.7	20.3	17.6	21.8	16.7	19.5	19.5	17.2	27.9	22.3	21.0	24.6	21.2	42.4	21.8	23.5	17.9	19.4	23.2	14.3	19.9	24.9	29.4	25.2	21.4	22.0	20.2	26.1	18.5	14.8	22.9	68.8	20.7	16.2	35.5	22.6	26.7	10.1	7.9	9.6	6.2	4.9	7.2	1.9	11.0	17.1	22.8	9.0	10.4	8.9	18.5	10.6	11.3	15.7	15.0	14.0	11.5	34.7	8.6	9.2	8.9	14.4	21.9	11.9	17.7	12.3	14.4	21.1	9.7	16.0	7.1	23.8	20.2	7.2	14.5	11.7	13.1	9.4	11.9	27.9	18.4	14.5	13.0	21.7	50.0	9.1	19.8	12.7	11.5	36.6	18.7	19.1	9.6	16.1	19.5	13.5	19.2	11.2	9.3	12.5	13.8	14.8	11.3	13.6	14.1	10.3	11.6	12.7	15.9	50.6	7.8	14.3	14.5	9.4	3.4	4.9	6.7	3.4	6.3	7.9	7.2	5.4	3.1	10.1	5.9	6.7	9.6	4.9	6.2	7.9	5.4	1.9	22.3	24.3	31.6	26.6	21.8	16.7	22.3	21.0	17.9	22.9	20.8	28.0	26.8	21.6	19.8	33.6	32.3	38.2	17.4	38.7	22.7	7.9	20.9	16.6	25.5	0.9	30.1	18.7	46.7	29.1	27.5	18.8	26.1	18.5	21.3	20.8	42.9	30.0	20.3	23.2	2.0	23.0	23.7	11.8	24.4	25.6	30.4	26.6	14.0	26.9	19.5	27.1	19.4	21.7	15.8	25.6	21.7	24.7	32.3	21.2	29.4
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133345-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease mutation, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	12.1	7.6	9.8	20.2	10.8	31.9	11.5	27.1	14.4	12.0	8.6	10.0	4.3	8.1	12.1	8.0	12.0	11.5	7.8	8.0	9.3	8.1	6.9	9.2	11.8	29.7	12.5	7.9	11.1	6.2	10.2	8.8	32.5	8.7	8.3	10.7	7.8	9.3	6.5	6.8	10.8	11.3	11.2	9.1	11.0	9.0	19.9	12.6	31.4	9.5	8.8	28.8	11.4	9.7	12.6	19.0	10.2	13.4	25.0	18.2	6.8	24.3	15.4	19.7	16.7	7.3	7.5	42.3	16.5	13.1	23.8	23.9	14.9	13.3	40.8	10.4	10.1	12.0	16.1	21.7	12.9	24.4	16.0	32.3	59.1	13.8	7.7	3.2	24.0	24.0	5.0	2.5	20.8	8.2	7.2	12.9	12.6	23.4	25.2	17.7	16.2	35.1	32.8	25.9	11.0	22.5	35.6	20.7	22.4	7.5	15.4	21.0	16.3	20.0	9.0	6.4	12.6	9.4	12.2	9.7	40.0	13.7	24.2	24.4	20.6	21.5	48.3	11.6	22.4	31.0	10.2	13.4	3.3	18.2	13.2	15.9	7.9	14.6	12.5	11.3	12.6	16.6	12.3	3.1	25.0	7.9	19.0	12.9	6.8	9.8	10.8	27.1	14.4	9.3	8.1	12.5	7.9	8.7	12.6	6.0	24.5	38.8	19.1	26.3	66.8	11.9	7.6	48.2	29.6	21.0	53.0	329.4	11.6	20.3	42.9	33.0	4.7	93.5	12.4	56.3	25.7	12.5	34.8	12.1	68.9	62.0	15.1	24.5	28.2	38.6	25.9	51.5	13.5	45.1	16.3	39.9	15.7	11.5	26.9	7.6	50.4	12.9	22.0	249.6	179.2	19.6	270.7	54.2	37.6	14.1
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.1	3.5	14.9	3.6	1.6	1.2	19.5	1.0	0.9	2.0	1.6	8.8	5.7	0.0	2.2	1.9	1.6	1.0	1.6	2.2	1.2	3.7	2.6	6.4	5.3	10.5	3.9	1.3	4.1	3.6	1.1	2.6	0.9	3.9	8.3	14.5	7.3	1.4	1.5	8.5	13.9	15.1	25.7	5.9	1.9	25.4	16.4	2.1	1.2	1.5	8.8	31.3	1.2	8.4	2.6	13.4	1.0	6.7	2.8	2.5	3.3	0.6	1.3	3.2	2.2	8.6	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2	6.0	13.3	10.0	8.3	4.6	74.9	13.7	5.1	9.4	12.5	19.2	119.8	30.2	5.0	13.8	1.5	14.6	5.3	0.0	8.5	9.4	14.7	11.7	36.9	5.5	19.8	90.6	12.6	6.2	10.5	1.1	17.8	11.9	6.8	4.6	11.5	22.7	9.2	10.5	14.5	5.6	144.9	19.4	8.2	2.3	13.4	2.3	26.9	18.7	11.0	6.7
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell type enhanced"	"Detected in some"	7	"Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2"					"Low region specificity"	"Detected in some"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.0	1.4	0.1	0.5	55.3	0.7	0.5	0.8	0.8	20.8	0.9	2.1	2.2	0.3	0.9	0.5	3.9	0.3	0.6	0.2	3.1	21.7	0.7	3.9	0.2	0.9	2.2	0.5	0.4	1.2	0.2	0.4	1.4	1.3	20.8	0.6	0.3	3.3	3.3	18.4	74.7	1.9	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.2	1.3	1.9	0.5	41.2	1.2	1.1	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.5	5.9	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8	0.0	1.0	0.0	0.1	0.8	1.4	1.1	0.0	0.0	1.2	0.0	2.0	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.5	3.8	0.9	0.6	0.0	0.0	0.6	4.8	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.8	1.1	0.0	0.4	0.6	2.1	6.5	0.4	0.0	2.5	1.1	4.0	0.0	0.8	0.0
H3F3A	"H3.3A, H3F3"	ENSG00000163041	"H3 histone family member 3A"	P84243	1	226061851-226072001	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 258.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 258.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	39.0	43.4	37.2	83.4	33.4	126.8	67.9	45.0	42.8	44.6	54.0	31.6	62.9	47.9	43.4	60.6	66.3	42.4	49.6	59.4	36.1	31.2	45.9	59.2	73.2	217.9	37.8	23.2	44.4	79.7	30.8	34.8	59.1	29.2	38.4	59.4	42.7	49.0	49.7	37.0	47.1	50.0	42.0	48.6	71.9	41.4	87.6	31.7	148.9	38.5	71.0	84.1	43.5	47.6	39.2	44.6	258.7	56.9	23.6	34.9	60.5	53.9	30.8	120.2	67.8	33.4	38.9	90.3	25.6	31.1	41.6	32.9	32.1	90.0	51.9	56.9	31.4	20.7	51.8	59.4	46.6	40.9	32.1	102.6	64.2	45.6	42.9	33.1	65.9	78.0	35.6	54.0	29.1	38.3	56.4	61.5	67.9	90.4	88.9	47.3	31.2	136.8	122.6	163.0	137.1	61.1	92.6	87.8	133.8	86.0	57.7	117.4	174.5	73.0	92.4	63.2	71.8	104.7	154.7	34.6	30.3	42.3	40.9	74.1	39.6	50.7	90.7	28.9	63.0	64.7	40.0	56.9	80.8	23.1	44.9	23.6	39.2	25.0	24.9	44.6	36.0	23.7	25.7	258.7	23.6	50.8	36.6	34.9	60.5	37.2	33.4	45.0	42.8	36.1	31.2	37.8	23.2	29.2	31.7	485.3	628.9	1112.7	1421.3	1190.0	539.7	34.4	1036.9	1187.2	831.4	919.5	155.1	1193.7	1374.4	1195.9	1414.0	1038.4	1355.7	2359.5	1184.4	1689.1	947.0	1270.6	649.3	699.9	1338.0	554.6	1437.2	842.8	2198.6	1327.8	1016.5	1622.8	1010.6	1191.2	1707.9	908.2	1197.9	2104.2	985.0	1310.8	429.3	976.6	889.6	588.0	858.5	1210.5	1352.2	961.6	1983.9	1893.1
H3F3B	H3.3B	ENSG00000132475	"H3 histone family member 3B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 570.8;bone marrow: 441.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 570.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 570.8"	"Low cell line specificity"	"Detected in all"											"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	57.2	41.2	38.1	58.9	48.6	441.9	71.4	60.2	47.0	86.6	44.6	65.9	42.7	37.9	60.5	77.7	93.2	70.2	75.8	35.1	38.5	33.9	42.8	48.1	64.2	62.3	50.4	41.2	141.0	90.9	33.0	41.5	58.5	42.7	60.5	26.6	65.8	58.4	55.4	71.1	114.0	58.0	63.7	51.8	65.9	45.1	66.9	46.2	78.6	58.9	69.1	55.7	78.5	71.9	78.9	88.1	570.8	98.4	80.0	77.2	203.5	117.9	104.8	43.8	43.2	25.0	39.2	60.6	55.9	49.5	68.7	55.2	112.2	84.0	59.1	53.4	32.5	48.6	46.5	34.6	77.3	39.1	32.2	78.0	52.7	55.9	94.9	56.5	87.5	67.9	42.8	47.9	70.4	90.8	30.6	51.6	38.6	74.6	106.3	35.3	173.6	125.6	73.5	35.1	38.2	117.1	93.6	80.2	64.4	54.2	70.1	88.9	98.7	56.7	83.2	120.0	24.4	65.2	94.6	48.1	123.3	109.1	53.2	148.0	128.6	76.0	71.0	65.2	83.5	67.2	182.8	98.4	259.3	74.4	86.9	70.2	78.9	71.8	70.5	86.7	65.3	77.2	64.5	570.8	80.0	78.9	88.1	76.0	203.5	38.1	48.6	60.2	47.0	38.5	33.9	50.4	41.2	42.7	46.2	851.6	868.5	887.7	3350.2	2457.1	1722.8	361.5	690.4	1184.5	958.9	922.9	382.9	1428.6	1080.9	1926.0	2467.5	1156.8	1059.1	327.1	1563.3	1285.8	1898.2	1719.4	1592.3	352.8	1655.2	575.2	1610.5	672.8	901.1	452.7	934.0	1810.8	1808.5	1233.6	1221.5	2460.8	1745.6	1627.3	545.9	699.9	1161.2	983.1	2751.1	2035.3	943.0	3026.0	2929.8	1269.9	852.2	2611.9
HIST1H3A	"H3/A, H3FA"	ENSG00000275714	"Histone cluster 1 H3 family member a"	P68431	6	26020490-26020900	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1;testis: 78.7"	"Cell type enhanced"	"Detected in some"	5	"Club cells: 2.3;Spermatogonia: 1.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 5.6;U-2 OS: 9.0"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (3.07e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.36e-5)"	"unprognostic (2.85e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.21e-2)"	1.6	2.1	0.8	6.3	0.5	23.5	1.2	8.0	7.2	2.1	1.2	0.0	1.2	0.9	1.9	4.8	3.0	1.5	2.1	2.5	0.9		1.8	1.1	2.1	2.6	0.0	2.5	1.6	2.9	0.9	1.1	1.2	2.4	1.4	1.8	1.6	1.2	1.0	0.9	1.3	1.5	2.3	0.8	2.6	1.3	78.7	0.0	40.1	1.6	4.1	8.4	0.9	0.0	3.9	5.2	14.6	1.6	8.8	3.9	1.5	1.5	0.0	1.7	0.0	1.5	0.7	0.0	2.4	0.0	2.0	4.3	0.0	0.8	1.5	0.9	0.0	0.6	0.0	2.6	0.6	4.0	0.8	3.1	2.5	0.8	0.0	0.0	0.3	2.2	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.2	0.2	0.0	5.6	4.0	1.8	2.2	1.1	2.5	2.7	1.2	0.0	0.5	1.3	1.2	2.5	1.9	3.2	0.5	0.0	0.2	2.0	0.0	0.0	9.0	0.8	1.0	0.5	0.4	0.0	1.1	3.1	2.9	11.1	1.5	4.3	3.9	1.6	3.3	2.1	2.8	2.3	3.0	3.9	2.2	1.7	14.6	8.8	0.9	5.2	3.8	1.5											0.0	1.4	0.8	0.4	0.3	0.6	0.3	0.0	1.4	2.3	0.0	0.0	0.2	0.0	0.0	0.6	0.4	1.8	0.0	0.0	0.2	0.6	0.2	1.1	0.5	0.6	0.0	0.0	0.6	1.5	0.0	0.0	0.6	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.3	1.4	1.9	0.1	0.0	1.9	0.2	0.1
HIST1H3B	"H3/l, H3FL"	ENSG00000274267	"Histone cluster 1 H3 family member b"	P68431	6	26031650-26032060	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 343.5"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 12.0"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (2.82e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-7)"	"unprognostic (8.52e-2)"	"unprognostic (2.78e-1)"		"unprognostic (1.90e-3)"	1.7	0.7	0.0	36.1	0.0	18.1	3.6	0.0	0.3	0.8	6.9	0.0	0.0	0.3	0.8	2.5	11.8	0.5	1.9	2.4	0.0		0.6	0.3	3.4	10.4	0.0	0.0	0.3	0.3	0.3	0.0	7.8	0.0	0.3	0.8	0.0	1.0	0.3	0.3	0.3	6.3	0.8	0.0	14.7	0.5	26.9	0.0	343.5	0.8	18.2	27.7	0.3	0.0	0.8	0.1	1.2	0.0	0.0	1.4	3.1	1.8	4.6	1.3	4.0	0.0	0.4	0.0	0.2	0.8	0.8	0.7	1.1	1.0	3.0	2.0	0.3	1.2	0.7	1.6	1.2	1.7	2.0	4.4	3.2	6.0	1.3	0.0	2.4	2.1	2.9	0.0	0.6	0.0	0.1	1.0	0.9	6.5	5.9	1.1	1.0	7.4	7.4	3.1	0.7	3.2	4.3	2.9	8.5	0.5	0.0	2.1	1.7	5.1	1.6	0.5	0.1	2.8	1.5	1.4	1.4	4.1	0.7	1.7	9.6	12.0	3.9	3.4	4.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.1	0.5	0.0	0.2	1.2	0.0	0.0	0.0	1.4	3.1											0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.1	0.2	0.0	0.6	0.1
HIST1H3C	"H3.1, H3/c, H3FC"	ENSG00000278272	"Histone cluster 1 H3 family member c"	P68431	6	26045411-26045821	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 306.0"	"Cell type enhanced"	"Detected in some"	14	"Distal tubular cells: 1.7;Enterocytes: 2.1;Extravillous trophoblasts: 1.6;Spermatogonia: 3.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 11.1"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.27e-2)"	1.7	0.2	0.0	23.3	0.0	12.8	1.8	0.0	0.7	1.0	5.1	0.0	0.0	1.2	0.5	1.5	10.1	0.4	1.6	1.8	0.0		2.8	0.6	3.0	10.9	0.0	0.0	0.2	0.4	0.2	0.0	6.6	0.0	0.6	1.1	0.0	1.0	0.2	0.2	0.7	5.4	0.2	0.0	18.8	1.0	29.9	0.0	306.0	0.2	9.9	25.2	2.3	0.0	2.2	1.0	0.3	0.2	3.3	3.7	1.9	2.6	0.6	1.3	0.0	0.6	0.0	0.0	2.1	0.9	5.1	5.2	0.0	0.4	0.0	0.1	0.5	2.4	1.3	0.0	0.5	3.6	3.7	0.4	4.2	0.5	3.7	0.4	2.7	1.7	0.0	0.4	1.4	0.0	0.7	1.6	0.4	0.0	0.0	0.0	0.0	4.0	5.2	2.3	2.6	5.1	4.7	0.0	0.0	0.6	5.6	0.1	1.7	5.1	3.2	0.5	0.2	1.4	1.6	0.0	0.0	0.0	2.1	3.5	2.4	0.1	0.0	1.5	11.1	3.5	0.0	0.2	0.0	1.5	0.1	0.0	1.5	0.6	1.1	1.0	2.2	0.6	2.2	0.3	3.3	0.0	0.9	3.7	1.9											0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.2	0.0	2.1	0.0	0.0	1.6	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.8	0.0	0.5	0.0	1.0	0.1
HIST1H3D	"H3/b, H3FB"	ENSG00000197409	"Histone cluster 1 H3 family member d"	P68431	6	26196840-26197250	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 185.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.1;U-266/70: 11.4;U-266/84: 6.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	1.2	2.7	0.6	18.3	0.6	24.3	1.5	2.0	1.3	4.4	4.1	0.0	3.0	2.9	1.0	3.0	8.0	1.2	2.3	1.3	1.2	0.9	2.3	3.1	2.5	8.0	0.8	0.7	4.3	1.0	1.0	1.6	2.6	0.3	6.4	1.2	0.7	3.3	4.3	1.0	1.6	3.8	1.4	2.4	9.2	2.2	12.4	0.0	185.6	1.4	5.9	19.9	3.2	6.8	8.9	3.4	15.3	1.8	1.6	6.6	0.5	0.9	0.2	0.0	2.1	0.0	0.5	0.9	0.0	0.5	0.3	2.6	3.5	0.2	2.2	2.1	0.3	0.0	0.6	0.2	0.5	0.0	3.0	0.8	0.0	1.7	0.0	0.1	0.7	1.1	0.4	0.4	0.0	0.0	0.0	0.3	0.4	0.3	8.1	0.0	1.7	2.2	4.1	0.4	0.0	1.1	2.6	0.0	1.2	0.0	0.3	0.1	0.0	0.0	2.1	1.0	0.2	0.4	2.9	0.0	0.0	4.0	0.0	1.6	11.4	6.2	0.7	2.0	1.7	0.9	8.9	1.4	3.3	2.5	0.8	6.6	5.5	1.6	2.0	3.0	8.9	1.5	2.6	15.3	1.6	1.8	3.4	1.9	0.5	0.6	0.6	2.0	0.6	1.2	0.9	0.8	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
HIST1H3E	"H3.1, H3/d, H3FD"	ENSG00000274750	"Histone cluster 1 H3 family member e"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 19.9;tongue: 25.6"	"Cell type enhanced"	"Detected in some"	6	"Hepatocytes: 3.4;Mucus-secreting cells: 2.9;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.9;hTERT-RPE1: 8.5;SCLC-21H: 13.4;T-47d: 8.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	4.8	0.0	2.8	1.2	0.2	2.6	2.4	1.2	2.6	3.6	1.9	5.2	6.1	2.5	6.9	14.5	1.6	3.0	7.4	0.0		0.7	0.9	2.1	4.1	4.1	0.0	2.5	0.6	2.5	0.5	2.9	1.8	4.6	2.4	0.5	4.4	1.8	6.1	1.3	6.1	2.5	1.8	2.3	3.5	19.9	3.2	22.4	3.6	25.6	8.8	2.7	0.3	2.6	3.9	6.5	1.8	0.5	3.1	1.4	2.0	2.2	3.2	1.4	3.8	1.8	0.2	1.5	1.6	0.8	0.6	0.7	1.2	0.0	11.9	0.6	1.1	2.5	0.0	0.4	0.7	3.1	2.8	0.4	1.0	0.7	1.2	0.2	1.9	2.6	2.7	0.3	0.8	8.5	1.2	0.2	0.3	2.4	2.2	1.9	0.4	0.1	0.2	1.5	2.1	1.5	0.6	0.3	6.4	1.2	13.4	1.5	2.1	3.3	3.6	0.5	8.2	1.3	0.6	1.5	0.5	0.4	0.3	0.9	0.3	0.2	0.7	0.1	0.8	0.4	1.8	0.0	1.3	1.5	1.7	1.4	1.8	1.7	1.2	2.6	1.7	1.8	6.5	0.5	1.3	3.9	3.1	1.4											0.0	2.2	0.0	0.5	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	2.0	0.0	0.2	0.2	0.0	0.6	0.0	3.4	0.8	1.6	0.0	1.3	1.2	0.7	0.6	0.0	0.0	1.0	2.9	0.3	0.1	3.5	0.0	1.0	0.0	0.0	0.1	0.1	0.5	0.0	1.1	0.0	0.6	0.1
HIST1H3F	"H3/i, H3FI"	ENSG00000277775	"Histone cluster 1 H3 family member f"	P68431	6	26250195-26250605	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 198.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.5;U-266/84: 9.5"									"HPA042570, CAB070190"	Approved					NA	NA					"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	1.1	0.9	0.0	26.8	0.0	8.0	3.9	0.0	0.2	0.5	4.5	0.0	0.2	1.5	0.7	2.4	8.6	0.4	2.2	4.2	0.0		0.3	0.2	2.5	17.0	0.0	0.0	0.2	0.2	0.2	0.0	3.8	0.0	0.4	0.4	0.0	0.8	0.2	0.7	0.7	4.6	0.5	0.0	10.8	1.1	2.8	0.0	198.6	0.4	11.5	25.3	0.9	0.0	4.5	1.3	0.0	0.6	0.0	0.9	0.4	1.4	0.0	2.2	0.0	0.0	0.0	1.6	1.3	0.0	2.5	0.7	0.0	0.0	0.2	1.1	0.0	0.6	0.9	0.0	1.1	0.0	1.5	0.5	1.7	4.6	0.0	0.0	0.0	2.7	0.0	0.0	0.8	0.0	0.0	1.3	1.8	2.5	1.9	0.0	1.9	3.5	8.5	0.0	0.0	2.5	3.8	0.0	1.3	0.0	0.3	4.4	1.0	1.6	0.8	0.0	0.3	3.2	2.8	0.0	0.4	0.0	0.2	2.0	2.2	9.5	0.0	2.5	3.1	1.1	0.0	0.5	0.0	0.5	0.0	0.1	4.5	0.1	0.0	1.3	1.3	0.3	0.0	0.0	0.0	0.6	0.0	0.9	0.4											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0
HIST1H3G	"H3/h, H3FH"	ENSG00000273983	"Histone cluster 1 H3 family member g"	P68431	6	26269405-26271815	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"lymphoid tissue: 247.1"	"Cell type enhanced"	"Detected in some"	23	"Spermatogonia: 11.1;Undifferentiated cells: 2.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SiHa: 10.3;U-266/70: 9.7"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (1.88e-1)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.23e-2)"	0.7	0.4	0.0	14.6	0.0	1.9	1.7	0.0	0.0	0.5	5.2	0.0	0.0	2.1	0.1	2.2	9.1	1.5	0.8	1.1	0.0		0.2	0.0	1.0	7.3	0.0	0.0	0.1	0.0	0.3	0.0	4.8	0.0	0.1	1.6	0.0	0.4	0.4	0.0	0.3	4.7	0.4	0.0	13.6	1.0	5.0	0.0	247.1	1.0	8.0	15.9	0.7	0.0	1.6	0.4	0.6	0.4	0.2	1.5	0.7	1.1	0.2	1.1	0.0	0.1	0.2	0.5	0.5	0.2	1.2	0.5	4.0	0.0	0.0	0.6	0.1	1.2	3.3	1.3	0.6	0.8	1.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.3	0.0	0.3	0.8	0.0	2.3	0.0	2.4	1.1	0.4	2.0	3.6	0.0	0.8	0.0	1.4	0.7	0.8	0.3	0.6	10.3	3.2	0.0	0.0	0.1	0.6	0.3	0.5	0.0	0.0	0.2	9.7	0.3	0.0	0.5	0.0	1.2	0.0	0.0	0.3	0.3	0.1	0.4	1.1	1.5	1.0	0.4	1.6	0.0	0.5	0.6	0.2	0.4	0.0	1.5	0.7											0.0	0.0	0.8	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	0.0	0.0	1.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.7	0.0	2.8	0.1
HIST1H3H	"H3/k, H3F1K, H3FK"	ENSG00000278828	"Histone cluster 1 H3 family member h"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 55.3;lymphoid tissue: 204.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 9.9;Intestinal endocrine cells: 5.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	6	"basophil: 15.9;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"K-562: 17.8;SiHa: 15.5;U-266/70: 13.2;U-266/84: 32.1"									HPA042570	Approved					NA	Yes					"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.2	2.6	0.0	25.2	0.0	7.5	1.7	0.2	0.3	1.7	4.7	0.0	2.5	2.3	1.6	2.5	9.0	0.6	3.0	1.3	0.0		0.4	3.1	4.4	8.1	0.0	0.0	2.2	1.5	1.4	0.0	3.4	0.1	2.7	5.3	0.5	0.9	2.8	0.8	0.3	3.9	1.0	0.2	11.0	3.1	3.4	0.0	204.8	1.3	10.6	22.6	1.7	0.9	1.1	1.8	15.9	1.1	0.3	2.0	55.3	1.0	3.9	1.7	1.4	2.4	0.3	0.2	0.6	0.4	1.9	0.7	1.2	1.1	0.7	3.7	0.4	1.1	2.1	0.6	0.9	1.2	4.9	2.4	0.9	3.5	5.0	0.6	0.8	1.5	3.2	0.3	0.4	0.4	0.8	0.8	0.9	17.8	8.6	0.3	7.8	1.6	1.9	0.8	7.2	1.5	0.8	0.0	8.9	2.0	0.4	5.2	1.0	15.5	3.2	0.6	0.9	7.5	0.2	0.8	0.8	2.5	0.5	0.2	13.2	32.1	2.7	0.0	4.2	0.2	15.9	1.1	2.1	0.3	0.3	0.4	0.3	0.6	0.5	0.8	1.1	0.4	0.3	10.3	0.3	0.3	1.8	2.0	55.3											0.0	1.0	2.7	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	9.9	0.0	0.2	2.9	0.8	4.6	0.0	1.5	1.8	0.0	5.8	0.0	1.8	0.0	0.6	0.0	1.7	1.0	2.9	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.1	4.3	4.3	1.7	1.4
HIST1H3I	"H3.f, H3/f, H3FF"	ENSG00000275379	"Histone cluster 1 H3 family member i"	P68431	6	27871905-27872315	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 236.8"	"Cell type enhanced"	"Detected in single"	15	"Alveolar cells type 2: 1.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"					"Cell type enhanced"	"Detected in many"		"NK-cell: 12.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 4.6;MOLT-4: 8.4;NB-4: 5.6;REH: 8.8"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	1.0	0.8	0.0	16.7	0.0	7.9	2.4	0.0	0.4	0.9	2.9	0.0	1.6	0.4	0.4	1.4	7.1	0.5	2.9	1.8	0.0		0.4	0.4	1.9	9.2	0.0	0.0	0.4	5.0	0.4	0.0	2.4	0.0	0.5	0.4	0.0	1.0	0.7	0.4	0.4	3.6	0.4	0.0	10.2	0.8	1.8	0.0	236.8	0.6	11.6	14.5	0.4	0.0	4.1	4.7	1.0	1.2	12.4	2.4	2.2	1.3	1.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	2.9	0.4	0.0	0.5	0.9	0.0	0.0	0.5	1.3	1.7	4.6	0.0	0.0	1.0	2.8	0.7	0.7	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.4	5.6	1.3	0.2	0.0	8.8	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.2	0.5	2.4	0.6	2.0	0.8	2.0	1.5	3.3	4.1	1.7	2.2	1.0	12.4	0.5	4.7	1.9	2.2											0.0	1.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1
HIST1H3J	"H3/j, H3FJ"	ENSG00000197153	"Histone cluster 1 H3 family member j"	P68431	6	27890382-27893106	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"lymphoid tissue: 290.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 4.8;U-266/84: 15.5"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.9	0.4	0.2	25.1	0.3	5.7	1.1	0.5	0.4	1.2	5.5	0.0	0.0	0.3	0.4	0.5	9.4	0.4	1.2	0.9	0.4	0.4	0.3	1.2	1.5	8.8	0.4	0.0	0.3	0.4	0.3	0.3	4.7	0.0	0.6	0.3	0.0	0.4	0.6	0.3	1.6	3.7	0.3	1.1	15.1	0.6	2.4	0.0	290.9	0.9	7.8	14.6	1.1	1.1	2.1	2.5	0.0	0.7	0.6	2.5	0.7	1.1	0.7	1.6	0.3	0.6	0.5	0.9	0.0	0.0	1.6	0.2	0.0	0.4	4.8	0.9	0.4	0.8	0.2	1.3	0.4	0.0	0.2	0.9	1.1	1.9	0.0	0.4	0.2	0.3	0.0	0.0	0.7	0.0	0.0	0.8	0.6	2.6	1.2	0.0	1.2	3.7	4.4	2.6	1.3	0.4	1.7	0.5	0.5	0.0	0.0	2.8	1.7	1.8	1.3	0.0	0.5	0.5	0.9	0.0	0.4	0.0	0.2	0.5	3.6	15.5	1.2	0.8	0.6	2.5	0.0	0.0	0.0	1.4	0.3	0.0	0.0	2.3	2.5	2.5	2.1	0.5	1.0	0.0	0.6	0.7	0.0	2.2	0.7	0.2	0.3	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
HIST1H4A	H4FA	ENSG00000278637	"Histone cluster 1 H4 family member a"	P62805	6	26021679-26021990	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 87.7"	"Cell type enhanced"	"Detected in some"	9	"Cone photoreceptor cells: 2.0;Enterocytes: 1.1;granulocytes: 1.1;Rod photoreceptor cells: 1.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	4	"neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.8;NB-4: 10.1;REH: 12.6"									"CAB021887, HPA042201"	Supported					NA	NA		30000000			"CAB021887: AB_2279758, HPA042201: AB_2677898"	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.5	0.5	0.0	5.2	0.0	7.1	2.1	16.7	3.2	0.6	1.5	0.0	0.0	5.2	1.5	1.8	3.7	0.3	1.2	3.2	0.0		0.5	0.1	2.0	3.5	0.0	1.8	1.4	0.8	0.1	0.0	0.8	0.2	0.4	1.0	1.6	0.8	1.0	0.8	0.9	1.1	3.6	0.1	2.5	0.7	2.6	0.0	87.7	2.5	3.6	9.6	2.0	0.0	0.8	0.9	14.0	1.0	1.2	1.4	0.2	3.8	1.8	3.5	0.0	0.8	0.0	0.0	0.3	1.3	1.6	2.3	0.0	5.7	2.6	0.9	0.0	0.1	5.0	2.6	0.0	0.5	0.4	1.8	2.6	1.5	0.0	0.0	0.6	6.1	0.0	0.0	0.5	0.0	0.0	1.6	3.6	1.3	4.1	0.0	1.5	13.8	10.1	2.3	1.0	0.0	12.6	2.2	2.2	0.0	0.4	4.3	1.9	1.6	6.2	0.1	0.0	3.3	2.8	0.0	3.1	7.9	3.0	3.0	1.5	2.4	0.0	1.4	4.2	5.9	0.0	1.0	3.4	1.3	0.8	0.2	0.4	1.1	0.3	0.9	0.8	0.4	0.3	14.0	1.2	0.2	0.4	1.4	0.2											0.0	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.3	0.2	0.3	1.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.2	0.0
HIST1H4B	"H4/I, H4FI"	ENSG00000278705	"Histone cluster 1 H4 family member b"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 102.5"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 2.2;Collecting duct cells: 1.8;Enterocytes: 3.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	6	"neutrophil: 25.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.8"	"Low cell line specificity"	"Detected in many"											HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	2.6	1.0	0.3	6.2	0.4	11.3	2.3	6.2	1.0	4.0	3.2	0.0	4.2	1.8	5.7	1.8	5.7	3.3	2.0	1.6	0.2		5.0	1.7	3.0	4.7	0.2	0.0	8.6	19.9	1.0	0.5	2.4	0.4	3.6	1.4	6.0	4.0	3.5	2.3	1.6	2.7	2.0	0.0	6.3	2.2	10.5	0.2	102.5	8.0	3.0	8.9	3.5	4.3	4.3	1.3	25.8	1.2	0.2	1.0	0.3	1.8	0.0	0.2	3.8	0.0	0.0	0.0	2.8	0.3	1.7	1.2	0.7	0.5	1.4	0.6	0.6	1.1	0.5	0.8	0.0	1.0	0.6	3.9	4.8	1.8	2.1	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	5.4	0.5	2.8	4.7	3.7	0.9	0.8	0.6	3.4	1.7	3.0	0.0	1.3	1.0	0.7	0.4	2.1	0.0	0.0	0.5	2.5	0.0	1.1	2.5	2.0	3.7	3.0	2.8	2.3	1.4	1.5	1.9	0.0	0.5	0.7	0.9	0.6	0.9	1.7	1.0	0.8	0.4	4.3	0.8	0.4	25.8	0.2	1.2	1.3	0.7	0.3											0.0	0.0	2.2	0.4	0.3	0.3	0.2	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.1	0.4	0.0	0.8	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.3	0.1	0.2	0.0	0.2	1.1	0.0	0.3	0.7	0.9	0.0	0.2	0.0	0.6	0.1
HIST1H4C	"dJ221C16.1, H4/g, H4FG"	ENSG00000197061	"Histone cluster 1 H4 family member c"	P62805	6	26103876-26104310	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 172.4;lymphoid tissue: 88.7"	"Group enriched"	"Detected in all"	5	"Erythroid cells: 5349.6;Spermatocytes: 1544.2;Spermatogonia: 2680.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 26.7;PC-3: 14.4"									HPA042201	Supported					NA	Yes		30000000			"HPA042201: AB_2677898"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-4)"	"unprognostic (6.95e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (5.74e-6)"	"unprognostic (2.42e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.79e-3)"	4.8	4.3	6.9	13.2	6.2	23.5	4.6	12.5	8.8	4.6	6.9	0.9	6.4	3.9	4.8	4.2	6.5	4.8	5.0	3.4	6.2	5.6	6.6	6.4	4.2	12.0	5.5	7.9	4.5	19.4	2.3	5.2	5.9	4.3	3.8	7.5	5.2	11.1	5.0	3.6	4.5	5.4	3.5	6.4	7.0	4.8	25.5	4.4	88.7	8.0	12.4	9.9	8.0	5.2	54.3	26.9	45.5	25.4	25.4	46.6	172.4	1.5	1.4	0.5	2.3	0.0	0.2	0.0	0.7	0.6	0.4	0.8	2.1	0.3	0.5	0.7	0.2	0.6	0.8	1.7	0.5	0.4	1.3	26.7	1.0	2.8	3.2	0.7	1.2	0.9	1.2	0.0	0.3	0.0	0.0	0.6	0.4	1.4	1.1	0.4	0.2	5.8	2.9	1.5	0.9	14.4	1.7	0.8	2.5	0.9	0.1	1.5	1.0	0.7	1.0	0.6	0.7	0.7	3.8	0.4	1.6	1.6	0.8	1.3	2.2	2.0	2.5	1.0	2.1	0.8	39.9	25.4	17.8	31.4	10.2	30.0	54.3	40.5	25.6	18.5	48.6	46.6	35.1	45.5	25.4	10.2	26.9	26.7	172.4	6.9	6.2	12.5	8.8	6.2	5.6	5.5	7.9	4.3	4.4	113.2	96.8	203.6	96.4	200.8	385.3	149.9	540.1	141.8	212.7	291.4	178.7	298.1	261.9	329.5	3.7	206.3	206.8	5349.6	321.8	569.2	94.6	66.7	135.8	494.9	220.3	125.5	94.0	248.6	132.2	25.7	128.3	121.7	37.1	83.0	263.6	673.8	310.1	136.8	154.5	261.4	631.5	226.4	105.6	1544.2	2680.9	182.2	184.2	191.9	173.9	53.7
HIST1H4D	"H4/b, H4FB"	ENSG00000277157	"Histone cluster 1 H4 family member d"	P62805	6	26188765-26189076	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 71.3"	"Cell type enhanced"	"Detected in some"	6	"Early spermatids: 1.1;Enterocytes: 1.2;Intestinal endocrine cells: 1.2;Muller glia cells: 1.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.9;RT4: 16.0"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	1.4	4.7	1.9	10.1	5.2	6.5	5.6	1.2	4.5	3.9	3.1	0.0	4.5	0.9	3.3	3.5	8.3	6.5	2.0	4.6	1.4		1.6	1.8	1.6	3.5	0.0	4.4	6.5	5.8	0.9	1.3	4.2	1.6	6.0	2.1	1.4	1.4	2.7	0.9	0.9	2.3	2.2	1.6	4.1	2.2	9.8	0.8	71.3	5.3	4.8	9.5	5.5	0.0	6.8	0.6	1.3	0.9	0.2	2.3	0.7	1.3	2.2	1.5	0.0	2.7	0.0	0.8	1.3	0.4	3.6	1.8	3.4	0.8	6.9	0.4	0.0	2.6	0.9	4.5	0.7	1.2	0.5	9.9	1.0	6.8	2.5	0.0	0.7	0.2	0.0	0.0	0.5	1.5	0.0	3.1	0.8	1.7	1.2	0.0	3.5	2.4	4.0	2.3	1.6	0.7	0.7	0.0	0.9	0.9	16.0	0.7	0.4	1.4	0.6	0.9	0.7	1.2	0.5	0.0	0.5	4.4	0.5	1.7	1.6	1.8	0.0	1.1	1.7	1.0	0.1	0.9	0.0	0.9	0.1	0.6	1.4	2.3	0.5	0.6	6.8	0.3	0.6	1.3	0.2	0.5	0.1	0.1	0.7											0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.1	0.6	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.3	0.4
HIST1H4E	"H4/j, H4FJ"	ENSG00000276966	"Histone cluster 1 H4 family member e"	P62805	6	26204552-26206038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.9"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 9.4;Mucus-secreting cells: 9.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.6;U-266/70: 14.9"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	2.2	4.8	2.4	5.4	6.8	13.0	4.6	15.1	17.3	7.3	4.7	5.2	5.1	7.4	4.9	6.6	5.2	6.5	5.0	5.1	2.0		3.0	1.9	2.6	5.1	1.3	5.7	11.2	1.6	2.5	2.6	4.7	2.4	10.5	5.0	6.7	7.5	4.6	1.8	2.2	4.6	6.5	2.0	4.9	4.8	7.7	1.8	71.9	6.5	2.7	7.7	7.8	0.0	10.4	5.1	4.8	8.0	3.7	5.9	2.1	1.3	1.0	1.7	4.0	0.7	0.0	0.9	1.5	0.4	0.7	0.5	0.6	1.5	0.5	2.1	0.4	1.0	2.5	0.9	0.1	1.0	1.1	1.0	0.4	1.6	0.8	0.0	0.6	1.6	0.4	0.1	0.6	0.5	0.4	0.5	1.4	2.9	3.4	0.2	0.5	7.6	3.6	1.7	0.7	1.4	3.4	1.9	3.4	0.7	0.5	4.9	1.2	1.1	1.7	0.5	0.6	1.6	0.7	0.7	2.0	2.8	0.6	1.2	14.9	5.8	2.1	0.4	1.4	1.4	3.2	3.7	2.9	3.8	3.1	5.3	3.9	5.5	3.6	5.1	10.4	5.9	4.5	4.8	3.7	8.0	4.7	3.3	2.1											0.0	1.1	6.0	2.2	0.3	9.4	1.0	2.5	0.0	0.0	0.0	0.0	2.3	0.0	1.7	0.0	1.3	7.9	0.0	0.0	1.2	0.5	7.7	4.7	0.8	3.7	1.6	3.5	2.5	1.9	0.0	0.9	2.0	0.0	1.0	9.5	7.0	0.2	2.9	0.4	1.0	1.5	0.0	0.0	1.7	2.7	0.5	2.9	6.4	5.3	1.3
HIST1H4F	"H4, H4/c, H4FC"	ENSG00000274618	"Histone cluster 1 H4 family member f"	P62805	6	26240426-26240737	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 118.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.8;MOLT-4: 11.3;REH: 5.1"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			1.2	0.5	0.0	8.8	0.0	7.1	0.5	0.0	1.7	0.9	1.3	0.0	1.8	0.5	1.2	2.2	5.9	0.5	1.4	1.8	0.0		1.2	0.5	2.1	4.5	0.0	0.0	0.6	0.5	0.5	0.0	4.1	0.0	0.6	1.0	0.1	0.5	0.5	0.5	0.5	1.3	0.5	0.0	9.3	0.8	18.9	0.0	118.4	3.1	3.7	19.1	2.4	0.0	7.9	7.9	14.8	3.6	2.2	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	11.3	1.4	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	4.3	3.9	2.8	3.2	6.2	4.9	5.1	4.6	7.9	4.3	2.7	14.8	2.2	2.4	7.9	1.3	2.0											0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.1	0.2	0.0	0.0	0.0
HIST1H4H	"H4/h, H4FH"	ENSG00000158406	"Histone cluster 1 H4 family member h"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 119.1"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 15.9;Glandular cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 6.0;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 37.3"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	6.2	3.6	4.4	10.6	4.4	5.2	23.0	6.4	4.6	7.0	6.6	1.2	5.6	6.5	4.5	6.8	13.9	4.0	5.5	8.3	5.2	5.2	5.2	3.3	5.5	4.1	7.1	2.8	9.4	2.8	1.2	4.0	9.0	2.5	16.7	4.0	3.8	3.9	4.5	30.9	3.7	9.9	7.6	10.9	10.9	3.8	11.0	1.9	119.1	9.5	10.3	23.1	7.3	7.3	1.6	1.1	17.5	1.0	0.2	0.8	4.4	2.4	2.5	0.6	0.3	6.0	0.3	1.5	3.9	0.4	1.1	0.3	2.4	0.7	1.1	6.5	1.0	0.7	1.8	0.3	0.5	0.3	3.6	1.1	2.3	4.6	2.4	2.6	0.9	2.1	6.0	0.4	1.2	0.9	0.5	2.0	0.7	7.3	7.3	2.1	3.1	9.5	6.1	1.2	2.7	3.4	6.5	1.4	4.2	0.8	2.5	4.3	0.8	7.9	4.4	2.9	0.6	6.4	3.2	0.6	1.4	12.3	1.2	4.3	9.2	37.3	2.2	0.7	8.6	2.0	1.9	0.6	6.0	0.5	1.0	0.3	0.7	0.4	0.6	0.5	1.6	0.4	0.6	17.5	0.2	0.3	1.1	0.8	4.4	4.4	4.4	6.4	4.6	5.2	5.2	7.1	2.8	2.5	1.9	3.0	9.6	15.9	3.8	1.6	0.2	0.0	0.0	4.0	1.2	3.5	0.0	1.8	3.3	1.4	0.4	0.4	8.9	0.0	0.6	1.3	2.6	15.4	3.5	0.4	1.5	0.0	3.5	1.3	8.2	0.4	1.1	3.1	1.7	2.8	8.7	1.0	1.6	2.9	1.1	5.1	0.2	0.0	2.1	1.8	2.5	1.3	8.7	7.5	5.0	2.4
HIST1H4I	"H4/m, H4FM"	ENSG00000276180	"Histone cluster 1 H4 family member i"	P62805	6	27138588-27139881	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 14.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 1.1;Cardiomyocytes: 1.8;Early spermatids: 2.7;Enterocytes: 1.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 29.8;SiHa: 17.9;U-2 OS: 30.7;U-266/84: 31.0"									HPA042201	Approved					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (2.49e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (6.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.02e-2)"	0.1	2.5		2.4		1.7	0.0		0.1	0.0	0.8			2.7	1.1	0.0	1.7	0.0	1.3	0.5			0.0	1.9	0.8	2.6			0.8	2.7	0.0		1.5		2.0	0.0		1.6	0.0	0.0	0.2	2.9	0.0		2.3	3.2	1.8			2.6		0.0	1.9		6.0	5.5	14.5	4.6	2.4	3.4	3.1	1.7	3.5	1.9	1.2	1.3	0.1	2.1	3.3	0.1	0.1	0.1	3.3	2.5	0.5	9.6	0.0	5.3	2.6	0.3	0.1	0.0	2.3	5.1	1.2	5.6	0.1	0.2	1.0	6.2	0.4	0.1	0.0	0.1	3.3	0.1	1.2	29.8	9.2	0.0	5.1	1.5	2.2	0.7	12.3	2.2	1.3	1.1	8.4	0.1	0.9	6.5	2.3	17.9	8.3	1.9	2.3	15.8	0.7	1.1	2.4	30.7	2.8	0.3	9.3	31.0	5.8	1.4	6.7	2.4	9.2	2.6	14.1	1.5	2.0	1.3	4.6	1.3	1.4	2.5	6.0	1.6	1.7	14.5	2.4	4.6	5.5	3.4	3.1											0.0	1.1	0.8	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	0.0	1.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.1	0.3	0.0	0.6	0.0
HIST1H4J	"H4/e, H4F2iv, H4FE"	ENSG00000197238	"Histone cluster 1 H4 family member j"	P62805	6	27824108-27824480	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.9;lymphoid tissue: 68.3"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 16.4;monocytes: 16.2;Mucus-secreting cells: 13.9;Paneth cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 58.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 31.9;MCF7: 32.0"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.9	9.4	2.9	15.6	4.1	25.9	4.0	3.7	15.5	5.3	9.9	0.2	6.8	7.9	4.4	4.7	7.6	5.6	6.2	7.5	5.9	1.9	4.0	18.1	8.3	26.7	2.2	7.1	5.2	4.1	0.6	4.5	3.2	2.3	8.0	4.6	0.7	2.0	3.7	0.7	2.7	7.6	3.8	6.0	13.9	7.5	19.3	0.8	68.3	8.6	8.0	10.8	5.4	4.9	12.0	7.7	58.9	10.8	10.6	13.2	10.8	3.9	4.7	10.8	18.2	6.5	2.7	6.3	4.5	2.3	4.4	2.8	8.8	1.3	6.3	8.0	1.9	1.1	9.3	0.2	6.7	1.4	8.9	1.7	4.1	9.5	31.9	3.8	6.1	5.4	8.6	1.9	2.8	1.5	0.6	4.1	3.5	8.0	13.3	0.0	32.0	10.9	6.2	6.8	6.5	10.5	4.5	0.7	4.4	0.6	1.7	5.9	8.1	7.6	4.5	7.1	1.5	5.8	3.0	4.0	2.2	10.8	1.1	0.0	8.6	8.1	10.9	2.8	7.7	4.3	58.9	3.4	14.8	11.7	8.5	8.9	11.0	11.5	12.7	5.2	12.0	6.6	8.3	6.9	10.6	10.8	7.7	13.2	10.8	2.9	4.1	3.7	15.5	5.9	1.9	2.2	7.1	2.3	0.8	0.0	3.0	3.0	0.5	0.2	0.0	0.3	0.0	2.7	2.3	0.0	0.0	0.7	0.0	2.5	0.8	0.7	8.6	0.0	7.3	6.2	0.5	0.7	5.8	3.9	4.0	0.0	16.4	4.3	4.8	0.2	0.0	1.8	0.0	16.2	13.9	0.0	2.0	14.0	0.0	0.3	0.0	0.0	0.3	0.5	2.5	0.0	1.4	1.9	10.5	0.7
HIST1H4K	"dJ160A22.1, H4/d, H4F2iii, H4FD"	ENSG00000273542	"Histone cluster 1 H4 family member k"	P62805	6	27831216-27831527	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lung: 2.9;lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 2: 1.1;Cardiomyocytes: 1.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 2.9;LHCN-M2: 2.9;RT4: 1.6;U-87 MG: 1.7"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	0.7	0.0	1.0	3.1	3.4	0.0	0.0	0.7	2.0	0.4	0.6	0.3	0.0	0.0	0.0	0.5	2.1	0.0	1.3	0.0	0.3		0.1	0.0	2.9	2.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.7	1.1	0.0	0.9	0.0	2.1	0.5	2.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0											0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H4L	"H4.k, H4/k, H4FK"	ENSG00000275126	"Histone cluster 1 H4 family member l"	P62805	6	27873199-27873510	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 133.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2"					"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 10.3;NB-4: 5.5;REH: 2.6"									HPA042201	Approved					NA	NA		30000000			"HPA042201: AB_2677898"										"unprognostic (1.15e-1)"				"unprognostic (6.05e-4)"				0.4	0.3	0.0	23.6	0.0	4.6	2.8	0.0	0.3	0.4	3.0	0.0	0.5	0.3	0.3	0.3	3.4	0.3	1.2	0.5	0.0		0.3	0.3	1.2	4.2	0.0	0.0	0.3	8.4	0.3	0.0	2.5	0.0	0.3	1.0	0.0	0.5	0.3	0.3	0.3	2.2	0.3	0.0	11.5	0.8	4.0	0.0	133.0	0.3	7.6	16.4	0.3	0.0	7.7	3.8	0.0	1.8	1.7	1.9	0.6	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	10.3	5.5	0.0	1.2	0.0	2.6	0.7	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	1.0	0.0	1.3	0.8	0.3	1.8	1.1	1.9	2.6	7.7	0.5	1.4	0.0	1.7	1.8	3.8	1.3	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST2H3A	"H3/n, H3/o"	ENSG00000203852	"Histone cluster 2 H3 family member a"	Q71DI3	1	149852619-149854274	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 126.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"					"unprognostic (1.15e-1)"					"unprognostic (1.30e-1)"				"unprognostic (3.99e-2)"				1.3	0.9	1.3	22.4	2.0	4.6	2.1	5.0	3.6	0.5	4.4	0.0	0.0	1.2	0.5	1.5	6.6	0.9	1.3	1.9	1.3	0.6	0.4	1.0	1.6	5.9	0.7	0.0	0.3	2.4	0.2	0.7	4.5	0.0	2.4	0.3	0.0	1.3	0.3	0.6	0.9	2.9	0.2	1.1	6.1	1.5	2.1	0.0	126.9	0.4	8.5	12.6	0.7	0.7	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.3	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	0.4	2.6	0.0	0.1	0.2	0.8	5.6	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.6	2.5	3.1	0.1	2.3	1.5	2.1	1.8	4.0	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.4	2.3	0.4	1.0	1.5	1.8	0.0	0.6	4.8	0.3	0.4	7.4	7.3	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2	1.3	2.0	5.0	1.1	1.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST2H3C	"H3, H3.2, H3/m, H3F2, H3FM, MGC9629"	ENSG00000203811	"Histone cluster 2 H3 family member c"	Q71DI3	1	149839538-149841193	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.1;prostate: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3"									"HPA042570, CAB069990"	Approved					NA	NA					"CAB069990: AB_10804539, HPA042570: AB_2678056"					"unprognostic (1.78e-1)"			"unprognostic (2.25e-1)"		"unprognostic (2.42e-1)"				"unprognostic (1.36e-2)"				0.4	0.5	0.7	0.4	1.4	3.8	0.0	5.1	2.9	0.1	0.3			0.8	0.2	0.0	0.4	1.0	0.0	1.4	0.7	0.2	0.1	0.6	0.3	0.5	0.3		0.0	1.9	0.0	0.1	0.3		3.6	0.0		0.9	0.0	0.2	0.5	0.6	0.0	0.4	0.4	1.1	1.4			0.1		0.0	0.4	0.6	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.3	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	0.4	2.6	0.0	0.1	0.2	0.8	5.6	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.6	2.5	3.1	0.1	2.3	1.5	2.1	1.8	4.0	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.4	2.3	0.4	1.0	1.5	1.8	0.0	0.6	4.8	0.3	0.4	7.4	7.3	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST2H3D		ENSG00000183598	"Histone cluster 2 H3 family member d"	Q71DI3	1	149813271-149813681	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;bone marrow: 9.3;lymphoid tissue: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 22.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (3.35e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.27e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-4)"	"unprognostic (6.95e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.48e-3)"	1.1	1.2	1.5	1.7	1.4	9.3	5.7	2.6	2.0	1.1	0.9	0.6	0.6	0.5	0.6	0.6	3.8	1.2	3.1	1.9	0.6	0.5	0.6	1.4	1.9	2.9	0.6	0.6	2.4	1.1	0.0	0.6	0.6	1.2	1.9	0.1	0.6	0.6	0.6	0.6	1.1	1.6	0.6	2.3	2.2	2.6	2.3	1.3	10.2	0.7	2.2	1.1	2.7	1.3	6.9	2.7	12.6	1.8	0.4	2.4	0.5	0.8	0.0	0.2	2.4	0.4	0.0	0.5	1.4	0.0	0.0	0.1	0.4	0.2	0.6	0.2	0.0	0.2	1.1	0.0	0.0	0.0	1.4	0.7	0.2	3.5	0.1	0.4	0.0	1.9	0.8	0.0	0.5	0.3	0.4	0.0	0.7	1.8	2.0	0.0	1.6	2.2	5.5	2.1	0.4	4.0	1.2	0.4	1.6	0.0	1.1	0.5	0.3	1.4	0.0	0.1	0.2	0.4	0.6	0.5	1.2	0.0	1.0	0.0	22.2	2.3	1.4	0.2	0.4	0.8	0.0	1.3	0.5	1.2	1.8	2.4	1.3	1.6	1.8	1.2	6.9	0.6	0.4	12.6	0.4	0.6	2.7	0.2	0.5	1.5	1.4	2.6	1.1	0.6	0.5	0.6	0.6	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
HIST2H4A	"H4/n, H4F2, H4FN, HIST2H4"	ENSG00000270882	"Histone cluster 2 H4 family member a"	P62805	1	149832659-149839767	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 56.4"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 14.3;Ciliated cells: 8.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 27.4;U-2 OS: 24.5;U-266/70: 22.9"									HPA042201	Approved					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (1.90e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.78e-4)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.99e-2)"	1.5	2.3	0.8	10.5	1.9	4.6	1.7	3.8	2.0	3.7	2.9	0.8	0.6	1.9	2.0	1.5	4.1	5.9	4.3	3.5	1.0		1.9	0.2	1.8	4.7	0.8	1.2	3.0	5.5	0.0	1.4	2.5	1.9	6.4	0.0	0.9	2.9	3.4	0.4	0.0	3.2	1.8	0.7	4.9	1.7	3.5	0.5	56.4	4.8	5.1	7.0	5.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.5	1.0	3.3	3.8	1.2	1.4	1.5	1.3	5.0	2.3	3.7	4.9	1.1	5.4	0.5	1.6	8.7	0.0	3.2	0.1	6.9	10.4	1.3	13.9	1.3	3.5	1.2	1.1	5.7	4.2	1.6	2.6	0.1	0.8	1.4	5.6	12.5	0.2	16.7	4.4	2.9	4.4	5.5	7.0	3.8	2.5	10.3	0.5	1.2	17.9	5.2	27.4	2.6	4.2	0.6	11.5	2.4	0.0	2.3	24.5	3.1	2.5	22.9	19.3	6.6	2.3	3.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.2	0.0	0.0	14.3	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2
HIST2H4B	H4/o	ENSG00000270276	"Histone cluster 2 H4 family member b"	P62805	1	149854045-149861210	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.4"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 3.0;Ciliated cells: 5.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.1;SiHa: 9.2;U-266/70: 10.9;U-266/84: 9.1"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"					"unprognostic (8.20e-2)"					"unprognostic (2.69e-1)"				"unprognostic (1.77e-1)"				1.5	3.2		0.0		1.2	0.5		2.3	0.0	0.1			1.3	1.9	2.4	0.0	2.8	0.0	1.9			0.8	0.7	0.2	0.4			1.4	1.1	0.0		0.2		1.4	0.4		0.5	0.5	1.8	0.0	0.3	2.0		1.2	0.8	0.0			0.0		0.0	0.0		8.3	4.1	9.4	3.4	2.1	4.4	4.4	0.0	0.0	1.0	0.2	1.0	1.1	0.2	1.7	3.3	0.2	0.0	0.0	0.7	1.0	1.7	0.9	0.2	0.0	0.6	0.0	0.2	1.8	0.6	0.0	3.8	0.0	0.0	0.1	0.0	2.7	0.0	0.3	0.0	1.4	1.3	2.4	0.0	5.6	0.1	3.6	0.3	0.5	0.1	1.0	0.0	1.3	0.4	0.1	0.4	0.7	6.1	3.7	9.2	1.0	0.3	0.0	2.0	0.2	2.2	0.4	2.2	0.6	0.2	10.9	9.1	1.5	0.9	0.3	1.4	2.6	2.1	2.4	2.5	3.4	4.4	3.2	2.9	2.1	3.1	8.3	2.3	3.7	9.4	2.1	1.7	4.1	4.2	4.4											3.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0
HIST4H4	MGC24116	ENSG00000197837	"Histone cluster 4 H4"	P62805	12	14767999-14771131	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.7"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 9.8;Enterocytes: 9.5;Rod photoreceptor cells: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.1"									"CAB011503, CAB037279, HPA042201"	Supported		Supported	Nucleoplasm		NA	NA		30000000	Nucleoplasm		"CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-3)"	7.1	4.6	2.3	7.4	7.6	2.5	4.7	6.7	4.9	6.9	6.2	1.1	3.3	5.0	5.4	7.1	8.9	6.0	5.4	5.9	2.8	2.5	11.0	3.3	6.3	7.2	2.5	2.1	8.3	36.7	2.1	5.1	7.1	2.1	16.0	4.8	6.1	12.7	5.5	2.8	6.4	8.9	3.3	3.1	21.8	10.1	6.6	1.7	16.9	9.9	6.8	18.6	6.6	6.8	5.5	3.6	19.7	2.1	2.1	3.4	1.1	2.1	0.8	0.1	2.6	2.9	0.0	1.5	1.3	0.1	1.1	0.9	1.4	8.1	2.0	0.5	0.7	0.0	1.4	0.0	1.0	0.6	2.5	1.1	0.0	5.2	2.1	0.8	0.5	2.0	2.0	0.6	0.2	1.2	0.0	0.0	0.6	0.0	2.6	0.1	1.1	0.5	0.7	2.8	0.7	0.3	2.2	0.0	3.9	0.0	5.8	1.0	1.4	5.3	1.4	0.3	0.6	1.0	1.0	1.8	0.5	4.2	1.1	1.6	2.8	1.7	5.8	1.9	0.0	1.3	0.0	1.9	0.2	2.0	2.1	3.4	4.1	2.3	2.2	2.1	5.5	2.0	2.2	19.7	2.1	0.7	3.6	3.2	1.1	2.3	7.6	6.7	4.9	2.8	2.5	2.5	2.1	2.1	1.7	0.0	0.0	2.2	1.3	0.5	6.2	2.0	0.0	1.4	1.2	1.8	9.8	0.8	0.0	0.7	0.0	0.6	9.5	0.0	1.0	0.3	0.9	0.6	0.0	0.9	1.4	0.0	1.7	0.6	2.1	0.0	1.1	0.6	0.0	1.8	1.4	2.3	0.8	2.0	0.7	0.8	18.8	0.0	1.3	0.2	0.5	1.0	1.4	4.5	1.4	0.5
CDK2AP1	"doc-1, DOC1, DORC1, p12DOC-1, ST19"	ENSG00000111328	"Cyclin dependent kinase 2 associated protein 1"	O14519	12	123260971-123272334	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 40.5;myeloid DC: 14.9;non-classical monocyte: 44.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 14.9;monocytes: 44.8"	"Low cell line specificity"	"Detected in many"											"CAB019377, HPA057648, HPA068833"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046"	"unprognostic (1.56e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (5.27e-7)"	"unprognostic (9.32e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.18e-1)"	29.9	28.3	60.4	20.1	55.4	21.0	61.5	27.4	61.6	42.6	22.8	62.8	15.0	13.1	34.5	45.2	30.9	25.5	29.9	30.1	61.0	52.4	20.8	18.2	21.1	22.2	76.4	30.3	16.9	16.4	24.2	22.4	21.4	53.6	33.0	21.9	16.4	51.0	35.4	26.6	21.6	12.6	41.0	96.8	17.7	19.4	22.7	59.9	17.9	16.6	22.1	18.0	36.9	23.4	0.2	14.9	5.1	44.8	0.3	0.5	7.6	16.2	22.9	61.2	65.2	49.6	61.9	11.1	53.0	49.7	42.5	32.7	17.2	15.6	0.0	23.7	81.4	15.8	15.0	64.8	34.6	35.4	10.0	16.2	8.8	14.0	27.2	26.5	13.5	9.5	39.3	36.3	24.6	16.0	38.8	60.2	20.1	11.6	0.1	79.9	31.5	17.8	21.8	40.1	20.2	17.2	68.3	26.5	7.0	34.5	39.5	58.0	67.9	38.9	19.1	52.0	17.0	36.9	13.6	36.8	39.7	20.7	23.2	34.8	2.8	5.3	15.0	21.3	6.5	86.3	3.8	13.0	5.1	0.2	40.5	0.5	0.2	0.2	0.3	14.9	0.0	0.1	0.2	0.7	0.3	44.8	1.4	0.1	7.6	60.4	55.4	27.4	52.2	61.0	52.4	76.4	30.3	53.6	59.9	26.8	31.2	0.0	1.1	1.1	0.2	1.6	7.6	18.7	34.2	12.2	0.0	1.2	1.7	19.8	19.8	5.6	5.1	0.0	14.6	2.8	4.1	0.3	18.5	7.3	5.2	3.2	7.5	13.5	18.0	109.1	12.4	7.2	3.3	10.8	19.8	20.0	19.4	10.5	13.4	2.6	0.2	0.0	1.0	1.5	5.7	2.5	1.1	0.0	18.0	0.8
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5527147-5563784	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"monocytes: 32742.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported					NA	NA					"CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	209.6	84.4	88.8	260.7	97.2	204.1	152.2	50.8	143.4	172.0	392.7	135.4	95.7	107.9	333.6	113.6	296.2	196.4	168.5	79.3	99.3	73.7	132.4	148.1	183.0	295.5	90.7	79.4	211.9	49.7	41.0	52.5	139.9	103.8	183.7	142.0	78.3	101.5	182.5	70.4	96.8	190.2	371.8	135.5	238.9	216.9	102.1	61.9	358.3	83.1	100.4	279.2	346.2	146.3	113.6	386.3	575.1	443.8	122.3	233.8	559.5	254.7	152.7	185.5	154.4	75.2	97.5	235.8	202.1	113.4	136.4	106.8	257.5	143.7	153.8	155.4	269.5	147.6	162.8	98.7	251.9	160.4	178.6	58.5	134.4	147.6	145.9	105.8	147.4	342.7	121.2	83.0	181.4	53.2	135.5	133.8	104.5	73.0	116.6	210.0	237.9	129.8	391.8	226.8	77.3	122.6	186.5	110.1	114.0	196.1	95.2	56.5	93.9	198.4	186.7	68.2	189.3	198.0	169.8	276.3	359.2	230.5	235.9	290.9	67.0	74.6	167.5	196.8	216.5	414.2	250.3	323.7	575.1	227.2	395.9	185.1	113.6	169.8	205.2	386.3	107.3	128.1	177.5	383.7	122.3	443.8	151.0	233.8	559.5	88.8	97.2	50.8	143.4	99.3	73.7	90.7	79.4	103.8	61.9	1069.0	822.3	2484.5	7353.8	5096.2	155.7	125.4	1202.6	477.8	624.4	2034.4	80.5	3302.0	1929.8	6734.3	80.2	1836.0	3281.7	1027.9	5552.5	10236.7	3325.6	3645.8	1466.1	2345.3	12685.3	254.3	1395.2	2304.3	7427.3	112.4	1635.9	7666.7	2841.0	32742.0	1861.9	1550.6	9573.5	2795.0	2519.6	1484.0	125.8	3233.8	4447.1	79.8	345.5	4127.8	2724.3	5423.3	1783.0	5007.2
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	20.9	27.6	26.8	23.6	24.0	13.8	19.1	31.9	32.4	28.2	19.6	13.3	14.6	11.8	25.7	16.2	27.0	20.4	20.2	16.9	21.4	13.5	21.1	14.8	16.3	19.0	14.1	25.0	26.5	14.2	30.5	19.0	40.2	15.6	25.1	15.9	18.2	21.8	24.5	15.8	28.7	15.8	25.2	16.6	16.4	15.3	15.8	19.2	19.6	23.7	11.5	22.5	28.9	28.7	5.2	4.0	6.0	4.4	9.6	9.9	1.9	9.3	12.3	12.7	6.6	9.7	12.3	33.8	8.8	10.8	13.6	14.5	14.1	17.0	15.4	7.3	11.9	8.9	11.7	27.7	10.6	21.5	43.5	10.5	13.9	18.1	9.4	11.9	17.3	9.6	10.8	11.6	11.2	16.7	16.3	11.0	10.9	7.7	0.7	12.8	10.9	19.0	25.3	26.6	7.9	5.8	15.2	27.2	10.5	10.0	19.9	3.3	7.6	18.5	7.3	9.2	30.5	10.2	11.1	12.0	12.8	9.8	3.9	13.2	4.2	7.7	33.0	9.6	7.9	9.4	6.0	4.4	4.0	7.3	4.3	7.3	3.7	7.3	6.3	3.1	5.2	6.4	9.9	5.0	9.6	3.3	4.0	7.0	1.9	26.8	24.0	31.9	32.4	21.4	13.5	14.1	25.0	15.6	19.2	23.8	11.0	14.3	21.7	66.7	28.8	19.8	10.2	25.4	28.4	12.2	41.2	51.8	14.9	10.5	1.1	20.4	7.9	0.0	10.4	21.2	32.2	20.9	26.6	11.4	13.3	49.3	21.8	13.5	19.0	1.4	22.7	10.5	27.0	15.4	10.2	17.4	9.7	8.6	27.3	14.6	15.6	19.4	61.4	11.7	23.0	66.5	69.5	17.9	10.8	23.7
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.4	0.9	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.6	0.1	2.4	0.5	0.7	0.0	0.4	0.0	0.0	0.0	0.2	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.4	0.0	0.0	0.0	0.3	0.0	1.6	1.2	2.0	0.0	0.7	0.5	3.5	0.0	0.3	1.4	0.7	0.6	3.0	0.0	0.2	0.6	0.6	0.0	0.4	3.9	1.1	0.7	0.4	0.8	1.2	1.2	0.2	0.6	0.8	0.8	4.0	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3	0.0	1.1	0.0	0.0	2.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.0	1.3	0.0	0.0	0.0	0.1	2.3	0.0	0.0	4.0	12.3	0.0	0.0	4.3	0.3	0.2	11.5	1.7	1.7	0.0	0.0	0.0	0.1	0.0	9.9	4.4	0.0	6.5	1.0	1.6	1.3	2.8	0.7	0.0	0.0	0.0
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"Additional sex combs like 2, transcriptional regulator"	Q76L83	2	25733753-25878516	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034646: AB_2674261, HPA058040: AB_2683586"	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	15.0	14.9	14.5	14.1	16.5	10.4	13.1	23.0	16.1	14.4	13.9	15.7	13.0	9.8	14.7	9.9	17.5	12.1	10.0	14.2	15.2	8.9	14.7	10.2	13.1	15.3	14.3	8.5	11.4	12.1	28.0	17.4	17.4	13.9	10.5	14.2	12.6	15.3	14.1	20.5	14.2	12.9	13.3	12.3	15.4	12.1	20.7	18.0	26.2	16.5	10.7	17.0	16.7	13.5	3.0	3.7	4.7	2.7	1.8	4.5	1.3	15.7	9.5	7.3	5.2	7.3	10.3	9.4	8.7	13.6	8.5	7.7	10.5	8.6	9.8	5.1	9.8	10.0	9.8	14.4	10.6	12.3	9.8	6.6	17.4	8.5	11.5	6.2	19.2	17.4	5.1	11.1	13.0	10.3	7.6	10.9	6.2	15.1	7.9	9.0	6.4	9.0	6.4	10.3	9.2	6.7	10.1	25.0	7.9	7.9	10.7	8.0	9.0	10.5	10.0	8.8	7.5	5.6	8.2	14.4	12.1	13.8	10.4	12.5	16.1	15.8	20.5	11.3	16.2	8.6	2.1	2.4	3.7	4.5	2.7	3.6	2.7	3.5	3.9	2.3	3.0	3.0	3.6	4.7	1.8	2.4	3.7	2.5	1.3	14.5	16.5	23.0	16.1	15.2	8.9	14.3	8.5	13.9	18.0	23.8	17.9	16.0	8.0	28.7	21.5	25.8	10.2	38.8	15.9	8.7	23.6	9.0	13.3	13.9	36.9	22.2	10.5	0.0	12.4	7.4	14.5	11.0	23.1	13.9	16.0	23.8	9.9	26.4	25.3	19.7	18.1	21.6	21.9	15.4	16.7	13.6	14.9	14.0	12.4	12.9	24.1	38.8	11.0	30.5	24.7	35.9	12.2	28.8	15.6	13.8
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440398-73522278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA067010"	Supported		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB037081: AB_477637, CAB037158: AB_477636, HPA067010: AB_2685763"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	23.3	22.3	21.4	26.4	23.9	20.7	24.6	32.4	23.4	24.6	24.2	21.1	34.1	15.3	26.3	19.8	18.1	20.6	16.5	19.8	22.4	21.4	17.1	23.4	19.4	24.7	29.3	19.4	31.8	20.2	34.9	27.0	23.1	22.3	23.1	20.5	16.4	18.0	30.8	28.9	14.6	19.2	28.7	22.9	22.2	18.8	16.2	27.3	46.5	23.5	17.9	27.7	24.7	24.4	5.3	6.2	6.1	3.1	5.6	6.3	1.7	21.0	21.7	29.9	33.4	15.5	16.6	10.0	20.5	15.7	19.7	20.8	17.6	16.0	39.8	4.8	18.2	30.1	14.8	36.3	13.6	29.8	22.4	18.4	23.7	25.8	15.2	17.3	35.7	20.1	11.8	13.3	24.3	30.0	14.8	15.7	21.8	41.2	25.1	22.1	20.0	36.5	16.4	19.4	16.2	16.2	37.2	26.2	26.5	11.2	16.5	30.0	25.6	29.2	32.6	17.0	26.7	20.0	17.9	18.3	34.3	19.8	20.5	34.8	14.5	23.1	68.2	19.4	33.8	31.0	6.1	3.1	1.9	6.3	2.2	5.5	2.5	4.8	4.6	2.1	5.3	3.8	4.1	2.2	5.6	1.7	6.2	4.7	1.7	21.4	23.9	32.4	23.4	22.4	21.4	29.3	19.4	22.3	27.3	71.5	120.0	59.6	29.7	26.6	70.4	68.2	28.1	69.6	93.3	19.2	41.2	44.5	6.6	33.2	6.4	50.4	22.5	0.0	19.8	50.2	34.4	24.5	48.7	47.1	29.2	57.2	33.4	30.7	35.9	5.9	56.7	29.8	11.8	39.7	25.8	48.9	24.9	5.8	71.8	11.3	51.0	32.3	46.7	59.6	105.4	22.1	28.9	43.6	35.7	33.8
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 239.1;Spermatogonia: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		35000	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	17.4	19.1	39.4	19.5	40.5	8.6	25.5	40.0	39.7	31.3	18.8	22.0	15.4	11.1	39.6	29.3	18.7	22.5	16.4	18.3	35.0	33.4	22.9	12.5	15.6	18.6	32.2	38.0	47.6	12.4	27.8	20.7	19.9	30.8	23.1	19.9	13.5	15.5	29.3	35.4	16.7	11.8	32.8	41.8	18.5	14.2	39.6	31.8	30.9	23.5	12.9	26.1	20.2	19.6	12.7	7.6	25.0	9.1	6.3	9.5	4.1	38.5	22.1	72.9	34.3	14.8	13.3	40.4	35.9	17.4	35.1	37.7	57.8	15.5	26.6	38.5	28.2	27.0	15.5	26.8	22.7	62.0	49.3	21.6	21.6	22.2	21.2	9.0	20.5	13.4	9.4	12.7	26.1	33.5	27.0	28.6	32.2	26.8	12.4	28.1	24.1	57.3	14.0	27.7	21.1	28.7	43.2	60.4	17.0	20.3	22.2	25.9	64.6	24.8	8.2	12.9	54.8	38.9	14.6	19.9	49.1	45.3	20.8	36.1	17.5	39.6	25.6	13.4	9.1	21.7	2.8	9.1	11.2	9.5	9.1	7.9	11.4	8.6	7.8	7.1	12.7	9.1	7.5	25.0	6.3	6.4	7.6	8.4	4.1	39.4	40.5	40.0	35.1	35.0	33.4	32.2	38.0	30.8	31.8	62.5	22.2	26.7	28.9	38.7	41.3	65.0	12.7	44.2	37.5	40.1	19.6	47.7	29.9	61.5	24.8	37.9	9.6	0.0	25.7	68.8	49.4	25.7	38.2	14.9	56.4	47.7	38.8	20.9	29.1	41.0	74.2	25.3	38.8	51.3	25.2	83.7	31.1	7.0	86.3	22.4	31.7	38.8	34.0	239.1	235.7	31.7	23.2	21.9	28.9	17.7
CD3EAP	"ASE-1, CAST, PAF49"	ENSG00000117877	"CD3e molecule associated protein"	O15446	19	45406209-45410766	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-251 MG: 65.8"					"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	7.3	5.9	7.7	8.4	9.7	4.0	7.1	14.9	9.0	5.6	5.5	6.5	2.9	4.9	6.4	3.0	9.9	7.1	6.4	6.7	7.1	6.4	5.2	6.8	4.5	7.2	8.1	6.0	8.7	18.3	6.6	7.3	5.1	8.0	5.2	4.9	3.1	7.2	4.6	14.2	8.4	4.3	6.6	5.6	5.8	4.3	5.2	9.3	3.6	6.1	7.8	8.5	5.5	5.8	3.5	15.9	1.3	3.7	3.2	4.1	2.1	10.4	10.8	1.7	7.9	2.6	2.1	7.0	5.0	1.7	8.9	5.2	10.6	7.5	16.3	5.3	3.7	7.2	10.1	15.6	14.3	6.3	8.0	10.1	9.0	4.1	7.8	4.4	9.1	3.2	3.2	9.2	12.9	7.1	2.2	6.4	6.0	20.5	3.3	8.6	12.3	6.9	2.6	12.7	11.6	9.1	9.4	6.9	10.7	3.5	7.8	10.8	4.0	10.7	14.3	2.3	3.8	7.2	5.5	6.2	12.7	13.3	7.3	65.8	5.9	23.4	17.3	6.3	13.0	9.1	0.9	2.8	0.3	1.7	3.7	3.4	2.8	2.2	2.4	5.0	3.5	3.1	4.1	1.3	3.2	3.3	15.9	1.2	2.1	7.7	9.7	14.9	9.0	7.1	6.4	8.1	6.0	8.0	9.3	6.0	12.8	10.0	23.3	109.3	4.5	1.2	7.6	6.7	12.5	1.8	9.8	13.7	1.7	15.9	0.2	9.0	1.7	0.0	5.8	19.4	6.6	7.7	5.7	4.2	10.0	11.1	4.6	4.9	2.6	0.5	8.9	7.0	11.8	2.8	4.3	3.5	11.0	0.0	10.6	6.1	5.8	0.0	8.9	0.5	18.9	96.7	6.4	0.0	9.5	11.5
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	23.5	34.9	21.9	50.0	33.5	27.2	25.9	29.4	25.1	28.1	29.5	29.3	38.5	18.6	37.2	35.4	29.1	28.0	40.3	52.8	23.5	19.2	29.5	25.0	25.5	30.9	33.6	19.4	34.6	27.4	58.4	25.3	29.5	27.2	21.5	26.0	26.5	24.8	46.2	33.7	31.1	24.4	36.6	30.3	29.4	27.2	29.7	28.9	75.7	38.4	33.7	38.4	34.7	24.3	12.6	16.8	12.8	9.1	13.5	16.7	5.8	20.4	18.7	46.4	17.4	19.0	21.4	27.3	22.7	22.2	25.1	23.2	31.2	15.9	44.1	9.0	25.7	16.4	18.3	43.5	25.0	33.9	33.0	22.4	61.6	29.1	19.4	16.5	48.3	29.6	20.7	12.4	24.3	17.0	31.7	29.3	24.7	48.4	22.0	23.8	25.6	45.8	15.8	44.4	19.0	17.7	39.3	28.5	24.1	15.9	24.2	22.0	28.3	29.2	32.6	22.6	53.2	14.9	27.5	27.2	25.7	54.7	18.8	26.5	35.7	21.2	56.3	17.0	29.5	18.7	9.0	7.7	9.2	12.2	9.1	12.0	10.5	10.3	11.1	7.9	12.6	13.0	12.3	12.8	13.5	8.1	16.8	16.7	5.8	21.9	33.5	29.4	25.1	23.5	19.2	33.6	19.4	27.2	28.9	56.6	102.0	59.1	45.6	60.9	103.2	110.8	66.2	96.4	79.6	83.7	66.8	38.6	11.6	71.4	71.8	70.5	43.4	23.3	62.1	41.7	66.9	40.2	81.1	60.6	61.2	131.9	93.2	49.7	44.2	45.3	60.9	57.6	45.5	56.9	59.2	71.6	76.6	24.6	70.0	30.3	60.2	51.8	73.5	97.0	107.1	59.1	56.9	61.8	61.8	37.3
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.5	21.7	24.1	11.2	15.4	13.3	13.6	13.2	15.2	20.1	20.1	18.8	14.4	27.4	8.3	17.6	15.9	20.3	29.4	18.5	25.4	20.9	13.4	24.0	14.5	22.8	14.3	33.2	22.9	17.9	15.1	22.5	16.2	15.6	17.8	21.7	16.7	14.7	15.1	17.8	23.8	13.6	18.4	16.1	18.4	22.4	18.2	9.2	14.9	30.6	17.6	16.9	20.6	16.1	11.4	22.7	11.3	16.1	20.9	16.7	12.8	9.8	15.6	16.7	19.9	27.4	6.7	12.3	16.6	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1	35.7	52.5	15.1	10.4	11.2	32.4	18.1	20.4	36.1	43.3	31.4	25.5	12.2	1.7	19.0	1.6	18.0	11.3	23.3	20.2	10.1	9.9	12.1	26.7	12.4	15.0	22.3	26.0	14.1	20.9	2.5	15.0	13.0	10.1	19.8	16.3	19.2	21.3	14.0	16.6	6.3	22.9	0.0	13.3	26.2	22.4	14.4	10.3	22.3	14.7	11.1
CREBZF	ZF	ENSG00000137504	"CREB/ATF bZIP transcription factor"	Q9NS37	11	85659708-85682908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021526, HPA063652"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA021526: AB_2670738, HPA063652: AB_2685075"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.38e-3)"	15.4	18.7	16.6	19.5	23.3	13.2	19.8	31.4	21.7	23.1	18.1	23.7	18.5	22.0	29.0	19.9	15.0	22.3	18.2	13.3	16.9	10.5	14.9	16.2	17.5	25.0	34.0	18.7	31.5	27.2	30.0	23.8	18.3	20.2	21.2	20.6	20.0	19.3	17.0	13.1	18.2	24.4	20.0	21.3	26.1	20.2	12.7	24.8	21.6	27.1	11.7	21.3	19.1	21.3	3.1	2.4	2.3	2.8	1.9	3.8	0.8	3.6	11.1	9.3	3.1	3.9	4.3	11.4	5.8	3.4	5.0	6.6	11.1	17.8	9.3	5.9	3.2	20.7	13.4	7.5	3.9	7.5	7.5	9.3	9.6	32.1	3.4	3.1	9.6	5.6	4.5	9.3	5.5	8.2	4.7	2.8	6.8	8.3	15.8	4.5	5.9	8.6	13.8	3.7	11.0	5.8	17.5	10.7	6.7	4.4	7.0	9.8	9.3	9.2	13.1	2.3	4.9	15.6	15.7	4.3	10.7	8.7	17.2	8.0	5.9	5.2	12.9	2.9	6.9	8.6	1.9	1.6	1.4	2.3	1.4	3.8	3.1	1.5	1.9	2.0	2.9	2.5	2.3	2.3	1.9	2.8	2.4	1.1	0.8	16.6	23.3	31.4	21.7	16.9	10.5	34.0	18.7	20.2	24.8	17.9	19.2	20.4	20.2	36.7	100.5	11.3	12.7	14.7	14.8	21.0	86.4	13.0	8.3	10.5	19.0	26.4	25.1	23.3	7.4	12.3	29.2	26.1	21.9	26.0	8.7	85.8	37.8	22.1	18.6	13.7	28.4	14.6	32.1	9.0	23.6	57.0	8.3	20.9	31.5	5.3	112.5	12.9	28.9	20.0	5.9	36.1	12.0	25.8	19.9	21.0
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 515.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		14000	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	33.1	19.7	11.5	35.6	10.4	13.8	24.4	22.8	18.4	29.5	25.1	63.7	22.8	50.0	14.1	18.9	13.9	29.6	44.3	28.4	39.6	15.5	31.2	35.0	14.0	26.4	22.3	83.2	33.3	14.1	37.0	35.2	59.0	13.7	21.4	18.8	66.6	25.0	20.7	15.1	32.6	18.1	31.5	15.8	42.1	29.2	18.9	24.6	19.6	17.9	23.9	25.6	20.5	45.5	26.6	14.5	25.8	17.5	22.0	17.3	24.6	23.2	40.0	28.9	38.2	73.9	14.4	63.2	11.7	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3	95.3	139.8	208.1	223.1	488.7	27.0	59.4	112.1	83.0	195.7	68.0	39.3	72.5	61.3	111.8	41.5	139.6	52.0	23.3	160.6	118.9	142.8	222.8	164.0	182.5	102.7	23.8	83.2	113.5	149.3	13.6	82.8	170.5	118.1	66.7	97.0	22.8	171.9	92.1	72.5	73.0	27.4	25.8	155.6	101.9	142.2	515.4	115.0	93.8	113.1	301.9
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223868-18264823	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB015226, HPA054505, HPA057799"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	30.9	20.0	22.9	41.8	29.5	50.8	28.9	41.5	30.2	31.0	35.8	11.4	24.0	28.2	32.9	19.7	31.0	23.8	19.2	33.5	26.8	14.1	19.3	23.8	29.2	42.7	30.7	17.6	28.3	19.3	20.5	27.8	24.3	27.7	33.9	29.9	11.0	26.8	21.4	40.2	23.2	35.9	51.3	28.1	29.8	24.2	12.6	32.9	58.8	44.9	33.9	38.4	45.1	43.3	40.0	40.2	57.7	49.3	34.0	46.3	35.0	60.9	18.0	47.6	39.7	9.6	16.7	27.7	56.2	31.0	50.7	68.8	29.4	22.9	69.4	59.6	25.3	40.8	36.6	35.2	27.9	85.4	46.7	33.6	42.9	32.3	34.2	9.3	65.3	34.9	8.2	13.9	35.0	27.7	24.0	24.2	25.6	52.1	0.0	32.3	21.9	47.1	29.3	29.2	24.3	20.1	62.8	63.2	40.7	24.4	35.3	29.2	26.8	50.7	44.1	30.6	32.6	39.6	26.9	24.6	59.5	33.0	33.1	69.9	4.2	10.2	73.2	14.2	33.3	55.1	51.1	49.3	21.9	41.4	39.3	46.3	40.0	42.1	42.5	40.2	33.2	33.5	32.0	57.7	34.0	43.9	31.0	40.6	35.0	22.9	29.5	41.5	30.2	26.8	14.1	30.7	17.6	27.7	32.9	113.2	133.1	112.0	157.1	241.0	64.8	174.2	152.8	109.7	146.7	75.0	76.6	208.5	69.6	136.5	15.9	140.0	115.1	443.9	150.2	201.0	139.1	206.8	105.4	107.1	166.8	25.4	84.9	75.5	163.3	15.6	175.4	212.2	96.2	259.7	117.1	119.5	110.8	110.4	180.0	82.7	127.2	207.0	187.2	63.1	177.2	204.1	90.8	150.3	203.5	166.1
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 17.3;Proximal tubular cells: 13.5"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 31.2"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	4.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244544-86278813	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	10.9	12.0	20.1	20.6	19.8	9.7	14.0	33.4	26.5	13.4	14.4	10.4	19.2	15.6	20.0	20.1	16.7	13.5	14.5	10.8	17.7	12.7	13.7	15.1	13.0	31.1	18.3	17.7	16.9	14.1	16.2	21.6	17.6	17.7	15.5	15.0	9.8	13.7	13.8	11.8	14.6	14.6	12.5	18.2	19.5	13.7	12.5	20.5	17.0	14.6	11.9	36.2	14.9	22.8	21.5	6.7	11.3	7.6	8.9	27.3	9.2	11.7	13.5	14.2	6.1	7.9	6.6	16.5	17.4	7.3	15.4	15.6	42.4	22.6	26.5	18.4	4.9	15.9	14.7	16.8	9.2	14.7	27.4	8.0	17.8	13.5	12.6	6.9	18.3	11.9	4.3	6.1	16.4	6.9	6.4	7.0	11.9	19.5	5.7	13.1	19.2	17.0	18.5	10.5	37.6	6.6	18.8	17.6	12.9	10.0	19.4	9.9	8.0	22.3	10.5	4.9	11.0	17.6	7.8	6.9	17.0	16.1	25.0	15.1	3.3	10.6	21.5	4.8	16.1	12.7	11.3	4.5	7.1	13.3	7.2	11.6	21.5	17.4	16.6	6.7	18.8	14.0	15.8	1.9	8.9	7.6	4.4	27.3	9.2	20.1	19.8	33.4	26.5	17.7	12.7	18.3	17.7	17.7	20.5	6.0	9.4	18.2	10.8	22.8	23.0	8.1	7.6	10.7	2.3	7.0	17.7	38.3	16.6	13.6	4.9	15.2	11.5	0.0	8.8	28.8	17.9	8.0	16.1	10.9	14.9	30.2	6.9	14.1	13.6	2.3	21.0	11.3	18.6	36.9	11.2	9.9	10.4	11.4	16.3	6.2	17.7	6.5	14.3	12.7	18.8	14.6	20.8	28.4	11.8	18.4
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.6	6.4	0.0	2.8	1.5	4.1	2.8	2.3	3.2	2.6	0.0	0.0	0.0	6.3	4.5	3.3	0.0	0.0	6.9	1.5	4.2	9.6	0.0	0.0	0.0	0.0	10.3	0.0	3.9	1.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	7.3	0.0	15.8	0.0	0.0	6.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.3	2.7	0.0	0.0	3.0	3.4	2.6	5.7	0.0	9.1	12.4	3.0	3.9	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9	14.9	11.8	22.3	5.6	7.4	59.2	4.5	22.9	9.4	19.4	24.4	39.3	19.7	6.6	12.9	33.8	11.9	8.9	0.0	10.6	12.5	13.2	5.8	13.9	6.4	14.1	36.5	21.7	20.3	9.1	44.9	25.3	9.9	18.6	16.2	15.5	28.2	11.0	5.8	21.5	7.8	48.2	25.8	8.5	6.1	30.6	9.7	4.7	14.9	15.0	2.6
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41091786-41180079	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	16.8	14.8	19.1	13.9	15.5	45.3	14.5	33.0	20.6	14.8	16.8	15.6	18.9	11.1	18.1	11.6	16.8	15.7	16.5	10.7	16.6	8.3	11.5	12.2	14.1	12.9	16.9	12.7	20.2	15.7	26.4	14.5	27.7	13.8	13.2	12.2	12.3	15.3	17.9	19.5	18.2	17.4	13.8	12.7	15.9	14.7	20.6	18.6	29.3	16.9	10.9	14.1	18.7	22.5	4.3	4.4	9.8	3.9	5.7	3.9	2.3	15.7	11.3	19.2	11.9	12.2	13.2	17.2	7.6	11.0	11.4	11.0	14.4	5.8	16.4	6.7	15.0	10.5	12.7	27.7	10.4	12.7	15.9	18.4	12.3	13.0	11.2	13.9	29.2	13.9	12.9	10.9	16.5	13.8	10.0	12.6	9.5	13.0	22.6	9.0	5.8	8.4	9.1	13.8	19.8	7.9	17.3	9.0	10.2	10.8	20.9	6.1	6.5	26.9	13.7	13.1	16.7	9.7	17.0	16.3	11.4	13.8	8.1	10.8	15.5	7.3	25.6	8.4	9.0	10.8	5.0	3.2	3.0	3.7	3.9	3.2	4.3	3.6	3.9	4.4	2.9	3.1	2.6	9.8	5.7	2.1	3.0	2.6	2.3	19.1	15.5	33.0	20.6	16.6	8.3	16.9	12.7	13.8	18.6	62.5	45.1	44.7	19.0	21.9	43.6	25.4	53.5	29.4	18.2	24.4	33.4	15.3	3.3	13.2	12.6	27.2	22.2	46.7	16.0	15.4	23.4	24.1	24.3	24.1	15.9	23.8	23.7	34.4	59.8	3.4	26.7	31.6	8.5	20.8	23.1	31.8	20.2	26.6	28.7	9.2	31.1	25.8	15.6	20.6	29.9	22.6	25.3	26.6	20.3	30.6
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	17.3	10.0	13.2	19.9	14.3	35.0	19.4	45.3	16.3	20.1	18.0	15.6	13.6	10.6	21.4	15.1	11.7	17.3	12.4	13.5	13.0	10.5	12.3	13.9	13.7	20.5	14.1	10.1	25.4	19.9	20.4	35.7	12.5	12.6	17.2	16.1	15.8	15.1	14.7	22.0	16.8	15.5	21.5	14.3	18.9	13.2	10.2	17.8	41.2	17.9	14.4	19.9	19.1	17.8	12.7	11.1	16.1	6.1	6.6	9.1	3.1	8.0	8.3	17.1	14.4	8.1	11.6	6.7	9.4	5.7	10.3	10.1	5.7	9.6	14.7	6.3	9.5	5.0	7.7	9.0	7.4	7.6	12.1	8.5	12.7	7.0	7.0	8.9	8.6	14.5	9.7	12.4	6.8	5.0	11.9	9.4	9.9	10.6	18.4	9.8	7.9	15.9	6.2	3.8	8.0	3.2	18.0	13.9	7.0	8.4	7.6	13.1	13.5	8.3	6.2	12.6	9.3	6.0	14.3	9.7	7.4	10.6	5.1	7.6	7.9	6.0	15.5	7.2	13.8	6.8	14.6	6.1	10.9	8.6	4.0	9.1	10.7	8.6	7.8	3.9	12.7	8.9	8.1	16.1	6.6	5.8	11.1	8.7	3.1	13.2	14.3	45.3	16.3	13.0	10.5	14.1	10.1	12.6	17.8	38.7	44.0	77.3	86.8	25.3	99.6	29.1	45.9	42.8	43.3	38.4	64.8	30.6	8.3	43.7	7.1	51.7	46.2	23.3	38.1	32.8	45.2	61.4	82.1	31.6	31.0	108.1	94.6	41.1	43.7	8.9	87.8	51.5	38.8	56.9	46.9	54.5	39.7	45.2	64.0	15.9	84.6	97.0	49.1	82.2	32.8	21.8	38.6	107.8	41.2	54.7
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"Q03468, P0DP91, Q8N328"	10	49455368-49539538	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 25.1;hTERT-RPE1: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	7.9	6.9	11.5	6.0	12.3	13.9	11.1	21.0	13.9	9.8	7.0	8.9	10.6	6.4	9.3	8.6	13.5	8.1	7.7	9.1	12.7	6.5	10.1	10.0	8.0	7.9	9.2	11.4	12.5	13.1	20.3	14.2	9.7	10.1	10.5	8.8	9.2	10.5	13.7	9.6	14.4	9.1	7.9	11.8	9.2	7.6	7.8	12.4	7.8	13.6	8.2	9.6	9.9	11.6	7.9	5.1	10.9	8.1	1.6	5.3	2.1	4.8	2.5	1.9	1.2	3.3	5.5	1.5	8.7	12.1	6.0	4.2	2.6	3.0	2.1	1.6	7.8	2.9	4.6	2.7	6.9	6.1	3.4	1.7	1.6	9.6	1.4	1.9	2.2	1.7	1.9	9.4	5.8	25.1	57.2	8.7	1.5	3.2	0.6	7.7	3.5	1.5	1.3	1.7	1.9	4.5	1.4	2.8	1.2	2.0	3.5	2.5	2.7	6.4	2.3	3.9	4.4	4.2	1.2	16.7	3.3	2.7	4.0	2.2	2.3	2.2	2.0	4.1	2.4	2.4	10.9	4.1	9.7	5.3	3.7	4.2	7.9	3.1	2.9	5.1	6.3	3.8	1.8	9.8	1.6	8.1	2.8	4.0	2.1	11.5	12.3	21.0	13.9	12.7	6.5	9.2	11.4	10.1	12.4	14.9	10.4	2.4	1.3	3.2	0.0	4.9	7.6	13.4	12.5	8.7	0.0	1.9	5.0	4.6	8.2	2.0	3.8	0.0	5.3	1.5	3.5	2.3	7.0	4.0	2.3	0.0	1.2	3.7	3.8	10.6	2.6	3.9	1.7	14.4	4.5	0.0	4.8	3.5	2.1	2.8	0.0	6.5	1.9	5.4	4.2	3.6	1.5	5.0	2.4	1.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	17.0	8.0	27.3	18.2	0.8	1.4	14.9	13.3	5.4	11.0	11.1	12.0	19.7	30.2	6.5	5.0	10.0	10.5	14.0	4.6	14.0	43.2	14.0	12.9	9.9	9.3	2.2	28.6	10.6	1.2	2.6	8.2	4.4	3.3	6.4	29.3	27.3	20.1	9.8	19.3	55.6	23.9	21.7	15.0	10.8	34.4	15.3	18.7	5.1	8.2	26.1	16.6	16.7	12.7	4.4	7.3	9.3	12.3	3.9	11.7	5.4	23.3	23.8	18.0	19.6	30.4	10.7	19.6	22.9	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3	0.0	7.9	6.7	5.7	23.6	4.8	6.5	2.5	14.7	7.9	7.0	33.4	13.6	3.3	9.1	72.2	7.1	6.7	23.3	7.4	29.5	10.8	4.4	21.8	1.3	10.4	14.3	8.6	4.3	8.9	19.2	2.8	10.9	13.5	19.0	10.2	2.0	10.1	9.3	0.7	1.0	21.1	6.5	9.9	126.7	62.4	25.3	25.5	18.7	18.6	4.0
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	4.9	6.6	12.5	8.1	14.8	9.0	10.3	21.3	19.5	7.4	6.8	6.6	5.1	5.1	11.5	8.6	10.1	6.3	5.7	7.2	9.4	6.9	6.4	5.2	5.3	10.6	6.8	13.2	8.3	4.7	8.5	13.6	7.9	8.6	7.6	7.3	13.9	4.9	6.9	7.5	13.5	6.6	6.9	8.0	7.6	5.8	11.2	5.7	13.3	9.0	4.8	12.1	7.9	6.9	2.5	2.0	1.4	1.4	9.0	5.5	1.9	12.2	4.7	15.8	8.7	5.6	8.9	14.6	8.5	7.1	10.7	9.6	9.7	4.9	12.4	13.8	5.1	15.3	9.3	8.3	7.8	15.5	8.8	11.7	16.6	9.4	9.6	5.6	20.9	8.7	6.9	4.5	12.5	5.7	4.2	11.5	10.8	13.7	7.6	14.0	2.8	12.8	15.9	24.1	5.8	8.6	11.1	21.7	8.6	12.1	11.9	14.6	7.6	14.9	14.1	8.9	9.2	6.7	20.2	7.2	7.8	7.5	13.3	12.8	6.7	9.2	15.7	2.9	21.1	4.5	0.0	0.7	1.4	3.2	1.4	5.5	2.5	3.5	3.9	2.0	1.5	3.1	3.6	0.2	9.0	0.8	1.4	2.7	1.9	12.5	14.8	21.3	19.5	9.4	6.9	6.8	13.2	8.6	5.7	8.9	8.8	10.0	10.8	7.9	25.7	7.5	5.1	1.4	4.5	12.2	96.2	13.1	1.7	5.2	1.5	6.8	2.0	0.0	4.5	9.1	10.4	6.7	8.1	2.0	7.2	25.4	10.3	4.9	2.4	1.0	11.5	5.3	8.5	4.6	4.2	13.3	4.5	2.9	7.4	6.8	128.0	6.5	8.1	13.0	28.1	7.9	13.2	20.1	3.9	6.3
GPR26		ENSG00000154478	"G protein-coupled receptor 26"	Q8NDV2	10	123666355-123694607	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"brain: 8.6"	"Cell type enhanced"	"Detected in single"	28	"Horizontal cells: 1.6"	"Cancer enriched"	"Detected in single"	13	"breast cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"SCLC-21H: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062736	Enhanced					NA	NA					"HPA062736: AB_2684855"	"unprognostic (4.15e-2)"				"unprognostic (5.75e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.12e-1)"			"unprognostic (9.09e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.12e-1)"			0.0	0.0	1.0	0.1	0.2	0.1	0.0	0.0	8.6	0.0	0.4			0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.6	2.4	0.0	0.3	0.0	0.1	4.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
H2AFY2	macroH2A2	ENSG00000099284	"H2A histone family member Y2"	Q9P0M6	10	70052796-70112280	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 38.2;Intestinal endocrine cells: 62.8;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 12.6;monocytes: 5.4;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"AF22: 49.3;AN3-CA: 28.6;SCLC-21H: 36.5;SH-SY5Y: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA035865: AB_10672099, HPA041189: AB_2677357"	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	4.7	3.7	9.3	9.0	9.8	2.0	11.3	21.8	12.1	16.1	10.9	12.2	26.0	9.8	22.5	14.8	18.7	18.1	17.9	13.9	7.3	9.8	12.6	10.2	6.3	5.9	6.6	9.2	18.3	12.5	14.3	18.8	2.6	6.3	19.7	12.1	10.6	11.7	23.5	15.6	11.4	10.6	16.7	9.3	3.4	9.2	18.9	7.4	6.9	15.3	11.7	9.9	14.1	12.5	0.0	12.6	0.4	5.4	0.9	6.4	3.1	1.3	7.3	49.3	28.6	0.6	1.5	0.0	2.2	0.0	4.3	3.0	0.2	14.7	0.0	6.2	0.8	2.6	7.5	3.7	11.9	1.3	19.2	17.8	0.0	0.0	15.1	3.0	0.5	0.4	1.9	8.7	1.5	2.4	6.6	0.0	2.1	0.0	0.0	4.1	10.2	0.0	0.0	20.4	0.0	12.5	0.0	0.0	0.0	8.8	9.1	36.5	35.5	7.5	0.0	0.1	10.7	11.0	5.6	0.0	0.0	8.6	3.5	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	3.6	5.4	4.5	0.0	4.8	4.3	12.6	0.0	5.0	6.4	0.4	0.9	3.3	0.1	3.4	3.1	9.3	9.8	21.8	12.1	7.3	9.8	6.6	9.2	6.3	7.4	0.0	2.7	0.0	17.3	7.2	11.3	6.0	7.6	8.1	2.3	14.0	0.0	0.4	21.6	38.2	0.8	2.8	2.6	0.0	7.0	0.3	4.8	11.1	2.3	3.6	4.8	0.0	62.8	3.7	3.2	1.8	3.4	6.3	1.7	46.9	11.0	2.4	11.8	3.5	4.6	5.7	2.6	6.5	0.5	2.3	3.8	9.5	0.8	4.3	19.4	15.3
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 73.9;Late spermatids: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Cell line enhanced"	"Detected in many"		"JURKAT: 30.4;MOLT-4: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	3.8	3.8	4.9	5.9	2.8	4.7	5.8	4.0	2.7	3.2	3.1	1.7	7.0	1.8	1.6	3.4	4.6	3.8	3.4	1.6	1.6	10.6	1.8	2.8	4.7	5.6	3.7	4.3	2.6	3.2	4.1	5.9	4.7	1.6	3.4	30.4	4.0	4.1	1.5	4.7	28.1	5.9	3.8	4.8	2.0	7.3	9.2	2.8	3.7	4.9	3.9	6.9	5.6	2.5	9.8	2.9	1.3	11.9	5.4	3.7	0.3	6.4	5.4	2.9	2.7	3.5	5.4	6.0	7.4	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3	3.0	9.0	3.7	2.2	7.0	11.5	10.1	7.6	0.0	3.4	10.4	2.0	1.2	0.0	2.4	73.9	5.8	4.5	0.0	1.8	1.5	8.0	5.0	2.3	5.8	2.9	15.9	5.8	13.5	22.7	47.3	10.9	5.5	5.0	0.0	5.5	10.1	1.7	0.0	11.7	1.2	7.1	0.0	5.6	2.2	2.1	8.4	1.1	8.7	5.7	2.2
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 111.9;Syncytiotrophoblasts: 182.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.6	2.4	6.5	1.5	12.7	9.8	23.6	9.8	24.4	4.9	8.0	5.2	3.9	5.7	3.9	23.2	7.3	2.9	7.6	4.2	2.1	8.8	12.4	11.1	7.8	12.0	5.4	3.6	15.7	13.9	7.2	5.6	7.0	8.4	4.0	4.6	8.2	11.6	28.3	2.8	5.9	10.9	7.1	2.8	5.6	22.9	18.2	14.7	0.5	1.6	17.0	8.9	2.8	12.0	13.3	10.1	17.1	21.0	2.2	12.3	7.9	2.8	4.9	19.2	16.0	6.8	7.1	4.5	5.8	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1	11.9	13.6	10.4	30.2	26.0	84.0	21.0	12.7	5.3	7.9	19.2	111.9	12.7	18.3	13.6	17.9	18.3	11.2	0.0	7.5	47.4	24.1	34.1	11.6	9.0	19.6	77.9	44.2	20.3	12.1	8.7	44.8	13.6	13.5	9.0	13.7	17.3	12.1	15.8	41.1	6.4	58.6	64.7	41.8	2.3	33.8	28.7	182.4	17.5	11.2	18.5
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm		NA	NA		39000	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.34e-4)"	14.6	13.7	23.4	12.8	29.8	19.0	14.4	34.2	30.1	12.7	14.1	24.4	14.9	16.9	16.0	14.7	13.1	15.7	11.7	11.9	21.7	24.8	32.8	43.3	15.1	13.9	27.2	22.4	18.7	15.5	26.7	24.4	15.1	27.0	12.3	15.9	15.1	12.2	15.3	18.2	11.3	16.1	15.0	20.9	15.3	14.2	24.7	22.4	19.0	15.7	9.5	14.0	11.7	12.1	5.7	9.7	6.3	12.4	4.0	5.8	5.0	15.1	12.9	25.3	9.6	10.2	9.3	17.1	7.2	6.2	14.0	13.8	12.4	13.0	14.6	7.0	8.2	17.9	10.8	15.3	7.7	12.1	13.6	9.7	20.0	15.4	12.7	9.6	9.2	31.0	13.5	12.6	10.9	13.2	12.5	11.6	18.5	21.9	16.2	8.8	5.3	13.0	14.4	9.4	6.9	12.3	11.2	27.2	15.0	8.0	6.6	13.0	12.8	14.6	4.4	8.7	34.3	18.3	8.6	9.4	10.9	14.1	14.9	6.9	14.9	14.8	10.6	11.1	11.9	10.8	0.0	5.8	6.3	5.8	9.7	4.1	4.3	4.0	4.2	8.6	5.7	3.9	3.7	2.9	4.0	12.4	9.7	4.4	5.0	23.4	29.8	34.2	30.1	21.7	24.8	27.2	22.4	27.0	22.4	17.9	30.9	11.7	10.4	6.6	37.4	9.5	12.7	9.4	20.5	17.4	47.1	9.6	16.6	6.3	37.4	7.7	17.6	0.0	6.4	10.4	8.4	7.6	5.8	45.7	9.7	38.1	13.8	11.6	10.0	14.2	13.0	9.2	5.0	15.4	11.6	26.8	6.8	11.5	10.6	39.4	33.8	12.9	8.0	31.5	13.0	5.1	8.1	6.7	13.6	6.4
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	7.0	0.5	2.4	0.1	17.0	56.4	0.0	15.0	40.3	42.3	56.3	0.0	9.1	41.5	12.9	9.2	13.6	20.5	0.3	15.2	16.9	12.8	0.1	10.6	3.1	0.0	31.9	3.6	0.7	53.1	27.3	21.6	30.8	20.3	44.4	36.7	0.2	30.4	23.4	0.0	48.7	3.4	6.5	0.0	5.5	23.0	15.6	47.9	5.9	2.7	1.1	0.0	19.6	0.1	42.6	10.2	0.0	4.3	25.0	10.9	5.1	30.6	6.3	28.4	13.2	39.0	31.3	12.0	26.2	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0	35.7	66.1	149.1	95.2	84.3	0.2	6.9	22.9	58.9	119.4	40.1	0.0	3.0	1.7	32.6	4.0	196.0	5.6	0.0	40.2	1.9	91.8	23.0	129.9	2.9	175.9	0.0	11.6	126.4	165.6	4.9	108.7	168.3	79.2	49.5	16.2	31.8	42.0	24.6	49.8	4.4	0.9	84.1	124.0	2.6	1.9	59.6	2.7	201.5	21.7	108.0
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8"	"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	15.2	0.1	0.4	0.0	115.4	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	79.2	20.3	0.0	0.0	24.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	45.5	0.3	0.0	0.1	0.1	0.0	0.2	0.0	56.5	0.1	0.0	0.1	4.5	68.8	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	871.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2792.3	0.0	0.0	0.0	0.0	192.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1348.9	0.0	0.0	0.0
IGF2		ENSG00000284779	"Insulin like growth factor 2"		11	2129112-2158658	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	8	"liver: 24.1"	"Cell type enriched"	"Detected in many"	5	"Leydig cells: 2784.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;RH-30: 3.3"														"Intracellular and membrane"	NA	NA																							1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	1.9	0.0	0.6	4.7	0.0	0.0	2.5	1.4	1.2	3.5	0.0	0.0	0.0	0.0	9.1	11.3	0.0	0.0	0.0	0.0	3.9	0.3	0.0	350.3	0.0	0.0	0.0	38.1	8.5	19.9	2784.7	1.7	3.3	0.0	0.0	0.1	0.0	0.0	605.3	0.0	0.3	64.7	7.3	3.2	4.3	3.6	0.0	0.0	0.0	0.1
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
KAT2A	"GCN5, GCN5L2, PCAF-b"	ENSG00000108773	"Lysine acetyltransferase 2A"	Q92830	17	42113108-42121358	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048958	Uncertain					NA	NA					"HPA048958: AB_2680571"	"unprognostic (1.71e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.41e-8)"	"unprognostic (3.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-3)"	16.9	15.9	30.2	13.6	28.6	8.6	14.0	24.0	42.0	11.2	11.9	10.9	13.1	14.9	13.9	8.9	11.4	14.2	11.8	7.6	27.8	11.5	10.0	11.8	7.2	11.2	27.6	18.0	23.5	16.5	14.8	11.9	10.7	26.0	12.9	9.6	6.0	17.3	14.5	20.1	19.9	13.4	9.7	13.9	15.6	13.0	7.8	29.7	5.3	11.7	6.4	10.4	11.2	21.7	2.0	1.6	0.1	0.4	0.6	2.7	0.8	10.8	21.0	3.1	11.6	4.4	3.6	13.7	7.1	3.8	15.8	7.8	14.2	8.9	21.4	17.9	5.4	11.9	16.3	12.7	11.3	5.6	11.9	26.4	5.3	12.9	12.8	4.6	14.2	14.3	4.3	9.6	8.8	5.6	4.3	6.2	5.4	13.3	4.1	4.2	11.7	33.8	10.4	6.6	27.2	0.0	8.1	6.1	14.1	4.2	11.0	15.0	6.6	7.6	16.7	5.7	2.4	12.3	6.8	4.8	8.0	8.1	11.6	12.6	11.0	10.5	11.9	5.8	12.2	4.4	0.0	0.4	0.0	0.8	0.0	1.7	2.0	1.9	2.4	1.6	1.6	2.7	0.7	0.1	0.6	0.1	0.4	0.3	0.8	30.2	28.6	24.0	42.0	27.8	11.5	27.6	18.0	26.0	29.7	11.9	11.5	13.1	11.2	10.9	14.2	4.7	20.4	4.0	5.7	17.4	9.8	20.4	3.3	7.9	1.0	17.1	3.8	0.0	6.8	15.3	10.1	8.2	11.5	13.7	10.6	9.5	15.1	19.0	8.5	1.3	30.2	7.2	6.8	6.4	8.6	5.8	6.5	5.8	27.3	2.5	7.4	12.9	10.0	4.7	19.6	12.2	9.4	6.4	16.9	7.3
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	4.0	2.2	3.6	9.1	8.6	5.2	5.1	7.6	5.4	7.9	1.2	2.6	13.7	2.1	9.6	6.8	1.1	5.5	1.6	4.5	12.4	5.2	12.0	6.3	0.4	4.3	1.8	15.6	3.7	3.0	4.7	3.0	9.5	5.1	3.4	7.7	19.4	7.6	1.9	3.9	3.6	0.9	3.8	3.9	5.1	4.2	2.9	7.3	8.1	1.1	2.4	2.8	4.6	17.3	3.6	4.8	8.1	4.9	9.1	3.7	3.4	5.8	7.4	15.4	3.3	8.3	7.9	19.2	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1	29.8	17.3	4.7	10.0	7.6	11.9	56.5	2.5	17.4	14.8	5.2	3.9	5.4	10.0	2.8	2.3	10.5	13.6	23.3	3.8	1.1	9.3	10.0	10.4	26.1	6.5	14.3	11.1	18.4	21.9	1.3	6.1	15.7	16.9	5.4	5.7	12.6	3.7	0.0	4.9	5.3	11.2	6.5	9.9	0.9	0.9	11.3	8.2	13.8	3.1	7.1
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223853	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;granulocytes: 7.6;monocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	7.3	10.5	19.1	12.2	17.8	27.9	13.4	13.5	14.6	8.6	15.6	10.6	7.2	9.8	7.5	8.2	11.7	17.5	7.5	8.1	13.8	9.6	10.0	8.9	12.1	11.4	15.1	12.0	8.8	7.8	3.9	9.8	5.5	13.5	7.0	15.9	7.1	7.6	6.4	19.1	13.3	10.3	10.0	13.0	10.5	7.1	18.7	13.8	16.0	33.5	7.6	11.5	9.2	10.0	1.6	4.2	7.6	9.6	0.3	0.8	1.2	8.4	5.1	7.2	14.9	9.5	15.3	14.2	7.9	8.4	5.2	7.4	8.7	4.9	21.4	19.3	13.1	16.3	10.3	12.1	14.4	11.6	17.9	9.6	10.4	5.6	9.0	4.8	14.5	11.5	7.5	16.8	13.2	12.5	8.5	5.5	10.7	24.7	3.0	9.0	7.7	8.3	6.2	2.2	21.6	8.4	16.6	14.0	15.5	7.5	11.2	19.8	7.6	6.4	15.6	14.8	8.7	15.4	11.8	4.2	10.5	5.5	7.6	9.2	3.0	8.4	12.0	4.2	11.0	24.3	1.3	5.3	7.6	0.6	9.6	0.4	1.3	0.6	0.6	4.2	1.6	0.6	0.2	5.6	0.3	7.5	1.8	0.8	1.2	19.1	17.8	13.5	14.6	13.8	9.6	15.1	12.0	13.5	13.8	0.0	8.0	4.7	3.6	11.3	4.6	9.4	5.1	17.4	14.8	1.8	9.8	2.3	1.7	4.9	0.6	2.4	14.4	0.0	3.8	4.4	3.8	5.9	2.3	6.0	6.8	4.8	6.4	4.9	30.8	0.2	3.4	16.9	6.8	7.2	9.9	6.6	4.9	15.6	6.3	9.1	14.4	0.0	4.7	0.4	12.4	13.9	1.1	4.5	9.7	5.2
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119269-67258087	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.6	14.6	18.6	25.3	23.9	38.1	21.0	36.5	22.8	20.0	21.9	17.8	20.7	15.3	32.0	18.6	32.7	20.2	19.3	18.8	17.4	12.7	16.8	20.3	24.3	30.1	17.9	14.9	27.4	15.3	26.1	21.1	26.0	17.5	23.3	17.1	21.0	22.2	20.5	32.8	28.7	24.1	25.0	14.6	29.0	19.8	27.6	18.6	32.2	19.9	20.3	37.3	24.9	25.9	7.2	1.9	5.0	1.9	4.6	5.2	2.8	25.5	15.4	9.4	14.6	9.3	13.6	7.1	11.2	13.0	20.1	13.8	24.1	13.4	19.7	19.7	15.7	12.4	25.0	15.5	11.1	16.3	33.0	6.9	14.5	18.4	6.0	9.9	12.3	20.1	11.2	13.6	19.7	13.8	11.1	14.6	11.5	13.4	27.8	9.7	17.0	15.9	8.9	19.0	15.9	13.2	20.3	15.8	11.0	8.4	16.1	12.8	10.2	35.9	20.7	21.3	11.6	31.1	12.6	19.5	13.5	9.1	18.5	9.5	15.5	17.0	12.5	11.9	8.9	9.3	0.6	1.9	0.5	4.8	1.5	5.2	6.4	3.6	4.2	1.2	7.2	3.8	3.5	5.0	4.6	1.0	1.9	4.3	2.8	18.6	23.9	36.5	22.8	17.4	12.7	17.9	14.9	17.5	18.6	35.7	36.8	25.7	19.5	36.6	73.1	27.1	38.2	25.4	28.4	15.7	129.6	18.9	0.0	15.1	20.3	31.6	30.8	0.0	12.5	11.7	30.7	26.1	26.5	32.7	19.2	90.6	30.5	27.0	41.3	10.2	19.8	42.0	18.6	31.5	24.9	25.1	20.3	23.0	21.5	9.1	113.7	19.4	25.9	56.1	34.8	41.8	27.0	45.7	23.2	39.3
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7839904-7854796	"Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 190.4;granulocytes: 180.6;Suprabasal keratinocytes: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.7;neutrophil: 11.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	10.7	6.7	3.1	10.6	5.3	17.5	4.4	9.0	7.6	3.9	5.0	6.7	3.1	7.5	6.3	6.1	4.8	6.7	10.4	6.9	3.1	2.5	6.0	6.2	9.8	12.2	5.6	3.1	12.3	9.6	4.0	8.7	6.6	6.6	5.4	1.7	10.2	4.2	3.3	4.7	5.5	8.0	7.6	8.0	8.4	6.1	7.2	3.1	5.9	6.1	7.1	3.1	5.2	4.3	0.7	0.9	11.6	0.8	0.1	0.6	0.4	4.0	5.7	10.9	16.0	4.0	3.0	13.7	3.2	4.8	2.3	2.5	8.2	3.0	9.4	3.9	2.6	3.3	10.1	5.2	4.5	1.4	3.7	3.9	4.4	5.4	5.2	11.5	5.7	13.6	4.6	6.9	5.6	4.6	6.2	4.1	10.1	7.2	4.0	1.0	6.7	8.7	5.2	5.5	3.9	3.3	9.8	2.4	2.5	4.2	7.0	5.8	18.3	4.1	9.6	8.3	6.3	5.4	7.3	2.0	3.4	6.3	6.1	4.5	4.9	0.9	3.2	4.8	3.4	6.7	3.7	0.8	1.3	0.4	0.5	0.4	0.4	0.3	0.2	0.5	0.7	0.4	0.6	11.6	0.1	0.3	0.9	0.1	0.4	3.1	5.3	9.0	7.6	3.1	2.5	5.6	3.1	6.6	3.1	23.8	34.8	16.9	105.1	190.4	43.9	9.9	28.1	6.7	28.4	7.0	29.5	13.0	1.7	24.3	25.9	38.3	46.3	0.0	21.8	12.3	68.9	86.7	180.6	19.5	22.0	36.5	76.6	28.3	40.4	6.5	15.3	69.4	54.0	9.0	35.8	8.9	40.4	43.5	13.1	7.7	16.8	19.4	94.7	18.6	17.3	164.4	43.5	15.2	34.6	91.6
KLF2	LKLF	ENSG00000127528	"Kruppel like factor 2"	Q9Y5W3	19	16324817-16327874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 353.6;Ito cells: 251.0;Smooth muscle cells: 179.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 33.3;U-266/70: 22.9;U-266/84: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055964	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055964: AB_2682989"	"unprognostic (3.22e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.56e-2)"	59.2	17.9	4.4	35.3	6.4	51.2	33.6	3.1	8.7	33.7	16.3	8.5	15.6	6.4	46.3	30.8	28.2	35.3	35.9	29.5	5.2	4.3	12.3	8.1	58.9	64.6	6.3	4.2	54.4	6.6	5.4	9.4	15.9	10.2	26.8	4.9	38.3	10.3	11.1	43.7	19.5	14.4	42.6	7.6	35.6	46.1	23.2	2.5	10.9	16.7	39.4	24.1	50.2	36.1	19.4	1.3	32.0	12.4	10.6	23.5	7.1	3.4	1.1	0.1	0.8	0.2	0.5	1.4	8.3	1.2	3.1	1.3	0.1	11.5	0.3	1.8	4.3	0.6	1.2	0.3	0.0	1.0	0.3	1.4	0.0	0.6	0.1	3.0	0.0	6.0	0.8	0.1	1.0	0.1	4.8	6.9	7.3	0.2	7.5	1.6	0.2	0.7	1.5	0.1	4.9	1.1	0.2	2.2	12.2	0.1	0.2	0.2	0.1	0.6	6.0	4.5	0.0	0.2	4.0	33.3	6.3	4.5	0.4	11.2	22.9	22.0	0.8	2.8	0.0	2.8	21.6	3.3	9.4	17.8	12.4	14.4	17.4	23.5	18.0	1.3	19.4	22.7	18.6	32.0	10.6	10.5	0.2	22.1	7.1	4.4	6.4	3.1	8.7	5.2	4.3	6.3	4.2	10.2	2.5	32.8	89.9	111.6	9.0	21.2	4.3	39.3	7.6	4.0	7.9	3.5	7.9	3.9	0.0	6.4	1.8	353.6	13.6	0.0	5.1	6.9	75.5	10.2	32.4	7.6	71.7	0.0	44.5	251.0	130.3	3.5	82.8	76.1	60.8	0.0	41.9	5.2	38.7	3.5	68.6	1.3	5.9	64.7	179.5	0.9	1.3	23.1	5.5	58.6	4.9	13.1
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	12.1	5.6	15.2	11.4	9.3	11.1	4.5	5.5	8.0	5.8	6.7	11.3	8.8	15.0	11.3	8.0	10.3	10.6	16.1	6.1	11.6	16.5	6.2	29.4	5.2	6.1	5.2	17.5	5.7	5.3	6.2	12.7	17.0	7.3	9.0	9.8	19.1	12.8	7.3	9.5	11.6	10.3	9.2	5.0	8.4	8.8	14.6	5.0	8.5	9.2	12.5	8.1	13.8	4.5	2.9	8.3	7.8	5.9	13.2	9.9	9.0	7.2	9.8	3.7	2.9	10.1	3.7	12.9	5.9	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4	65.5	59.8	31.5	64.8	77.2	147.8	34.4	38.2	53.5	35.2	36.6	143.3	12.2	3.3	26.8	6.6	70.1	19.7	0.0	22.3	8.1	43.5	71.4	26.7	23.1	14.2	184.3	63.8	45.4	32.6	4.7	61.9	26.1	40.5	33.3	29.3	117.0	23.2	14.4	73.9	6.9	144.6	64.7	59.7	11.1	14.9	70.4	5.0	50.7	27.3	49.9
MECP2	"MRX16, MRX79, RTT"	ENSG00000169057	"Methyl-CpG binding protein 2"	P51608	X	154021573-154137103	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 194.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000593, HPA001341, CAB037264"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347"	"unprognostic (1.27e-3)"	"unprognostic (2.60e-3)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.22e-1)"	"prognostic favorable (7.32e-9)"	"unprognostic (7.63e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.05e-2)"	18.6	21.4	29.2	17.0	27.1	33.8	17.6	39.1	33.5	20.2	19.2	17.6	15.9	13.9	20.0	15.1	18.8	21.1	19.5	23.1	22.5	14.0	17.1	16.4	22.8	19.7	22.5	26.7	29.0	21.2	24.3	22.9	13.9	25.4	23.0	8.0	20.8	18.7	23.7	31.6	14.1	15.3	16.2	21.1	23.3	15.0	9.7	24.4	13.8	19.1	8.7	14.3	18.7	28.6	5.6	4.2	22.4	4.9	2.9	6.8	1.8	19.4	11.6	9.8	12.2	8.4	6.0	8.3	9.8	11.0	12.0	19.6	8.9	9.5	23.4	23.2	8.6	19.0	9.3	14.7	11.5	6.1	17.7	17.7	9.0	10.6	5.6	10.3	11.3	18.9	6.1	6.5	11.2	13.2	9.5	9.3	11.5	9.7	20.0	7.2	11.6	13.6	13.0	7.6	14.7	13.0	11.8	10.7	7.7	8.5	8.9	13.8	8.0	7.6	8.9	18.7	5.5	5.8	14.7	9.7	9.1	18.1	18.5	19.7	24.0	17.8	26.6	13.2	22.3	15.6	22.4	3.5	13.3	6.8	3.2	4.8	5.6	4.8	5.5	2.4	4.9	4.6	4.4	16.9	2.9	4.9	4.2	5.0	1.8	29.2	27.1	39.1	33.5	22.5	14.0	22.5	26.7	25.4	24.4	6.0	33.8	38.3	36.3	27.4	82.7	40.4	30.6	17.4	33.0	43.6	194.4	13.1	56.3	31.6	0.5	36.8	24.4	0.0	27.0	13.6	26.3	29.6	50.8	30.8	23.4	93.8	35.1	60.8	37.0	2.1	49.5	41.8	28.7	60.5	17.4	46.1	29.3	28.1	69.3	21.9	81.7	32.3	40.0	7.7	36.0	25.3	15.4	82.9	16.4	29.4
MORC1	"CT33, MORC, ZCW6"	ENSG00000114487	"MORC family CW-type zinc finger 1"	Q86VD1	3	108958239-109118142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 21.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 45.5;Late spermatids: 21.8;Spermatocytes: 37.7;Spermatogonia: 41.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"	"Group enriched"	"Detected in some"	10	"Karpas-707: 4.4;RPMI-8226: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036413	Enhanced					NA	NA					"HPA036413: AB_10669989"					"unprognostic (1.66e-1)"				"unprognostic (4.30e-2)"	"unprognostic (2.17e-2)"		"unprognostic (2.63e-1)"	"unprognostic (7.45e-6)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	2.2	21.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	37.7	41.6	0.0	0.0	0.0	0.0	0.1
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.3	10.7	19.9	19.8	7.6	13.0	17.6	10.7	8.1	10.6	10.2	13.8	18.1	26.2	11.1	7.8	7.5	18.4	14.4	10.2	7.2	17.1	24.2	13.6	9.7	14.1	16.9	17.1	10.5	14.6	12.9	7.5	17.3	14.8	15.0	19.6	15.4	11.4	5.5	24.0	30.8	33.9	28.7	19.1	22.7	29.1	12.1	8.5	8.4	10.5	32.2	33.5	14.4	16.7	15.3	10.6	15.1	16.3	10.8	8.6	9.1	14.1	11.1	23.4	11.2	16.6	10.7	11.6	14.9	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1	3.0	13.6	15.6	26.8	13.9	0.0	8.1	15.3	2.7	7.9	33.2	0.0	10.1	14.9	11.4	24.8	18.0	14.8	23.3	17.3	6.9	18.4	25.2	5.7	11.5	9.4	0.0	17.9	12.9	12.5	9.1	33.4	11.0	11.8	8.2	18.6	0.0	14.9	7.0	30.1	7.7	0.0	19.4	23.4	21.9	11.6	16.7	7.8	15.7	21.8	39.4
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139081	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.4"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	6.8	8.0	8.5	19.7	18.4	21.9	10.3	24.3	12.2	9.8	8.0	8.6	4.9	8.0	9.0	8.5	7.2	7.6	7.4	5.3	9.0	8.2	7.6	7.3	8.6	19.9	8.1	9.8	12.0	7.0	6.7	13.9	13.0	9.2	7.0	8.4	6.7	6.7	6.8	7.1	8.1	9.5	6.8	8.5	12.7	7.2	17.3	9.2	43.4	9.6	7.1	19.4	7.9	8.3	11.7	12.0	14.7	10.6	13.0	14.3	6.2	7.4	3.6	12.5	8.2	2.2	2.1	14.5	4.8	3.8	8.3	10.4	6.1	4.1	24.1	8.8	3.0	7.1	4.0	11.5	5.0	12.3	9.3	8.4	16.6	5.5	8.2	3.3	21.6	7.1	2.6	2.7	7.8	4.7	3.8	7.9	18.8	18.7	7.6	5.1	3.1	31.0	18.0	21.3	3.3	4.8	25.2	15.4	6.5	7.7	8.1	7.8	9.5	7.9	9.4	9.6	13.8	5.6	15.3	4.5	5.5	8.2	5.2	7.1	5.9	6.7	42.8	1.1	12.9	3.5	9.4	9.4	14.7	11.3	10.6	12.9	10.0	11.7	14.3	12.0	11.7	13.9	12.4	7.2	13.0	6.3	11.4	12.9	6.2	8.5	18.4	24.3	12.2	9.0	8.2	8.1	9.8	9.2	9.2	26.8	27.2	56.4	25.5	41.3	0.0	11.7	7.6	17.4	28.4	36.6	0.0	60.2	6.6	29.9	3.7	39.3	25.4	23.3	16.9	56.8	29.0	28.2	57.8	13.4	30.0	0.0	30.9	35.0	26.7	5.0	30.2	40.6	16.9	42.3	29.2	0.0	27.2	31.6	22.3	12.9	0.0	38.8	23.6	122.6	74.3	37.8	50.8	48.4	30.8	32.0
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.5	31.3	4.1	18.8	5.3	6.2	14.0	13.6	6.0	13.7	10.6	23.0	8.0	26.7	15.8	8.0	6.8	24.7	17.0	20.4	6.4	13.3	45.9	12.8	19.3	20.4	8.6	15.0	11.7	9.0	11.7	20.1	10.0	3.7	9.1	15.4	20.9	12.3	5.8	16.9	17.5	5.9	18.8	6.1	16.4	22.7	6.9	17.7	3.2	15.7	8.7	16.7	13.9	9.7	9.2	2.7	9.3	6.1	11.7	11.9	10.7	11.1	38.8	11.1	7.5	10.9	11.3	17.6	15.3	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6	8.9	16.4	12.7	5.2	11.4	7.6	3.6	15.3	10.7	19.4	3.5	11.8	2.6	0.0	8.1	0.4	10.8	5.9	0.0	10.7	4.1	5.9	5.4	4.7	6.6	5.7	9.5	10.9	8.6	3.4	0.4	5.2	5.0	3.3	3.6	8.1	3.5	7.2	3.5	11.3	2.2	5.7	6.5	10.3	2.6	12.0	10.5	0.9	6.9	10.3	5.1
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492812	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		30000	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	61.5	8.6	3.3	20.1	4.1	0.9	45.7	4.4	4.3	33.8	35.5	5.3	17.2	14.0	36.0	20.5	34.3	20.3	38.2	29.3	3.3	2.5	24.8	24.8	30.3	13.4	3.3	3.8	23.7	44.8	8.6	7.6	32.2	6.1	27.4	12.7	20.0	44.5	19.0	20.0	17.1	29.9	40.8	3.6	12.3	24.2	12.6	2.9	9.4	23.0	21.3	18.6	32.0	32.4	7.9	1.7	0.8	3.1	0.0	3.5	2.2	36.1	39.7	4.3	17.6	20.3	20.2	16.6	36.9	30.7	24.4	20.6	26.4	19.9	3.6	26.7	56.8	16.3	30.7	6.4	25.7	12.8	16.0	16.2	3.4	21.6	9.7	30.1	0.3	18.3	15.7	12.8	22.4	12.9	22.4	31.3	2.3	2.7	3.0	20.6	27.6	0.4	0.2	2.7	22.7	7.4	1.4	5.9	6.5	22.4	18.9	1.7	9.6	23.2	33.9	14.8	11.1	27.8	1.8	41.0	35.4	27.2	17.3	31.8	2.4	1.9	1.5	28.2	0.8	30.6	0.2	1.3	0.0	1.5	3.1	0.8	7.9	3.5	1.6	1.7	6.7	1.3	0.7	0.8	0.0	2.6	1.6	3.0	2.2	3.3	4.1	4.4	4.3	3.3	2.5	3.3	3.8	6.1	2.9	116.1	28.1	21.6	34.2	35.3	2.0	63.8	53.5	6.7	40.9	82.0	0.0	49.1	18.3	52.4	13.7	49.6	118.0	23.3	44.8	23.7	45.2	47.9	11.5	36.3	17.3	4.8	37.9	89.0	11.3	8.0	39.1	20.0	60.8	33.3	90.6	4.0	74.6	84.6	45.6	11.3	2.2	116.4	76.0	2.1	8.1	37.3	39.8	6.4	57.2	33.6
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	4.2	7.9	4.9	6.0	0.1	22.1	12.7	7.0	7.7	0.3	0.0	0.0	0.3	8.3	0.2	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.4	0.5	0.0	6.5	0.2	3.4	1.9	15.7	7.4	0.7	2.0	0.0	3.3	0.0	0.0	0.2	15.7	0.0	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.4	2.1	0.1	0.1	12.9	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0											0.0	0.0	0.0	3.8	0.0	28.3	9.0	2.5	2.7	3.4	5.2	94.2	0.3	1.7	1.6	0.7	2.3	0.0	0.0	2.3	0.4	7.4	4.6	0.0	0.0	1.2	41.3	1.2	3.7	0.0	1.3	46.1	0.0	0.0	1.8	2.5	4.8	1.9	0.0	36.0	0.3	26.9	6.5	9.2	0.7	0.9	0.0	0.8	0.0	0.4	1.4
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	10.7	10.2	12.0	15.5	15.2	23.5	29.0	14.2	12.5	29.7	14.6	9.4	26.4	11.0	18.2	30.7	10.0	16.3	18.3	15.4	13.2	13.3	13.0	10.5	19.7	16.7	16.9	12.0	31.5	24.9	21.1	26.6	7.7	14.6	16.9	6.2	14.6	17.6	28.5	12.9	7.7	12.1	18.9	12.3	18.8	12.7	26.7	12.8	5.0	22.4	9.3	21.3	20.7	29.2	1.5	0.5	3.2	0.4	1.1	4.6	0.9	1.5	2.1	4.8	3.1	2.1	1.2	9.6	3.3	5.2	2.5	2.8	2.9	1.4	0.6	2.0	7.8	16.8	0.5	1.0	1.7	0.6	1.9	1.0	4.5	3.5	1.3	0.4	2.6	11.2	2.5	2.2	4.9	4.4	3.7	1.6	1.6	1.7	3.9	2.0	1.2	0.8	1.6	1.7	0.4	1.5	1.9	0.6	1.6	0.3	2.0	3.2	3.4	1.7	1.8	2.7	0.9	1.3	3.2	3.1	5.0	1.4	2.9	3.5	2.6	4.3	5.2	3.6	2.8	2.9	0.2	0.3	0.7	1.4	0.4	4.6	1.2	2.8	3.5	0.5	1.5	3.3	1.7	3.2	1.1	0.4	0.3	0.9	0.9	12.0	15.2	14.2	12.5	13.2	13.3	16.9	12.0	14.6	12.8	17.9	22.7	25.1	75.0	30.1	69.3	17.0	2.5	12.0	10.3	22.7	35.3	14.3	29.9	11.6	144.2	27.0	13.3	0.0	15.8	11.3	18.6	51.5	69.1	6.2	10.6	42.9	11.5	27.6	8.6	57.2	40.0	15.1	35.4	13.6	13.8	32.4	13.9	11.2	38.5	20.3	62.8	77.6	51.5	61.1	42.1	21.0	31.4	46.8	9.6	66.3
PHF19	"DKFZP727G051, MTF2L1, PCL3, TDRD19B"	ENSG00000119403	"PHD finger protein 19"	Q5T6S3	9	120855652-120894896	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 30.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 86.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.78e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (2.74e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.01e-2)"	7.6	7.9	10.3	18.2	21.0	30.0	9.6	10.8	9.9	11.7	10.8	9.3	4.0	4.4	11.7	9.5	14.3	11.7	11.0	8.7	10.9	7.7	5.0	2.9	9.0	23.5	17.0	5.6	14.7	2.5	3.5	15.4	7.8	9.1	11.4	11.1	10.4	4.5	11.6	4.9	6.5	9.6	17.2	10.5	14.0	10.0	5.2	17.0	24.3	5.1	18.6	27.3	11.2	23.0	2.1	5.6	0.9	30.1	1.6	12.1	3.7	8.7	31.2	7.1	15.1	5.5	11.4	1.1	9.5	13.4	44.8	32.4	17.6	20.6	18.2	6.1	13.0	14.2	21.0	19.9	20.4	20.8	18.7	7.6	18.6	41.7	11.2	3.0	28.2	9.2	6.4	3.4	19.3	20.6	12.0	28.8	18.5	51.1	52.4	23.5	21.8	18.7	26.9	7.1	27.3	50.0	14.5	7.6	51.1	13.4	3.0	21.2	9.8	19.1	0.3	9.6	6.3	18.1	11.9	10.7	9.9	11.8	9.4	21.2	26.6	86.9	30.6	6.2	17.1	27.2	0.3	5.6	0.7	2.3	22.0	1.8	2.1	5.2	1.9	5.6	1.3	2.5	2.0	0.9	1.6	30.1	1.9	12.1	3.7	10.3	21.0	10.8	9.9	10.9	7.7	17.0	5.6	9.1	17.0	0.0	9.3	5.2	8.0	8.2	4.3	4.5	2.5	0.0	10.3	0.0	9.8	0.6	1.7	2.4	1.5	8.4	2.0	0.0	1.8	2.2	12.3	5.1	25.4	1.1	24.2	0.0	1.2	4.9	16.3	2.2	7.2	20.2	15.1	2.8	4.1	14.5	2.4	2.9	14.5	1.1	22.2	0.0	14.6	5.6	14.2	5.9	1.1	17.5	10.0	4.7
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.4	21.6	9.6	18.5	9.5	7.6	14.0	8.7	5.8	12.6	7.8	27.0	7.5	21.7	9.3	8.9	12.2	11.0	24.7	12.9	11.2	9.0	12.8	18.7	9.2	18.1	6.7	17.7	10.1	5.8	8.1	18.6	14.5	4.8	9.7	10.1	24.7	5.5	8.6	8.4	13.1	7.5	17.5	12.7	14.3	15.8	21.1	10.2	5.6	15.5	15.0	7.8	9.6	12.8	6.9	6.9	7.5	6.2	15.4	15.3	12.1	13.0	17.5	7.8	7.5	19.0	7.9	15.3	13.4	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9	3.0	7.8	6.1	2.9	3.8	11.5	7.8	15.3	6.7	3.4	8.7	15.7	5.7	3.3	5.9	2.4	5.7	4.2	0.0	4.0	4.4	3.8	4.3	5.8	7.2	10.2	11.1	9.2	4.9	2.8	1.5	5.8	3.1	5.0	1.8	6.1	2.9	5.0	0.0	4.9	3.0	10.1	0.0	4.7	4.2	7.5	2.4	3.2	4.4	9.0	3.7
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
POLR1C	"RPA39, RPA40, RPA5, RPAC1"	ENSG00000171453	"RNA polymerase I subunit C"	O15160	6	43509702-43562419	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	16.2	20.8	11.8	15.6	18.6	7.4	22.1	11.8	19.2	19.1	19.1	16.4	14.1	14.0	22.5	18.0	24.0	23.3	14.5	12.7	11.7	13.3	26.9	26.6	12.4	13.5	12.4	10.3	22.9	30.7	14.2	20.5	18.5	13.4	19.3	17.4	19.1	24.1	15.4	17.5	21.9	12.8	16.2	9.9	21.3	16.1	20.9	11.4	17.4	35.2	18.3	27.9	16.3	16.8	23.0	18.6	2.1	13.4	17.5	26.2	14.7	19.8	16.6	7.3	19.7	11.2	12.2	11.5	12.1	9.0	13.7	11.7	21.9	6.7	22.5	13.3	11.8	11.7	12.1	17.5	15.5	16.0	11.9	18.3	15.3	16.7	30.3	14.1	23.4	10.8	10.8	15.0	18.7	23.7	8.1	10.7	9.5	35.3	6.6	11.9	28.0	12.2	17.0	13.4	80.8	14.4	8.4	11.4	15.1	16.4	27.8	13.5	9.0	10.6	9.2	16.0	5.6	10.0	20.7	12.7	9.8	13.2	10.5	19.1	9.6	21.2	37.6	6.6	16.1	10.8	2.1	13.4	1.9	16.0	10.3	21.7	21.6	19.0	15.8	18.6	23.0	26.2	23.5	1.3	17.5	8.3	16.9	13.6	14.7	11.8	18.6	11.8	19.2	11.7	13.3	12.4	10.3	13.4	11.4	11.9	15.3	11.0	39.5	55.0	7.2	4.5	17.8	44.2	26.1	5.2	5.9	25.7	13.3	23.9	7.2	21.5	4.9	0.0	21.0	14.4	16.4	14.9	13.9	11.1	11.7	4.8	12.5	15.4	7.0	5.6	10.6	9.4	20.3	6.4	11.2	8.1	16.9	14.0	11.0	20.8	14.5	6.5	25.3	27.7	39.0	35.8	11.3	14.1	15.2	34.1
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485935-37503697	"Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	15.4	12.2	10.5	20.2	11.6	9.3	19.7	10.7	9.0	19.0	13.9	10.0	14.9	7.0	20.5	14.7	15.1	17.3	13.7	14.9	9.1	9.2	7.6	23.9	10.1	15.5	9.0	9.2	36.9	25.9	10.3	9.6	8.7	9.5	17.3	9.3	9.5	19.5	18.4	17.2	13.1	9.0	22.4	10.2	10.8	13.0	11.2	11.5	16.0	15.3	13.3	17.1	21.9	16.8	8.1	3.9	1.4	4.3	9.0	16.9	5.5	19.7	18.6	10.3	16.3	19.3	24.9	6.7	17.6	6.8	18.3	16.2	15.9	6.6	28.8	8.5	20.2	12.4	8.3	25.1	20.9	23.1	27.8	11.8	13.8	23.6	11.3	14.5	26.4	9.8	26.4	7.4	35.7	30.9	11.5	9.2	16.1	36.0	12.7	16.0	9.5	18.2	9.0	18.3	13.6	15.3	16.2	9.5	13.8	9.5	7.4	14.7	12.1	11.7	9.4	15.1	8.9	9.2	17.6	6.3	21.7	33.1	18.5	35.0	7.0	9.8	30.3	7.5	16.8	18.0	0.0	2.5	1.4	10.6	4.3	16.9	7.4	10.2	10.8	3.9	8.1	12.8	11.1	0.8	9.0	3.4	2.7	5.4	5.5	10.5	11.6	10.7	9.0	9.1	9.2	9.0	9.2	9.5	11.5	0.0	6.7	8.5	20.9	25.1	6.4	7.6	15.3	5.3	9.1	0.0	3.9	12.9	6.6	12.3	4.4	7.5	2.7	0.0	18.2	17.4	12.1	6.6	8.1	15.8	6.6	3.2	1.7	3.7	8.6	8.6	13.8	7.3	5.0	8.2	7.3	6.7	14.5	0.0	14.2	4.1	5.7	0.0	17.9	11.5	16.1	15.6	7.0	12.9	12.1	11.6
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II subunit E"	P19388	19	1086579-1095380	"Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 562.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	41.4	26.2	29.6	22.8	27.9	19.8	27.6	19.0	36.9	20.1	26.5	18.6	18.4	20.1	21.4	22.6	34.1	26.3	25.8	27.6	29.6	26.3	34.0	57.9	25.1	25.1	30.1	22.6	22.0	21.0	39.7	13.0	26.4	33.4	24.3	29.5	20.3	17.9	18.9	33.2	23.7	26.9	25.7	22.1	23.1	21.5	29.3	15.5	31.9	30.6	21.1	36.7	22.1	20.6	12.8	28.2	17.9	30.4	16.7	17.5	20.9	14.3	13.3	18.7	14.9	25.7	16.0	8.7	10.7	14.8	17.6	10.4	15.6	5.3	12.1	4.8	31.5	2.7	11.7	35.0	11.7	33.0	12.5	10.6	15.8	16.5	14.3	10.2	23.1	11.9	11.7	7.7	12.3	23.4	18.4	16.2	6.4	17.7	13.8	19.8	11.9	12.7	7.2	15.0	10.4	10.2	13.6	18.5	11.5	18.1	16.7	9.5	10.8	17.8	12.4	7.4	17.5	13.1	10.8	22.0	8.9	9.9	16.2	12.3	21.3	28.4	21.0	14.7	15.0	10.2	12.1	30.4	17.9	16.4	20.5	17.5	11.7	15.5	17.2	28.2	12.8	12.4	12.7	16.1	16.7	22.2	19.6	14.7	20.9	29.6	27.9	19.0	36.9	29.6	26.3	30.1	22.6	33.4	15.5	29.8	62.4	90.1	75.3	92.6	50.5	67.4	50.9	58.9	45.5	52.4	39.3	221.3	147.6	142.7	13.0	69.6	118.5	23.3	122.2	211.1	104.5	73.3	70.3	80.1	223.7	52.4	67.8	65.7	94.1	29.8	64.2	133.4	94.5	562.7	71.8	57.9	139.5	77.7	58.4	154.9	42.3	25.8	93.9	81.4	85.2	95.9	196.2	79.8	97.1	90.4
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II subunit F"	P61218	22	37952607-38041915	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	31.7	31.4	37.5	23.4	43.8	23.0	28.2	32.6	54.5	25.2	27.8	57.3	20.4	26.3	24.2	18.7	24.6	23.2	20.3	37.8	33.5	31.2	25.1	58.5	17.9	19.8	44.8	44.1	30.2	26.1	43.5	28.8	21.2	38.4	21.4	21.0	21.0	38.0	29.6	67.9	19.0	25.7	20.8	39.6	16.8	26.9	21.9	48.3	13.1	28.5	23.4	18.0	19.0	26.8	36.1	49.5	52.4	36.7	40.1	38.5	29.3	34.3	40.7	28.8	30.7	34.6	20.3	25.7	32.3	18.9	33.1	31.2	47.2	12.2	26.6	23.3	27.9	33.2	24.8	39.6	31.2	16.4	32.5	66.9	24.8	41.9	64.0	30.2	48.3	15.9	26.9	23.7	44.7	17.3	17.2	28.3	29.7	47.3	22.5	24.0	48.9	37.5	58.3	41.4	40.0	31.0	37.4	26.4	31.0	18.2	21.4	43.3	16.2	29.7	21.3	46.5	17.5	14.9	33.5	25.9	29.2	41.5	36.1	36.4	25.3	39.2	55.5	29.7	24.6	32.8	34.5	36.7	52.4	34.3	33.3	32.1	36.1	30.0	33.2	33.4	28.9	27.3	27.2	46.2	40.1	28.1	49.5	38.5	29.3	37.5	43.8	32.6	42.7	33.5	31.2	44.8	44.1	38.4	48.3	35.7	81.8	93.0	98.8	181.6	23.8	0.2	117.2	73.6	56.9	115.1	23.6	207.5	164.2	148.0	67.2	91.8	136.4	46.7	138.2	263.3	141.6	91.0	88.8	237.4	154.9	27.0	112.4	95.2	90.9	30.1	147.9	85.4	214.2	119.0	111.6	70.5	150.4	114.3	142.1	213.7	31.1	155.2	124.9	159.7	214.2	196.1	177.2	87.1	119.2	105.4
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II subunit H"	P52434	3	184361718-184368596	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	18.1	32.6	19.6	19.2	17.5	14.8	24.5	24.2	24.6	28.8	29.9	13.8	19.8	32.0	19.9	23.5	26.7	23.1	26.7	16.3	17.8	16.3	34.1	41.0	17.8	21.7	16.4	17.0	21.8	46.4	15.8	20.7	27.2	17.0	19.2	33.6	19.7	26.0	17.0	19.9	20.7	38.8	20.0	13.2	21.5	25.6	20.6	12.5	28.1	29.7	23.1	26.3	18.5	16.2	17.4	18.2	7.7	15.3	14.6	26.6	11.5	49.5	17.4	18.8	27.8	21.0	14.9	23.4	18.7	19.7	25.7	33.1	44.5	23.8	28.1	47.0	14.6	39.1	20.1	33.6	33.6	22.9	27.4	44.4	26.9	20.5	27.8	19.0	28.3	15.7	19.2	19.2	16.7	30.3	23.1	26.5	28.2	20.7	18.6	20.3	58.8	27.9	37.9	20.4	62.1	36.4	16.4	17.3	38.0	30.5	22.5	28.5	20.3	15.8	49.1	27.2	19.0	61.4	22.8	13.8	12.2	19.4	16.3	49.8	37.5	38.8	52.5	19.4	30.3	16.3	3.4	9.6	7.7	15.2	15.3	18.4	17.4	18.0	16.2	18.0	16.4	26.6	19.7	0.7	14.6	9.6	18.2	18.7	11.5	19.6	17.5	24.2	24.6	17.8	16.3	16.4	17.0	17.0	12.5	35.7	40.3	38.7	63.2	100.7	21.3	13.7	53.5	36.1	31.8	41.8	15.7	88.4	119.3	59.7	14.9	50.9	83.1	0.0	78.5	122.8	54.6	65.8	31.1	57.8	53.4	23.8	53.5	32.5	21.4	9.6	42.6	31.5	49.0	30.7	62.9	23.6	80.3	69.9	26.2	102.6	23.4	38.8	60.4	72.4	110.1	64.7	102.3	28.8	72.3	83.9
POLR2K	RPB10alpha	ENSG00000147669	"RNA polymerase II subunit K"	P53803	8	100150584-100154002	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047477			Supported	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA047477: "	"unprognostic (3.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.75e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (5.73e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.43e-2)"	31.4	43.7	51.1	22.0	38.7	32.9	41.5	34.7	53.0	33.8	28.5	24.7	20.8	21.2	29.3	42.7	33.1	23.8	23.9	35.3	46.2	51.0	47.5	46.6	27.3	29.7	49.0	35.0	26.2	20.2	28.2	36.8	27.1	46.0	37.8	31.8	21.5	32.7	33.3	23.3	21.8	28.4	34.8	40.4	31.9	26.6	22.6	23.7	24.9	36.6	22.3	31.5	39.3	23.1	29.0	30.0	24.2	19.2	25.0	30.9	24.2	38.7	19.6	25.4	17.9	27.3	24.9	17.1	28.7	23.7	29.3	35.7	12.1	26.7	26.0	57.1	22.7	17.2	17.9	27.2	23.7	38.8	41.3	30.1	35.3	24.8	25.5	21.6	22.7	25.7	20.2	31.7	23.3	23.9	19.2	26.6	30.7	27.5	25.5	28.6	24.6	57.5	33.7	26.4	55.8	39.0	22.6	14.7	37.5	36.5	21.9	53.4	35.1	19.5	17.5	41.6	25.8	35.8	34.7	20.1	17.3	24.9	26.7	30.5	26.3	41.5	40.9	32.9	40.1	26.9	24.2	15.2	22.1	23.7	19.2	28.2	29.0	30.9	29.4	19.0	19.7	27.1	29.3	5.8	25.0	18.2	30.0	30.9	24.2	51.1	38.7	34.7	53.0	46.2	51.0	49.0	35.0	46.0	23.7	62.5	52.6	109.1	130.8	144.5	56.3	82.6	79.0	57.6	46.6	139.6	15.7	120.3	373.0	129.1	4.5	101.4	82.6	93.5	113.7	159.7	121.8	169.5	108.3	110.7	133.6	46.1	117.2	79.2	67.1	12.6	108.4	91.7	129.9	180.3	82.5	71.2	120.6	71.9	114.2	283.0	42.3	71.1	124.9	125.4	165.5	148.7	115.1	121.8	77.5	235.5
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II subunit L"	P62875	11	837356-842545	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 87.6;PC-3: 112.2"	"Low region specificity"	"Detected in all"							HPA073614			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073614: "	"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	42.9	27.7	22.4	18.4	18.3	16.9	63.3	10.1	18.8	16.6	28.3	9.9	29.7	18.7	14.1	23.8	37.5	15.0	28.5	86.7	19.2	17.3	32.9	43.3	26.3	21.2	18.8	10.7	16.6	88.3	14.8	21.1	21.0	12.5	19.3	11.5	23.0	41.6	35.4	44.8	17.3	18.9	21.5	13.5	19.2	17.1	18.3	9.3	18.7	37.9	41.8	15.7	17.6	21.0	28.6	52.3	43.0	44.1	41.7	38.6	42.2	16.0	87.6	8.3	10.3	23.9	17.4	7.5	20.7	14.5	20.5	13.7	25.6	15.0	10.1	5.7	25.7	17.4	10.8	12.3	24.8	6.5	9.3	60.4	9.6	26.1	32.3	14.2	9.2	7.8	28.6	11.2	11.6	5.8	12.5	16.2	10.7	10.2	11.2	24.1	40.5	9.3	9.7	13.0	18.7	112.2	9.1	6.7	15.4	24.7	12.4	16.8	5.3	20.6	21.2	15.9	4.7	12.7	5.5	18.0	13.9	11.0	7.6	12.8	6.8	7.8	9.8	21.0	9.1	12.2	26.4	44.1	43.0	36.1	38.4	38.6	28.6	34.4	35.7	41.7	26.0	29.5	35.6	11.5	41.7	25.9	52.3	33.0	42.2	22.4	18.3	10.1	18.8	19.2	17.3	18.8	10.7	12.5	9.3	381.2	358.3	236.7	203.3	543.4	62.5	432.3	639.5	250.3	323.0	499.0	23.6	587.7	1090.9	434.7	67.7	336.6	720.6	350.4	588.2	345.4	532.7	243.7	259.8	1459.1	606.2	47.7	482.2	661.1	436.0	177.8	283.0	301.5	624.2	530.2	452.3	186.9	631.2	462.9	239.7	1293.9	56.1	155.2	446.5	174.7	248.7	608.9	376.0	284.4	422.8	251.0
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"	P49335	X	83508261-83512127	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"brain: 39.0"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 10.4"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	145	"AF22: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062295			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.5	0.5	3.3	0.5	39.0	0.6	0.5	5.0	15.2	0.5	0.7	2.4	0.0	0.5	0.5	0.5	0.5	0.5	1.3	0.5	2.8	1.6	2.5	0.5	0.5	0.5	2.4	3.7	1.1	0.5	0.5	0.1	0.5	2.4	0.5	0.6	0.0	0.5	0.5	0.5	0.5	0.5	0.6	1.7	0.5	0.5	0.5	6.6	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	39.0	5.0	4.2	2.8	1.6	2.4	3.7	2.4	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"NTERA-2: 33.7;SuSa: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.4	1.1	0.2	0.3	0.2	1.1	0.2	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2	0.2	0.1	1.7	0.3	0.2	0.4	1.2	0.2	0.2	0.2	0.6	0.3	5.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.6	1.0	1.4	1.6	1.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	9.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.6	1.0	0.4	0.8	1.4	1.1	0.7	0.3	1.6	2.5	1.9	1.4	1.0	1.6	1.0	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Mucus-secreting cells: 239.8;Muller glia cells: 245.0;Peritubular cells: 441.6;Sertoli cells: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	47	"plasmacytoid DC: 48.0"	"Lineage enriched"	"Detected in many"	47	"dendritic cells: 48.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 34.4;HSkMC: 8.4;REH: 32.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	79.6	24.3	14.0	6.2	23.2	8.3	30.4	11.6	32.0	49.1	7.1	8.5	18.6	5.9	19.9	17.1	10.9	11.6	11.8	20.1	14.7	15.5	30.2	85.9	5.6	3.7	10.0	22.5	33.5	17.5	7.2	81.3	2.6	22.2	17.8	6.9	6.6	49.4	51.8	37.2	9.1	6.1	4.3	19.6	12.2	6.1	13.8	8.9	9.1	37.7	9.2	2.5	6.2	5.5	0.0	48.0	0.0	1.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	34.4	1.9	0.1	0.4	0.6	0.0	0.1	1.4	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	3.8	0.2	0.0	0.1	8.4	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	3.4	6.2	0.6	0.7	0.6	2.1	32.9	0.0	0.0	0.7	0.0	6.2	0.2	0.5	0.4	7.2	1.0	0.0	0.0	1.9	0.0	0.3	0.2	0.1	7.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.0	0.0	0.3	14.0	23.2	11.6	32.0	14.7	15.5	10.0	22.5	22.2	8.9	26.8	30.8	3.7	47.7	15.2	21.5	61.3	12.7	8.1	40.9	141.3	3.9	2.5	11.6	55.0	2.1	17.5	18.7	0.0	1.1	2.2	69.9	113.7	8.1	13.2	3.4	6.4	213.7	10.4	3.7	4.2	101.5	8.8	28.7	3.6	239.8	245.0	13.9	15.8	441.6	3.8	20.0	556.2	153.3	1.6	1.6	11.5	5.6	6.9	22.1	20.7
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		27000	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	23.8	33.6	28.2	34.3	27.8	23.4	29.1	30.5	35.1	32.2	24.1	32.0	42.3	20.5	36.0	29.2	26.0	35.4	21.3	24.0	27.9	24.8	25.2	25.4	23.0	43.9	30.6	29.0	37.6	31.3	27.0	32.9	26.2	26.9	24.2	35.5	31.2	30.1	43.1	31.8	24.9	26.8	32.6	26.9	27.6	28.8	53.4	31.4	73.3	35.8	20.5	65.2	32.5	26.6	33.7	45.4	26.7	39.4	33.1	32.4	48.4	15.6	13.7	39.2	28.6	12.1	11.5	15.9	11.9	10.4	24.4	23.8	19.6	32.2	47.5	13.2	14.1	14.1	10.1	42.9	12.4	26.3	18.5	20.6	44.3	27.7	25.7	17.5	41.8	19.2	12.6	15.8	18.4	12.0	19.0	18.0	32.9	31.1	34.1	20.8	10.9	53.5	13.1	43.6	15.5	16.0	52.0	41.3	41.2	17.1	33.5	37.5	22.3	28.2	10.1	19.3	40.4	17.3	19.3	14.9	14.8	15.1	18.7	16.0	27.0	28.3	53.3	17.7	33.8	22.7	26.4	38.8	26.7	31.1	39.4	32.4	33.7	29.7	31.4	45.4	26.6	26.7	28.8	10.2	33.1	35.3	38.3	30.3	48.4	28.2	27.8	30.5	35.1	27.9	24.8	30.6	29.0	26.9	31.4	38.7	41.4	104.6	60.7	63.4	104.9	19.4	79.0	50.9	46.6	69.8	135.5	102.1	71.3	72.0	18.9	58.2	40.2	23.3	50.7	69.8	69.6	53.3	47.4	69.1	71.5	100.1	93.2	70.6	73.4	13.7	73.6	63.2	47.2	72.1	69.7	74.5	62.2	28.8	83.1	53.7	104.1	97.0	47.5	120.2	77.3	67.8	71.5	85.3	75.6	47.1
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870414	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 376.6;Syncytiotrophoblasts: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		25000	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	16.0	81.2	16.6	21.1	26.7	20.3	15.5	13.3	16.2	34.6	22.8	15.3	103.2	13.1	32.3	77.3	20.9	24.5	19.7	36.2	15.1	13.1	17.3	18.5	14.3	19.7	13.7	15.5	41.6	19.0	47.8	16.0	28.7	12.2	26.2	18.1	16.5	19.0	87.6	78.2	16.4	17.9	25.9	15.9	16.0	23.5	31.6	13.6	30.8	18.1	18.2	24.5	24.3	18.5	36.6	29.4	23.7	41.2	32.8	37.7	27.3	54.1	40.3	30.7	40.4	19.3	22.8	19.5	27.0	27.1	39.8	45.1	23.6	35.9	59.9	41.5	26.1	45.8	28.7	54.7	40.1	52.8	33.9	75.1	25.3	49.0	28.0	16.4	38.2	30.7	17.7	14.8	45.8	33.6	25.6	39.8	25.3	25.3	32.0	31.4	36.4	42.7	35.4	34.5	26.2	37.5	37.5	56.5	70.7	28.9	36.5	28.6	21.2	50.9	24.5	23.9	45.1	81.3	23.2	18.3	19.2	19.7	50.6	29.9	22.4	32.0	78.7	24.7	25.8	23.3	16.6	18.3	23.7	36.4	31.3	34.8	36.6	30.4	37.7	25.4	31.0	32.2	35.9	7.4	32.8	41.2	29.4	27.9	27.3	16.6	26.7	13.3	16.2	15.1	13.1	13.7	15.5	12.2	13.6	47.6	54.2	48.2	88.5	66.4	28.9	94.0	30.6	84.3	85.3	52.4	27.5	376.6	66.3	71.3	10.8	45.8	40.0	0.0	65.2	134.7	86.4	63.3	56.6	33.9	93.5	23.8	58.3	39.9	27.6	22.8	105.3	44.7	79.2	75.7	53.5	73.6	61.9	31.6	176.0	51.2	38.7	135.8	87.2	52.9	107.5	53.3	445.1	67.8	67.4	67.3
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109053-120115937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.1;brain: 9.2;testis: 27.8"	"Cell type enriched"	"Detected in some"	39	"Spermatogonia: 154.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Cell type enriched"	"Detected in some"	6	"T-reg: 8.1"	"Lineage enriched"	"Detected in single"	30	"T-cells: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8"									"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.2	3.9	0.4	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	8.1	0.0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	0.0	3.9	0.1	1.7	0.1	1.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.0	1.4	0.0	1.3	0.0	0.0	2.9	154.2	0.3	0.0	0.0	0.1	0.0
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197389784-197435091	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		840000	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	53.9	49.9	36.5	54.5	44.9	88.0	57.9	60.8	47.3	72.3	54.2	44.3	45.6	36.8	64.6	72.0	50.5	53.3	43.1	39.6	34.7	26.0	49.7	50.7	53.1	65.3	56.5	27.7	73.6	60.5	66.2	81.4	64.6	46.7	50.0	51.0	37.0	54.4	45.4	49.3	48.5	67.8	41.2	50.2	88.1	48.8	33.3	53.5	113.0	53.3	38.0	65.7	62.4	56.0	32.7	41.9	41.1	37.8	39.6	45.9	29.4	30.2	27.8	62.7	34.2	48.6	49.7	52.6	42.4	43.4	37.0	45.5	53.0	32.7	57.9	28.6	43.1	38.4	29.4	62.6	34.4	58.0	44.3	38.9	61.2	68.0	62.3	36.7	65.0	44.7	51.9	33.7	38.6	47.5	63.1	43.1	38.6	43.8	40.0	41.0	26.6	59.7	62.6	49.3	34.3	44.0	52.7	53.6	38.4	51.5	77.0	35.2	43.6	40.5	24.8	29.0	81.0	24.5	49.8	43.4	29.1	25.0	29.3	30.1	36.4	59.2	83.1	27.9	39.3	32.1	27.7	33.1	39.1	37.5	37.8	40.6	32.7	32.5	35.3	41.9	30.8	33.9	33.9	41.1	39.6	36.1	23.8	45.9	29.4	36.5	44.9	60.8	47.3	34.7	26.0	56.5	27.7	46.7	53.5	166.7	222.4	88.0	131.1	105.8	96.4	104.9	73.9	257.0	221.8	87.2	68.7	93.6	48.0	91.8	6.7	106.2	77.2	46.7	82.1	86.2	104.2	87.4	231.0	63.5	87.0	89.0	106.0	112.3	145.9	14.9	111.4	119.2	72.6	130.8	98.8	119.0	91.7	60.4	98.3	63.2	88.9	116.4	99.9	81.4	93.6	103.8	119.3	119.3	74.2	125.4
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261958-41309497	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 270.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1600000	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	20.1	3.4	4.6	2.4	7.5	0.3	73.2	10.8	5.6	58.4	6.1	15.2	8.0	3.0	35.6	19.3	9.7	25.9	15.5	43.9	7.8	2.5	30.6	1.5	1.8	0.9	4.5	6.7	12.5	1.5	0.6	0.7	9.9	24.1	12.8	7.8	19.3	73.2	27.1	1.9	20.8	5.4	21.4	2.8	5.0	11.0	11.1	13.7	0.0	3.3	18.4	5.1	10.9	41.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	6.3	0.1	5.7	0.3	1.2	10.9	57.4	16.6	15.8	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.8	4.4	23.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.0	21.4	1.6	1.6	270.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	17.1	0.0	0.0	0.0	1.3	0.0	35.3	0.0	0.3	1.5	0.4	0.0	3.3	23.2	0.0	0.1	0.1	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.5	10.8	5.6	7.8	2.5	4.5	6.7	24.1	13.7	0.0	0.0	0.0	104.7	10.0	1.5	175.8	0.0	0.0	1.2	59.3	2.0	0.7	68.0	3.1	4.8	6.7	0.0	0.0	0.0	55.3	47.0	19.9	0.0	0.0	1.7	1.6	0.0	15.4	0.0	13.0	535.6	1.4	94.5	0.0	0.0	51.5	0.1	0.0	122.4	3.5	1.5	0.0	4.1	1.6	20.6	4.8	0.7	0.0	0.0	8.5
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.3	9.6	15.2	16.9	14.5	11.2	9.5	11.6	12.0	16.0	14.3	10.5	7.2	17.6	6.3	7.7	10.0	6.7	18.8	3.9	17.2	9.4	10.9	9.3	7.2	8.2	13.3	10.0	7.2	10.3	9.4	9.6	16.6	17.2	6.4	10.1	11.8	9.6	11.6	6.7	9.3	13.9	18.8	5.4	15.3	16.9	12.0	6.9	7.5	5.2	9.8	13.5	21.3	14.1	14.7	13.7	10.2	9.3	5.3	12.5	11.6	11.0	11.2	8.1	9.6	34.9	6.4	15.2	5.1	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3	17.9	6.1	10.4	16.4	34.8	11.7	27.0	15.3	1.4	9.1	5.2	25.5	5.7	5.0	3.9	171.4	12.8	17.4	23.3	4.7	4.3	17.6	23.9	11.5	14.8	7.8	11.1	41.1	14.1	20.9	29.0	16.4	13.5	15.1	1.8	16.9	7.0	6.4	10.5	18.4	6.3	13.4	0.0	38.2	20.6	15.4	41.5	10.4	13.8	12.4	14.9
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.6;skeletal muscle: 108.7"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	14.1	11.0	30.2	8.1	36.0	10.7	9.1	14.3	38.8	11.0	8.4	78.1	4.0	9.3	9.7	7.8	17.1	12.9	10.7	20.3	36.9	23.5	9.0	12.0	10.8	8.8	52.3	20.5	17.3	9.5	10.1	6.2	7.7	40.8	9.8	7.6	5.8	14.9	11.2	108.7	13.7	9.3	12.8	86.6	9.9	9.0	7.9	46.3	3.2	10.1	23.4	8.9	10.6	7.1	13.2	21.5	28.0	33.0	16.6	23.5	22.1	8.2	5.2	4.4	11.1	25.6	17.6	3.0	6.1	10.9	9.5	12.3	9.3	5.3	2.9	13.3	11.3	7.3	4.5	8.1	13.1	5.8	13.2	8.4	5.6	5.9	5.6	18.1	3.9	12.4	18.4	15.8	7.8	9.4	11.8	16.7	9.4	5.2	22.9	14.5	4.7	7.8	3.0	0.7	14.1	7.3	10.4	12.6	8.0	7.7	7.4	11.3	5.1	7.1	9.5	6.7	3.9	4.3	10.1	15.8	12.9	2.8	19.9	9.0	9.4	4.5	6.6	10.3	9.8	11.9	19.5	27.3	28.0	23.5	33.0	14.6	12.2	11.4	16.1	21.1	13.2	7.5	12.5	20.7	16.6	25.8	21.5	15.5	22.1	30.2	36.0	14.3	38.8	36.9	23.5	52.3	20.5	40.8	46.3	14.9	20.8	11.4	27.5	45.8	26.8	30.8	7.6	29.4	20.5	12.2	33.4	28.9	31.5	27.0	174.5	26.3	34.2	23.3	15.3	12.8	23.1	19.4	25.3	16.2	56.7	28.6	16.8	23.9	33.7	57.6	28.7	34.2	43.9	14.4	20.4	20.6	21.1	18.6	38.5	23.3	27.0	19.4	35.0	12.7	5.9	52.6	35.4	43.6	15.8	22.6
SIRT3	SIR2L3	ENSG00000142082	"Sirtuin 3"	Q9NTG7	11	215458-236931	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026809, CAB037142"	Approved					NA	NA					"CAB037142: AB_1079982, HPA026809: AB_10601160"	"unprognostic (1.76e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.85e-9)"	"unprognostic (1.04e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.75e-2)"	8.2	9.3	15.1	8.2	26.3	8.6	17.4	16.7	24.5	8.4	9.9	16.2	8.2	11.2	11.2	36.8	8.4	13.2	6.9	19.8	14.7	14.8	10.4	15.2	8.6	10.7	11.9	16.2	17.4	12.8	15.0	18.7	6.1	17.1	12.6	12.9	15.4	12.0	11.9	21.2	17.3	11.3	9.2	8.8	11.1	9.0	16.5	11.9	4.4	13.4	9.3	12.6	7.9	7.1	7.2	6.3	3.7	8.0	10.5	9.3	4.0	7.1	9.7	13.2	14.0	16.6	19.6	6.5	10.2	9.4	8.8	7.1	8.1	17.1	4.5	4.8	7.0	7.8	13.2	6.6	6.1	8.2	8.5	9.5	5.5	9.9	10.0	7.0	7.2	13.8	15.3	12.1	8.1	9.0	14.2	5.5	8.8	11.3	8.9	4.0	8.8	3.0	11.2	6.0	7.3	10.8	8.0	10.9	7.4	8.8	4.9	7.7	6.1	8.6	13.4	4.5	8.9	9.7	1.8	7.4	9.0	4.3	2.5	3.0	15.6	12.4	6.0	9.5	6.0	4.8	0.0	4.2	3.7	5.6	3.6	6.2	7.2	5.2	6.4	4.0	6.8	9.3	7.6	2.4	10.5	8.0	6.3	5.5	4.0	15.1	26.3	16.7	24.5	14.7	14.8	11.9	16.2	17.1	11.9	3.0	6.2	7.6	6.9	4.4	6.6	20.2	10.2	6.7	4.5	5.2	7.9	10.1	28.2	6.4	17.0	6.0	8.0	0.0	5.1	9.1	7.5	4.8	10.3	16.3	7.6	9.5	5.8	8.0	2.7	17.6	8.3	3.8	10.1	3.6	8.4	11.5	4.4	8.7	8.5	15.7	8.4	0.0	5.2	17.0	11.4	3.6	5.7	6.1	9.8	3.9
SIRT4	SIR2L4	ENSG00000089163	"Sirtuin 4"	Q9Y6E7	12	120302316-120313249	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage"	Transferase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 6.6;Early spermatids: 17.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029691, HPA029692"	Enhanced					NA	NA					"HPA029691: AB_10600118, HPA029692: AB_10611520"	"unprognostic (2.62e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.74e-3)"	"unprognostic (2.31e-1)"	0.4	4.4	1.8	0.7	1.6	0.0	0.9	5.1	3.2	1.1	2.6			3.8	1.9	0.6	1.3	1.4	1.0	4.4	1.7	1.7	3.6	3.7	1.5	1.0	1.2		2.8	1.9	2.4	0.6	0.6		1.1	0.8		3.0	1.4	10.2	3.3	1.2	1.8	0.7	1.2	1.9	5.8			1.9		0.8	1.2	1.0	5.1	4.8	8.5	1.8	2.9	7.4	1.8	0.9	2.3	3.2	1.6	10.1	3.4	1.5	2.3	2.7	1.8	5.0	2.5	1.6	1.7	2.7	1.3	2.6	0.6	3.2	1.1	3.3	3.2	4.2	0.0	0.5	1.9	2.5	1.7	0.8	3.0	2.7	1.0	0.7	5.5	2.6	4.8	3.2	0.2	2.9	1.3	3.0	2.7	1.8	0.8	1.9	3.8	5.9	1.6	2.6	0.2	3.2	2.7	1.7	0.2	1.4	5.6	3.8	0.7	0.4	1.6	2.7	1.4	0.5	4.0	3.4	0.4	1.5	1.0	2.4	8.5	1.8	0.2	5.2	0.7	7.4	3.3	3.4	4.1	1.0	5.1	5.9	5.2	0.0	2.9	0.1	4.8	0.3	1.8											6.0	1.3	2.0	0.5	0.3	0.9	4.2	0.0	0.0	3.4	0.0	2.0	1.2	6.6	1.2	17.1	0.1	0.0	0.0	1.0	0.9	1.3	0.4	0.0	1.5	0.6	4.8	0.0	0.0	0.0	2.3	1.1	0.4	0.0	0.0	0.8	1.7	0.8	1.1	2.1	3.8	2.8	0.0	1.0	1.7	0.7	1.3	0.7	0.7	0.6	0.0
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574529-13615158	"FDA approved drug targets, Predicted intracellular proteins"		Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 47.2;Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	5.9	6.2	8.8	6.8	10.4	5.9	9.2	11.1	13.5	4.9	7.2	6.4	12.5	8.1	6.8	6.7	5.7	8.0	6.6	22.9	8.5	8.3	9.9	29.9	9.8	6.9	9.5	6.9	8.8	10.5	12.9	7.6	5.3	8.3	6.5	8.3	6.2	8.6	8.7	25.8	8.8	8.5	6.2	6.9	9.5	7.6	6.6	6.1	7.5	8.5	7.0	6.5	6.8	6.0	9.2	4.6	10.9	9.3	7.3	10.0	5.6	5.8	4.6	5.9	7.6	3.7	4.8	4.4	3.0	3.2	3.3	5.0	7.3	7.0	8.4	18.3	2.4	7.3	9.5	4.1	5.9	5.0	3.8	6.8	5.3	4.2	11.8	6.1	4.3	4.6	5.2	12.1	2.9	10.4	7.2	6.0	11.9	7.5	3.2	3.9	7.1	4.7	8.5	4.9	9.1	7.3	8.4	3.8	15.3	6.8	6.4	9.7	3.5	3.4	5.9	13.4	16.7	6.8	2.8	5.3	5.1	2.9	3.1	3.3	7.8	8.8	5.7	2.9	4.3	4.8	0.5	4.5	10.9	8.1	6.1	8.2	9.2	10.0	7.9	4.6	9.1	9.5	8.5	1.5	7.3	9.3	4.6	7.2	5.6	8.8	10.4	11.1	13.5	8.5	8.3	9.5	6.9	8.3	6.1	26.8	2.7	9.1	9.2	3.7	6.4	47.2	10.2	21.4	17.0	10.4	0.0	17.1	44.7	10.5	2.2	8.7	9.6	23.3	6.0	9.0	4.9	5.7	0.0	22.2	8.5	1.6	5.8	10.4	10.4	0.5	7.5	6.1	5.0	5.4	12.6	8.4	6.7	13.9	5.3	24.0	6.2	0.0	5.0	6.5	7.8	4.0	8.9	6.9	16.5	7.3
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 17.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027284, HPA028246, CAB037261, HPA053669"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224"	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	6.2	5.9	6.7	10.1	12.8	22.6	6.4	17.0	11.4	8.2	12.9	7.0	9.0	14.3	5.5	4.6	28.8	7.2	10.6	3.9	6.7	2.6	7.9	9.8	7.9	11.3	11.0	6.6	4.8	18.7	4.9	7.8	8.8	7.6	7.1	6.7	3.7	12.7	7.0	5.3	15.7	15.3	5.1	5.7	14.1	18.4	8.9	8.8	8.3	6.7	7.3	16.4	8.3	12.3	3.9	1.8	17.4	3.4	1.3	2.6	1.2	15.3	12.8	1.6	5.6	4.2	4.0	10.3	7.8	6.6	9.2	8.7	11.0	12.3	6.9	6.1	4.3	5.8	11.1	6.3	4.8	3.0	5.9	13.6	6.0	6.2	17.3	12.8	7.8	12.4	4.0	15.2	8.8	7.3	3.8	6.8	3.8	6.4	3.4	4.3	12.1	8.3	11.1	4.0	23.9	13.3	5.6	3.3	6.4	8.9	10.1	6.7	8.8	9.0	21.7	10.0	3.2	9.0	18.7	5.3	4.1	9.1	7.7	14.1	5.7	1.8	5.0	10.1	10.7	6.7	3.0	2.3	17.4	2.6	3.4	0.9	3.3	2.0	2.1	1.2	3.9	1.8	0.6	3.8	1.3	2.6	1.8	1.0	1.2	6.7	12.8	17.0	11.4	6.7	2.6	11.0	6.6	7.6	8.8	11.9	9.8	27.4	19.4	33.8	22.2	4.0	20.4	16.0	3.4	17.4	53.0	25.1	8.3	18.8	17.0	15.3	59.6	0.0	12.0	29.1	12.9	25.0	11.5	14.7	23.3	28.6	19.5	14.1	19.8	9.1	13.3	24.8	23.6	45.9	28.5	19.3	36.4	49.1	9.6	10.5	35.9	0.0	17.5	37.1	38.4	48.6	41.2	44.8	31.8	44.5
SLC50A1	"HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1"	ENSG00000169241	"Solute carrier family 50 member 1"	Q9BRV3	1	155135344-155138857	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 115.3;Mucus-secreting cells: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018095	Approved					NA	NA					"HPA018095: AB_1856048"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (4.36e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.39e-2)"	11.6	23.4	4.9	16.3	5.7	7.2	13.6	4.2	6.7	13.6	19.8	5.6	28.7	17.2	11.5	49.0	20.3	10.0	21.3	7.5	5.1	7.0	23.8	34.5	22.8	24.3	5.3	4.3	13.6	55.3	12.7	10.3	19.5	6.2	14.4	25.0	11.3	37.5	17.2	4.5	15.9	28.6	9.8	6.1	27.0	19.9	9.3	6.7	12.8	23.4	15.9	25.0	12.4	10.2	32.2	15.3	12.0	18.2	24.0	14.7	15.3	15.8	4.9	5.2	9.4	13.7	13.1	10.7	6.2	16.1	10.5	14.1	8.6	54.8	11.2	17.1	9.1	11.1	22.6	7.1	18.8	8.2	19.6	2.4	9.2	4.6	5.4	21.2	6.1	12.5	14.3	42.7	12.4	30.7	13.7	9.3	5.4	10.1	17.3	10.1	15.6	4.5	8.7	7.0	30.1	16.3	8.6	3.0	33.6	21.3	4.6	9.2	6.9	10.4	21.3	16.9	8.0	44.3	8.8	5.3	7.0	6.1	9.1	3.1	19.6	11.6	9.8	11.3	13.9	6.9	11.3	12.9	12.0	10.4	18.2	12.6	27.1	13.6	12.2	15.3	32.2	14.7	12.9	5.8	24.0	16.8	14.9	13.7	15.3	4.9	5.7	4.2	6.7	5.1	7.0	5.3	4.3	6.2	6.7	20.8	28.1	41.2	17.9	14.3	6.6	4.1	10.2	22.7	26.1	22.7	11.8	31.6	11.6	37.2	0.4	30.6	61.6	23.3	42.8	115.3	23.2	36.2	23.1	16.3	41.3	6.4	22.4	22.1	24.0	1.1	12.4	30.6	27.0	43.3	113.0	6.2	34.6	38.6	5.3	20.4	6.7	6.5	21.7	9.3	5.2	16.2	52.5	27.4	43.3	33.3
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513463-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751, HPA074181"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: "	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	21.0	39.5	24.7	24.8	32.6	34.5	21.9	26.9	29.2	24.0	23.8	27.7	24.6	17.9	27.3	26.3	19.8	23.0	23.8	29.8	25.0	25.1	21.1	21.0	33.3	29.5	30.2	26.5	29.4	24.6	33.1	33.3	27.7	29.6	23.1	22.5	16.3	22.0	25.7	24.6	14.7	22.6	22.9	34.6	28.6	22.8	37.8	32.8	44.3	28.5	15.1	29.7	25.6	23.7	11.7	13.2	15.4	19.4	15.6	16.3	10.6	11.9	9.4	34.6	21.7	20.3	14.7	20.7	15.2	18.1	22.1	18.8	16.0	16.8	32.4	10.5	12.9	8.9	9.5	31.6	14.2	21.5	21.5	11.2	24.2	13.9	13.1	15.0	29.9	14.3	12.9	10.3	15.7	13.5	13.0	17.1	16.6	21.8	20.5	14.4	10.7	34.8	10.4	28.1	20.0	13.5	38.7	22.2	10.5	17.3	14.6	27.7	23.5	19.8	14.0	17.5	27.1	10.1	14.0	18.2	14.7	11.3	15.3	14.9	22.6	27.0	39.4	11.5	25.1	14.9	5.0	10.7	15.4	13.9	12.7	16.3	11.7	14.2	15.0	13.2	11.5	14.9	14.7	9.7	15.6	19.4	10.1	16.1	10.6	24.7	32.6	26.9	29.2	25.0	25.1	30.2	26.5	29.6	32.8	285.9	217.7	44.0	61.8	41.2	94.8	89.1	28.1	137.9	128.5	41.8	60.9	60.5	33.2	66.8	37.7	52.0	32.2	0.0	53.1	58.4	45.4	47.0	98.4	21.7	39.5	81.0	76.6	36.2	50.0	18.9	55.8	51.0	28.7	101.0	33.6	83.9	56.1	32.8	58.4	29.3	110.5	51.8	54.2	117.2	123.0	35.8	85.4	55.4	37.9	62.6
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	12.8	15.4	15.4	22.2	14.6	8.6	20.1	26.7	25.1	15.4	13.6	9.4	14.4	12.6	19.6	17.5	17.2	16.5	13.9	12.9	13.6	14.7	16.6	14.9	21.6	22.8	17.6	11.1	20.8	15.0	17.2	33.0	18.3	14.9	15.4	16.5	10.2	14.9	20.9	11.8	26.5	13.9	15.6	17.9	17.6	13.9	15.3	16.2	42.0	20.2	11.4	17.8	16.0	15.9	5.5	4.3	3.5	3.0	7.5	6.2	2.7	7.4	9.7	30.1	19.7	8.7	14.3	15.6	13.3	12.5	11.1	10.7	8.7	12.2	19.2	9.2	11.4	10.1	6.5	21.2	11.2	16.1	14.7	9.6	13.8	10.5	13.3	12.6	20.1	14.8	14.6	9.3	13.8	17.8	13.8	17.3	16.8	22.8	8.0	16.8	5.9	34.2	10.7	20.9	9.4	4.8	19.9	17.2	9.8	13.0	9.1	17.7	26.2	10.2	17.2	14.6	19.3	8.8	13.6	16.3	14.5	15.5	8.9	10.1	11.3	16.9	23.0	13.6	10.8	17.9	3.5	2.5	0.3	4.6	3.0	4.8	5.5	5.1	4.9	4.3	4.2	5.5	6.2	0.0	7.5	2.9	3.7	4.1	2.7	15.4	14.6	26.7	25.1	13.6	14.7	17.6	11.1	14.9	16.2	11.9	9.9	6.0	5.4	10.4	19.7	12.3	5.1	37.5	34.2	8.7	15.7	11.2	1.7	10.8	1.7	14.3	5.0	0.0	8.7	9.4	10.1	5.8	22.1	11.0	9.3	17.5	8.6	11.1	14.0	1.8	13.3	12.3	3.3	7.2	12.6	9.4	12.3	8.2	17.3	12.7	18.1	6.5	7.2	26.5	34.0	8.4	8.0	16.2	10.9	3.8
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378576	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 100.3;lymphoid tissue: 70.2"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 45.4;neutrophil: 24.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 45.4"	"Cell line enhanced"	"Detected in some"		"HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	24.4	8.1	6.7	35.7	15.2	100.3	9.0	1.5	6.6	3.6	5.2	8.6	0.0	7.6	3.2	6.2	4.0	8.5	7.7	15.7	5.6	5.1	5.8	11.9	37.2	51.1	12.6	1.6	6.1	3.5	0.9	3.6	10.1	9.6	4.5	3.9	3.9	6.4	2.6	3.3	5.0	10.5	7.6	12.1	70.2	5.8	5.4	10.5	9.6	3.7	2.7	16.8	9.1	5.7	1.0	4.6	45.4	9.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	33.6	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	56.7	0.0	0.0	0.0	10.3	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	17.9	0.0	25.0	0.0	3.6	5.4	45.4	0.0	7.8	0.0	1.0	0.0	0.0	4.6	0.8	0.0	0.0	24.8	0.0	9.1	0.2	0.0	1.5	6.7	15.2	1.5	6.6	5.6	5.1	12.6	1.6	9.6	10.5	3.0	0.6	71.3	0.5	9.3	1.5	2.0	7.6	1.4	1.2	5.2	0.0	1.9	16.6	0.0	5.9	2.2	0.3	0.0	0.3	2.5	5.9	0.4	34.5	1.3	391.4	0.0	4.1	11.1	374.7	20.0	1.7	436.5	10.1	317.4	0.1	4.0	0.0	0.0	0.0	1.3	1.0	12.9	2.1	5.5	2.5	8.7	3.5	2.5	0.4	0.4
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.3	12.7	12.0	13.7	6.9	8.9	12.3	14.0	12.4	17.2	20.8	9.6	8.1	31.3	10.8	8.7	14.7	12.7	17.8	8.0	28.0	11.0	17.3	21.7	10.8	6.9	8.2	34.1	22.3	6.2	9.1	17.1	13.2	10.4	10.5	15.0	20.9	43.6	14.7	5.0	40.5	19.8	6.8	10.1	7.8	24.2	30.8	25.4	10.1	14.0	15.4	12.0	22.5	7.3	13.5	8.7	21.1	28.5	7.7	13.7	12.5	16.3	21.5	23.8	29.6	38.8	10.0	21.1	12.3	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5	38.7	37.9	23.1	41.1	52.0	74.2	24.8	35.7	28.1	37.5	33.2	102.1	49.4	14.9	23.6	8.9	34.9	15.6	23.3	19.1	45.9	33.8	46.2	15.1	37.5	27.9	58.8	28.3	38.6	41.9	10.7	24.7	37.6	23.6	86.6	31.9	41.7	22.6	10.5	24.1	24.5	76.3	12.9	32.5	100.7	141.1	62.7	58.1	39.9	33.0	48.2
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	7.3	6.9	5.5	8.6	8.2	4.8	6.4	7.6	8.1	7.3	4.7	8.2	5.0	4.8	8.0	6.1	5.9	6.4	5.5	5.6	4.3	6.7	4.2	6.3	5.5	11.5	7.3	3.8	13.7	5.3	5.3	16.9	8.4	8.0	6.6	5.2	6.4	5.5	5.6	2.8	4.1	6.1	6.5	8.9	8.3	6.5	11.7	8.0	6.4	10.0	3.3	10.2	7.4	7.0	10.5	7.1	2.7	3.3	4.0	6.7	2.4	8.4	4.6	12.4	4.3	4.3	3.8	11.0	5.7	4.4	6.9	8.5	4.8	9.3	7.7	11.2	2.0	5.5	8.5	8.2	3.5	9.8	5.0	6.2	4.6	3.7	4.6	4.9	11.1	2.1	2.0	3.8	7.7	9.8	3.3	2.8	5.4	14.0	3.5	9.4	3.1	12.9	7.8	25.0	9.7	13.2	8.0	24.8	7.4	2.9	4.5	7.0	14.8	8.7	5.1	6.0	6.6	2.9	5.6	3.7	7.0	7.0	12.3	14.1	4.3	3.9	10.0	6.2	7.1	9.2	1.5	2.1	2.7	4.6	3.3	6.7	7.3	4.1	4.2	2.0	10.5	4.9	6.0	0.4	4.0	3.2	7.1	3.4	2.4	5.5	8.2	7.6	8.1	4.3	6.7	7.3	3.8	8.0	8.0	0.0	0.6	2.2	5.2	7.6	9.1	1.4	2.5	1.4	1.2	3.5	5.9	6.6	1.7	2.7	1.2	1.5	1.2	0.0	0.6	5.7	6.8	3.7	1.1	2.1	3.9	6.4	1.2	1.8	4.5	0.4	5.2	2.8	0.0	1.8	1.8	3.1	1.1	1.9	2.1	1.3	7.3	6.5	3.1	7.7	10.2	2.5	4.9	3.2	2.8	7.8
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.2	12.2	16.9	5.2	8.5	13.1	27.3	13.4	13.4	14.7	12.7	11.3	9.9	14.4	7.1	10.9	14.3	7.0	14.7	16.6	16.3	14.0	16.0	15.5	5.2	15.1	11.0	12.2	17.4	10.3	9.7	10.8	15.9	11.6	22.0	7.9	10.3	15.4	14.7	8.1	9.1	10.4	20.4	7.9	9.0	5.5	14.3	4.5	14.9	11.0	7.2	18.4	11.5	15.6	11.8	11.7	5.4	9.7	10.2	17.7	20.9	17.3	18.5	7.5	9.0	20.5	10.7	14.1	15.1	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2	17.9	19.5	12.3	24.6	14.3	21.2	3.7	2.5	40.2	38.7	12.2	25.5	22.4	11.6	17.0	4.7	12.8	1.6	0.0	16.3	29.6	12.8	9.4	8.1	4.9	11.3	14.3	1.7	8.6	12.9	1.5	17.5	12.3	0.0	14.4	2.9	23.3	13.4	3.5	12.4	19.9	20.2	19.4	13.4	35.8	32.4	11.5	19.8	13.1	4.0	20.2
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.0	11.6	19.0	16.7	18.5	22.8	18.9	21.8	17.8	17.3	12.3	16.4	14.3	15.5	20.4	14.9	16.7	16.9	19.5	15.5	16.2	9.1	15.8	9.7	13.1	19.8	18.2	13.0	30.4	19.1	13.0	16.9	12.4	15.5	17.5	6.3	17.2	22.7	17.8	13.6	21.3	14.2	12.1	12.0	25.1	14.9	13.0	17.0	12.7	15.2	10.3	15.6	14.3	16.3	3.1	4.0	1.0	3.4	3.5	4.7	2.2	5.9	6.6	3.7	13.2	3.3	3.4	19.2	7.2	2.9	5.9	2.1	7.1	4.6	6.7	9.7	2.7	3.4	11.8	2.3	2.9	1.4	5.8	9.9	3.8	9.9	4.9	2.4	4.0	12.2	5.2	3.8	5.0	1.9	2.4	11.6	11.0	9.2	2.3	3.0	13.2	6.3	13.4	15.2	2.2	6.8	16.0	3.2	5.3	2.5	5.3	19.2	9.3	14.6	4.1	24.2	2.6	16.2	4.2	4.5	11.0	9.4	10.8	6.5	11.1	8.5	13.9	5.6	4.9	7.0	0.0	3.2	1.0	4.1	3.4	4.7	2.3	1.6	2.6	4.0	3.1	1.9	3.4	0.2	3.5	1.4	1.5	2.3	2.2	19.0	18.5	21.8	17.8	16.2	9.1	18.2	13.0	15.5	17.0	17.9	18.6	9.0	6.3	5.8	9.1	2.5	2.5	5.3	7.9	3.5	19.6	7.5	5.0	4.4	0.4	13.9	7.4	0.0	6.1	5.3	6.5	3.3	5.8	10.9	5.8	1.6	6.9	29.4	11.3	1.8	10.9	5.4	6.8	5.4	7.5	9.4	4.5	3.5	8.5	3.8	9.7	6.5	4.4	8.8	10.9	4.5	6.2	6.4	7.6	2.6
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.9	3.1	4.2	4.2	4.1	16.2	7.6	4.4	3.3	5.7	4.1	10.6	10.7	9.5	8.5	4.3	1.9	11.7	4.9	6.9	6.3	2.6	2.0	9.7	17.5	6.3	4.1	8.8	5.2	4.5	7.5	4.5	7.4	9.0	7.1	5.0	6.6	18.8	7.8	1.2	7.4	17.0	3.2	2.9	2.4	3.5	4.7	8.1	6.5	6.3	3.0	6.3	2.6	9.6	3.0	6.1	11.9	2.2	6.9	8.6	5.7	12.9	6.5	8.4	9.5	8.0	3.1	9.4	2.9	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6	83.4	80.4	125.3	241.5	216.9	84.2	23.0	129.9	91.0	139.9	27.9	37.3	149.3	38.1	80.3	12.9	79.2	61.0	0.0	125.2	151.7	105.8	205.9	100.6	46.5	62.1	65.2	105.6	52.2	91.2	12.3	119.0	105.3	75.9	66.7	101.9	39.6	109.2	66.6	63.6	64.8	75.6	71.1	94.7	37.0	70.9	177.4	134.6	106.5	115.9	265.8
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	11.9	12.3	10.2	14.9	15.8	18.4	13.1	18.1	19.3	13.9	12.7	17.5	15.2	11.4	16.1	12.1	13.3	14.0	11.7	11.5	10.3	10.5	12.3	12.4	11.8	16.8	11.5	13.8	17.3	14.0	10.1	13.2	20.0	18.0	13.1	12.1	14.4	13.7	15.5	14.5	14.5	14.7	13.9	11.7	17.7	13.2	51.4	9.9	15.7	13.7	11.7	15.9	13.1	13.1	32.0	26.3	30.8	25.6	19.6	31.9	12.4	7.4	8.4	14.8	18.5	7.9	8.8	13.8	12.3	9.0	11.8	12.3	16.6	7.5	15.5	9.7	9.6	16.7	11.2	18.9	9.9	13.2	17.9	13.0	16.2	9.6	14.4	10.7	18.3	14.0	8.8	11.3	13.9	15.7	9.4	9.0	21.1	27.7	9.8	10.5	11.8	18.8	18.5	15.1	14.7	6.4	16.5	12.0	13.6	8.9	4.0	6.1	14.3	14.3	10.7	9.5	12.8	7.6	23.5	10.4	8.3	11.9	13.6	18.4	14.7	19.7	25.0	11.3	15.8	13.2	30.8	19.9	23.5	25.0	19.4	28.9	30.9	24.3	25.1	18.5	32.0	31.9	26.6	28.6	19.6	25.6	26.3	22.0	12.4	10.2	15.8	18.1	19.3	10.3	10.5	11.5	13.8	18.0	9.9	8.9	8.6	8.3	4.8	4.8	7.5	8.3	15.3	4.0	9.1	12.2	7.9	13.8	3.3	6.2	14.2	8.7	6.2	0.0	4.0	10.9	7.2	7.0	1.1	7.3	9.0	0.0	6.9	13.5	15.6	3.2	10.0	5.1	1.7	4.6	7.4	6.6	5.4	8.4	9.9	5.8	6.4	12.9	5.7	53.3	16.6	5.8	11.3	6.4	7.5	5.3
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965804-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	12.3	16.6	7.0	17.9	11.1	15.9	12.8	10.7	13.4	17.7	14.7	10.0	11.3	11.0	15.8	17.8	23.8	12.4	12.8	12.0	7.7	6.9	13.4	17.4	13.7	19.7	8.7	7.9	14.4	13.2	11.0	21.0	27.9	10.8	13.0	16.8	10.9	13.2	11.3	11.1	16.3	18.7	17.8	8.8	19.8	13.1	5.8	8.1	33.4	12.4	15.3	19.6	13.3	14.7	18.9	41.4	18.8	24.3	14.2	13.6	7.2	13.3	6.8	21.5	12.5	5.3	4.8	21.7	10.1	4.2	14.2	8.0	11.6	6.1	31.6	6.2	8.4	2.3	9.0	25.6	11.9	11.2	12.9	20.7	24.8	10.3	5.2	5.0	30.7	18.8	5.6	15.9	10.5	8.5	8.7	13.9	18.7	27.7	5.3	6.8	14.0	34.3	17.3	26.0	9.9	10.9	35.4	11.1	11.2	15.5	19.8	28.3	19.6	12.3	14.5	9.0	13.2	23.2	16.6	8.4	4.4	7.3	4.7	12.0	11.6	15.3	27.1	4.9	16.6	8.5	18.5	24.3	18.8	13.6	16.3	10.3	17.7	13.0	11.2	14.9	18.9	13.5	12.1	16.0	14.2	15.9	41.4	12.6	7.2	7.0	11.1	10.7	13.4	7.7	6.9	8.7	7.9	10.8	8.1	35.7	18.4	41.0	33.6	70.2	45.5	23.0	35.7	40.2	40.9	31.4	25.5	58.2	31.5	66.4	3.9	43.9	26.9	23.3	46.9	70.7	38.1	38.3	38.3	30.1	39.3	33.4	78.4	36.2	38.6	2.1	25.3	39.1	15.1	39.7	39.8	23.0	64.5	34.5	28.3	18.0	37.1	45.3	30.7	9.9	25.0	89.8	131.0	39.9	38.9	48.0
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560656-68694482	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 59.1;Horizontal cells: 33.4;Leydig cells: 23.9"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.3;HAP1: 17.4;K-562: 9.7;NTERA-2: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	4.4	1.6	3.3	4.3	2.6	1.6	3.1	4.4	4.3	5.1	2.4	5.8	3.2	1.2	6.0	3.4	2.4	2.9	3.5	2.4	3.5	2.3	1.8	1.5	1.6	1.7	2.5	2.6	6.1	1.6	7.4	2.2	5.8	2.9	3.2	2.0	8.1	15.9	4.8	4.0	2.2	1.8	6.5	3.6	1.7	2.2	1.4	5.9	1.2	3.2	3.2	1.8	5.1	5.4	1.3	1.1	1.0	0.0	0.9	2.3	0.2	0.6	0.7	6.9	7.8	0.7	0.6	15.3	0.4	0.8	0.6	1.1	4.6	0.2	0.0	0.2	0.7	0.1	0.0	17.4	0.0	0.7	0.2	2.8	1.8	0.0	4.1	1.0	1.6	0.9	0.9	0.1	0.4	0.0	1.4	0.1	2.9	9.7	1.2	0.6	0.5	2.7	1.2	10.2	0.0	0.9	2.7	2.2	0.2	0.3	0.7	1.9	3.1	0.3	0.4	1.4	7.2	0.9	1.2	0.2	0.6	1.4	0.0	0.5	0.5	0.5	2.7	0.1	0.0	0.1	0.0	0.0	1.0	1.5	0.0	2.0	1.3	0.8	1.3	0.2	0.5	1.4	1.1	0.0	0.9	0.0	1.1	2.3	0.2	3.3	2.6	4.4	2.6	3.5	2.3	2.5	2.6	2.9	5.9	3.0	3.8	0.0	1.9	1.0	2.2	4.5	2.5	1.4	4.5	0.0	9.8	16.6	0.0	1.4	0.4	3.3	0.0	0.0	0.3	59.1	11.8	2.1	0.0	2.1	3.3	33.4	13.2	7.4	0.0	0.6	23.9	0.1	1.7	0.0	0.0	17.3	0.9	0.0	19.4	0.8	10.8	6.5	3.8	0.5	0.7	1.0	23.3	1.7	0.4	0.3
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629302-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 53.9;skin 1: 32.5"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1"	"Region enriched"	"Detected in single"	13	"olfactory region: 2.9"	"Low region specificity"	"Detected in many"			"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.1	0.3	0.7	0.2	0.4	0.0	16.1	0.4	0.9	17.3	2.4	0.2	7.7	0.0	3.7	3.4	19.6	1.6	2.0	0.4	1.4	0.2	0.7	0.1	2.8	0.0	0.2	0.5	0.3	1.6	0.0	0.6	53.9	0.4	5.7	0.7	1.9	19.7	7.9	1.0	32.5	0.3	0.6	0.4	0.1	0.3	0.7	0.2	0.3	4.2	21.0	10.1	2.1	11.1	0.1	0.2	0.8	0.1	0.2	0.2	0.0	2.9	3.7	0.0	0.0	0.0	0.0	45.8	4.7	8.6	6.0	1.1	0.7	0.0	0.0	0.3	3.1	3.2	10.0	6.4	1.3	4.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	5.1	1.7	1.7	0.0	0.0	1.9	0.0	0.7	0.0	38.8	4.7	0.2	2.2	2.3	4.9	0.0	0.0	1.6	0.0	2.3	1.2	0.0	3.1	73.8	4.8	7.1	20.6	1.0	0.0	3.9	0.1	2.0	3.5	0.0	0.0	0.0	0.9	0.0	27.1	0.4	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.1	0.0	0.7	0.4	0.4	0.9	1.4	0.2	0.2	0.5	0.4	0.2	0.0	7.4	0.0	26.2	117.7	0.4	0.9	0.0	5.3	4.5	8.7	0.0	77.5	0.0	0.2	0.2	1.0	0.0	0.0	0.0	49.1	11.3	18.8	0.0	0.0	6.8	0.0	2.9	1.3	0.3	0.0	0.0	0.9	20.3	0.0	1.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.5	130.6	88.3	0.0	1.7	12.8
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	1.0	6.1	0.8	1.7	0.7	4.6	1.1	1.4	1.7	1.7	1.4	7.7	8.0	1.3	3.0	7.4	1.1	2.7	0.1	3.0	13.1	11.0	0.5	2.3	1.3	4.6	1.7	1.3	1.7	1.2	0.5	0.1	1.2	8.0	10.6	3.3	0.4	1.3	6.4	2.4	0.0	2.1	7.4	9.1	7.0	14.3	1.1	1.1	3.3	13.1	5.6	3.4	7.4	0.3	3.3	3.6	4.0	3.5	7.1	6.3	2.7	12.2	14.6	12.2	1.8	11.7	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2	14.9	21.9	30.9	26.1	25.2	11.0	14.9	30.6	24.1	19.4	27.9	15.7	41.3	18.3	35.7	9.4	29.1	15.7	23.3	37.7	49.1	24.4	31.4	20.8	36.5	36.4	7.9	26.5	25.2	23.8	4.4	22.2	24.5	8.5	25.2	24.4	9.8	42.8	19.5	17.3	24.1	13.1	19.4	21.1	5.1	11.2	17.1	38.1	26.2	24.4	24.0
TWISTNB		ENSG00000105849	"TWIST neighbor"	Q3B726	7	19695462-19709087	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	16.4	13.9	11.5	13.6	17.6	21.5	15.8	13.2	20.8	16.1	14.0	9.9	12.3	8.5	20.4	9.4	14.8	14.3	9.7	14.6	13.5	12.5	13.3	15.9	9.9	16.6	13.1	11.7	17.5	12.6	15.4	12.0	16.4	13.5	15.3	11.0	6.4	11.4	14.5	25.5	13.8	11.4	22.7	13.4	17.7	12.4	10.8	11.3	20.8	13.6	14.1	18.8	20.2	14.4	10.8	7.7	3.5	5.0	14.6	11.6	5.0	11.7	9.0	6.6	9.9	7.8	9.6	5.2	6.8	5.1	8.0	9.3	7.3	10.4	13.2	19.9	8.4	10.1	10.7	13.5	12.7	14.9	4.1	10.4	12.2	7.2	5.6	11.9	24.9	8.9	8.7	9.0	8.7	10.5	5.4	13.0	9.3	18.8	11.9	11.4	4.3	13.7	23.3	17.3	12.3	10.2	11.2	11.5	13.9	13.1	6.1	4.8	7.3	6.2	16.9	8.4	11.4	6.8	22.4	10.8	16.6	8.9	15.3	16.4	15.3	9.4	33.6	11.2	37.5	24.2	3.5	3.9	1.1	7.2	5.0	10.8	10.8	8.6	9.5	6.0	10.4	10.0	11.6	0.3	14.6	4.7	7.7	7.8	5.0	11.5	17.6	13.2	20.8	13.5	12.5	13.1	11.7	13.5	11.3	14.9	23.5	21.4	59.8	110.2	25.7	20.1	10.2	24.1	37.5	8.7	11.8	32.6	36.5	21.9	4.1	30.8	6.3	23.3	23.7	26.9	40.3	29.1	118.6	27.1	30.4	31.8	23.4	29.4	15.2	2.5	29.7	41.4	59.1	25.2	16.5	19.0	19.5	14.0	32.9	24.5	12.1	19.4	57.7	25.0	44.7	125.0	13.8	37.3	21.5	43.6
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 63.9;REH: 145.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.9	11.6	17.5	12.4	0.5	2.0	2.8	13.0	6.2	13.6	13.2	13.8	8.1	9.1	3.2	5.7	4.9	8.0	12.0	7.0	9.6	14.7	13.7	7.8	10.8	14.7	0.2	19.3	11.9	1.0	0.5	7.3	1.9	2.1	4.0	14.4	11.2	10.5	8.1	12.5	63.9	11.8	7.8	5.8	12.5	145.0	39.1	6.6	3.7	11.7	13.0	10.3	10.2	5.6	1.8	2.9	10.1	18.4	5.0	14.4	11.7	18.6	15.7	4.5	4.6	26.8	8.3	18.8	18.3	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9											0.0	0.0	1.5	0.6	0.0	2.6	1.6	2.5	1.4	1.2	0.0	0.0	1.7	0.0	1.7	2.5	0.0	0.9	0.0	0.3	5.8	0.5	0.5	0.0	0.6	7.5	3.2	0.0	0.0	2.1	0.9	0.6	0.7	0.0	2.8	1.5	0.5	2.6	1.9	0.4	0.0	0.8	0.0	1.5	4.2	6.9	0.0	1.1	0.0	4.7	0.7
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Approved	Nucleoplasm,Cytosol		No	No		870000	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	37.4	50.4	59.5	22.8	79.8	29.9	22.6	62.5	119.3	24.3	20.4	75.2	15.0	27.0	22.9	19.7	25.7	36.6	26.4	51.6	58.7	56.4	32.0	48.7	31.9	22.3	62.1	56.2	41.8	35.7	36.8	24.5	23.0	110.8	32.2	17.2	40.3	55.5	33.6	47.1	28.2	25.9	23.0	55.6	30.5	27.4	28.5	44.3	10.6	26.8	15.7	21.5	24.5	18.3	14.9	11.1	63.5	25.5	11.2	15.1	16.8	25.5	29.8	11.2	13.3	23.1	23.1	14.8	8.3	26.2	19.2	23.9	14.8	26.2	13.3	21.3	11.8	61.1	15.4	11.7	25.1	17.7	9.8	22.6	24.5	18.1	24.0	47.7	10.1	41.9	25.6	24.0	22.7	31.9	33.9	37.2	20.6	16.4	40.3	15.4	26.1	20.8	20.8	9.5	18.1	19.8	14.3	22.5	24.7	27.9	15.9	18.9	29.5	14.5	25.3	40.4	21.4	34.1	25.3	21.3	19.6	17.3	19.0	13.1	37.3	26.7	9.9	55.0	9.4	13.9	42.8	16.7	56.0	11.6	20.5	12.9	14.9	13.0	11.7	11.1	12.0	12.6	10.3	63.5	11.2	25.5	8.6	15.1	16.8	59.5	79.8	62.5	119.3	58.7	56.4	62.1	56.2	110.8	44.3	77.4	66.5	53.1	106.6	54.1	107.3	69.8	50.9	25.4	33.0	50.6	70.7	59.5	137.6	109.6	243.3	60.2	61.9	23.3	166.3	55.9	37.9	110.3	63.7	57.0	115.5	106.5	32.2	41.7	53.9	234.4	55.0	64.6	57.3	124.4	36.0	83.7	108.2	69.1	50.5	60.3	104.3	25.8	37.3	33.5	25.6	69.9	154.5	55.4	22.9	81.3
ZNF335	"bA465L10.2, NIF-1"	ENSG00000198026	"Zinc finger protein 335"	Q9H4Z2	20	45948653-45972172	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063999, HPA071230"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063999: AB_2685170, HPA071230: AB_2686369"	"unprognostic (1.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (4.48e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (7.04e-4)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.88e-3)"	10.5	8.3	12.0	12.2	13.6	28.8	10.7	17.9	15.7	10.5	10.3	9.7	4.0	11.5	14.2	5.2	11.2	12.3	8.2	7.0	10.7	5.0	8.6	7.8	10.4	15.0	8.1	11.6	15.2	10.5	13.2	10.4	13.7	8.2	10.7	6.7	8.4	12.0	9.2	12.3	22.9	13.5	7.9	7.6	13.9	10.6	16.5	10.1	19.4	14.9	8.8	12.0	11.4	9.5	3.7	3.6	5.0	4.5	8.9	7.3	3.5	9.1	9.3	8.3	9.0	4.4	5.6	17.7	8.2	5.7	8.2	5.9	20.1	10.3	11.0	12.2	8.0	7.5	13.2	8.0	12.3	3.7	7.5	10.9	9.1	13.6	10.6	6.9	11.8	15.6	9.0	10.5	10.7	7.7	5.9	7.0	11.6	8.6	14.8	5.6	18.6	13.9	11.5	5.7	6.2	15.4	11.5	5.5	9.2	7.2	14.4	8.4	7.4	12.2	17.2	8.6	5.2	13.0	9.8	7.3	17.7	7.7	11.2	11.1	17.3	8.8	11.4	14.3	7.4	9.7	2.4	3.5	5.0	7.3	4.5	3.7	3.3	3.6	4.9	3.6	3.7	3.1	3.4	3.6	8.9	3.6	2.5	3.6	3.5	12.0	13.6	17.9	15.7	10.7	5.0	8.1	11.6	8.2	10.1	11.9	15.9	11.8	11.4	16.7	17.4	2.8	2.5	1.4	4.5	1.8	25.5	7.2	0.0	3.9	22.2	8.3	13.7	0.0	5.1	7.0	7.8	9.9	6.9	5.7	5.3	12.7	20.6	7.4	6.4	17.7	6.9	10.2	8.5	2.8	9.2	5.8	6.6	10.5	4.9	1.9	11.1	0.0	8.6	3.7	8.3	19.6	10.0	16.2	9.1	11.4
ZNRD1	"HTEX-6, hZR14, RPA12, tctex-6"	ENSG00000066379	"Zinc ribbon domain containing 1"	Q9P1U0	6	30058899-30064909	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	11.7	13.5	6.7	14.1	7.2	8.7	17.1	7.4	8.9	12.3	15.3	6.8	9.1	13.2	12.5	10.2	15.4	13.0	10.4	11.0	6.4	6.3	13.4	12.2	14.8	18.8	8.3	6.1	13.6	22.0	10.2	9.4	11.4	6.2	12.5	14.5	9.7	14.7	10.2	13.5	11.2	14.2	9.1	6.3	17.5	12.7	22.9	6.8	37.0	15.0	15.3	18.9	12.2	15.0	8.2	8.4	6.4	5.9	8.1	13.0	7.9	4.1	0.9	4.6	6.5	2.2	2.7	1.7	1.6	2.4	2.9	2.6	4.6	2.9	3.3	1.4	2.6	4.9	3.5	7.6	6.2	3.1	2.3	7.7	7.8	2.1	6.8	9.3	8.2	3.6	5.4	3.6	4.6	15.8	1.7	8.0	16.8	13.1	2.1	1.9	5.5	7.1	17.8	0.0	9.2	5.4	8.7	4.3	6.4	2.5	6.9	1.6	3.1	2.8	4.4	2.6	2.2	3.3	6.8	1.7	3.4	3.0	0.0	5.1	5.2	9.8	10.6	1.2	13.3	4.5	6.2	5.9	5.7	12.5	5.6	13.0	7.3	10.8	11.5	5.6	8.2	9.8	10.2	6.4	8.1	5.2	8.4	10.9	7.9	6.7	7.2	7.4	8.9	6.4	6.3	8.3	6.1	6.2	6.8	20.8	16.8	48.4	63.0	69.8	13.3	13.3	20.4	16.0	22.7	21.0	2.0	21.3	43.1	28.3	106.8	37.6	47.7	0.0	39.7	37.2	41.2	27.6	31.1	25.8	31.4	11.1	42.2	28.8	38.9	11.9	36.8	27.6	28.7	33.3	41.2	14.0	40.2	59.6	23.0	47.3	13.3	19.4	39.1	52.1	5.9	60.3	14.8	62.3	48.4	68.8
WIF1		ENSG00000156076	"WNT inhibitory factor 1"	Q9Y5W5	12	65050626-65121566	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;lung: 67.7;retina: 29.6"	"Cell type enriched"	"Detected in many"	15	"Muller glia cells: 2337.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 16.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.4;LHCN-M2: 2.5;NTERA-2: 7.0;SCLC-21H: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (5.96e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.29e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.30e-5)"	"unprognostic (3.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.24e-3)"	0.9	2.4	23.3	0.8	35.2	0.6	14.2	1.6	20.6	1.6	0.8	1.0	1.9	0.6	5.5	14.5	3.4	1.5	0.6	0.7	10.4	3.9	1.0	0.6	67.7	0.7	1.4	8.2	0.8	0.8	0.6	21.4	0.6	0.4	9.5	0.8	29.6	24.8	2.3	0.6	4.2	1.8	1.2	0.7	0.7	0.9	1.0	3.5	0.0	0.6	3.6	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.5	0.1	0.0	0.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	35.2	1.6	20.6	10.4	3.9	1.4	8.2	0.4	3.5	32.8	159.2	0.0	31.4	11.2	20.4	1.1	0.0	62.9	48.9	1.8	7.9	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	1.9	16.0	7.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	3.1	21.9	0.0	0.0	2337.6	0.0	0.0	0.4	0.8	66.4	0.0	3.6	0.5	0.2	9.3	0.0	0.0	0.0	0.5
